Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3026989	p-t3-v	pmol/l (pmol/l)	17579	62682	0.05%
3026989	s-t3-v	pmol/l (pmol/l)	7242	15586	0.00%
3026989	p-t3-v	— (—)	4327	8714	100.00%	Distribution not available
3026989	s-t3-v	— (—)	1000	1739	100.00%	Distribution not available
3026989	trijodityroniini,vapaa(t3v)	pmol/l (pmol/l)	255	392	0.00%
3026989	p-trijodityroniini,vapaa	pmol/l (pmol/l)	132	199	0.00%
3026989	trijodityroniini,vapaa	pmol/l (pmol/l)	85	107	0.00%
3026989	p-trijodityroniini,vapaa,plasmasta	pmol/l (pmol/l)	80	107	0.00%
3026989	trijodityroniini,vapaa(t3v)	— (—)	7	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other heart diseases, wide

4934

16578

1.90

322.83

3.4

3.3

4.45

4.58

pmol/l

13.58

4466

14816

Nontoxic single thyroid nodule

502

780

7.54

317.76

4.0

1.6

4.57

4.43

pmol/l

2.41

455

685

Other antidepressants

5156

14617

1.87

314.28

2.9

3.6

4.45

4.55

pmol/l

9.33

4504

13236

Anxiety disorders

4975

19444

1.86

314.12

3.0

3.4

4.49

4.54

pmol/l

2.35

4310

17549

Neurotic, stress-related and somatoform disorders

4943

19375

1.86

313.56

3.0

3.4

4.49

4.54

pmol/l

2.56

4283

17486

Other arrhythmias

3449

13025

2.10

312.07

3.4

3.3

4.38

4.54

pmol/l

15.86

3104

11611

Recurrent or chronic depression

2376

7173

2.47

309.94

3.0

3.8

4.46

4.58

pmol/l

5.06

2092

6608

Anxiety disorders, excluding more controls

4592

15643

2.00

307.65

3.0

3.6

4.48

4.55

pmol/l

3.92

3975

14217

Graves ophthalmopathy

478

570

16.03

307.65

7.9

3.3

4.63

4.53

pmol/l

0.67

453

498

Atrial fibrillation and flutter

1842

4162

3.08

307.65

3.7

3.4

4.38

4.54

pmol/l

7.70

1710

3703

Anaemias

1404

1627

6.14

307.65

3.5

2.9

4.36

4.80

pmol/l

26.42

1251

1495

Hypothyroidism, other/unspecified

10759

8846

9.71

307.65

4.2

1.6

4.43

4.49

pmol/l

5.54

9687

7779

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

7278

7386

16.70

307.65

5.8

2.4

4.67

4.42

pmol/l

36.39

6792

6461

Exclusions for E4_PCOS_BROAD

1403

4058

3.98

307.65

3.3

4.37

4.55

pmol/l

7.95

1284

3632

Thyrotoxicosis with toxic multinodular goitre

1247

1007

25.13

307.65

5.3

2.4

4.86

4.30

pmol/l

36.95

1161

857

Hypothyroidism, strict autoimmune, 3 medication purchases required

7344

11922

4.69

307.65

3.0

2.6

4.30

4.59

pmol/l

81.94

6433

10645

Endocrine, nutritional and metabolic diseases

6197

5391

6.41

307.65

3.9

1.5

4.60

pmol/l

0.04

5620

4763

Nontoxic goitre/thyroid nodule

2528

7674

3.81

307.65

3.7

3.2

4.54

4.40

pmol/l

8.54

2278

6721

Atrial fibrillation and flutter with reimbursement

1548

2914

3.68

307.65

3.7

3.4

4.37

4.54

pmol/l

5.46

1441

2572

Used for control exclusion in common control thyroid runs

8552

7856

6.10

307.65

4.1

1.6

4.57

4.55

pmol/l

0.94

7740

6917

Thyrotoxicosis

6376

5598

22.95

307.65

6.4

2.4

4.80

4.35

pmol/l

87.54

5942

4902

Thyroiditis

794

1444

7.15

307.65

4.4

2.3

4.62

4.40

pmol/l

4.10

720

1257

Metabolic disorders

5679

15445

2.38

307.65

4.4

3.1

4.47

4.51

pmol/l

1.76

5111

13768

Mood disorders

5711

20036

1.92

307.65

2.9

3.5

4.45

4.54

pmol/l

6.99

4946

18078

Mood disorders, excluding more controls

5228

16187

2.02

307.65

2.9

3.6

4.44

4.54

pmol/l

8.10

4535

14699

Thyroiditis, ILD-related definition

1564

3034

6.94

307.65

4.2

3.2

4.47

4.52

pmol/l

0.70

1416

2717

Autoimmune thyroiditis

281

201

21.87

307.65

4.8

1.3

4.70

4.52

pmol/l

0.88

257

176

Disorders of thyroid, IBD co-morbidities

5479

2174

33.81

307.65

6.4

2.7

4.83

4.50

pmol/l

29.35

5141

1939

Malignant neoplasm of endocrine gland

1694

1559

24.57

307.65

7.3

3.0

4.50

4.51

pmol/l

0.12

1645

1370

Hypothyroidism, strict autoimmune

6843

8013

6.41

307.65

3.0

2.1

4.32

4.56

pmol/l

46.95

6021

7085

Other and/or unspecified nontoxic goitre

643

857

9.03

307.65

3.4

1.6

4.55

4.43

pmol/l

2.08

587

747

Disorders of orbit

569

944

8.41

307.65

7.1

3.3

4.58

4.51

pmol/l

0.44

540

840

Other metabolic disorders

2443

3295

11.59

307.65

6.8

3.0

4.58

4.50

pmol/l

1.96

2297

2945

Graves disease, strict definition

2863

2598

29.42

307.65

8.3

2.7

4.88

4.45

pmol/l

30.43

2715

2300

Hypothyroidism and >3 levothyroxin purchases

4304

1732

18.29

307.65

4.6

2.9

4.58

4.80

pmol/l

10.57

3920

1590

Thyrotoxicosis with diffuse goitre

3538

1819

41.19

307.65

7.6

1.5

4.81

4.45

pmol/l

25.38

3328

1602

Depression

5378

19587

1.94

307.65

3.0

3.5

4.47

4.55

pmol/l

5.97

4674

17690

Cardiodefibrillation

1885

6083

3.37

307.65

3.9

3.2

4.21

4.41

pmol/l

14.44

1742

5292

Malignant neoplasm of thyroid gland, including Hilmo

1804

1682

24.20

307.65

7.1

3.0

4.51

4.50

pmol/l

0.19

1755

1481

Malignant neoplasm of thyroid gland

1668

1459

28.10

307.65

7.3

3.0

4.50

pmol/l

0.03

1621

1283

Autoimmune diseases

7047

13662

2.79

307.65

3.6

3.2

4.46

4.62

pmol/l

22.90

6270

12314

Malaise and fatigue

2824

10150

2.37

307.65

3.1

3.4

4.34

4.52

pmol/l

16.63

2474

9035

Disorders of other endocrine glands

3001

11845

2.71

307.65

3.4

3.3

4.42

4.52

pmol/l

4.90

2672

10520

Heart failure and antihypertensive medication

1333

2570

3.66

307.65

3.6

3.0

4.19

4.50

pmol/l

16.79

1231

2254

Hypothyreosis and Thyroxine purchase for inclusion criteria

11083

12367

7.07

307.65

4.2

2.6

4.43

4.59

pmol/l

29.67

9975

11045

Mood [affective] disorders

5704

20023

1.93

307.65

2.9

3.5

4.45

4.54

pmol/l

6.97

4938

18066

Thyrotoxicosis, other and/or unspecified

5543

2571

49.42

307.65

6.8

1.6

4.82

4.45

pmol/l

42.96

5183

2238

Hypothyroidism, drug reimbursement

2688

1094

24.96

307.65

5.9

2.9

4.54

4.74

pmol/l

5.31

2525

1012

Hypothyroidism, levothyroxine purchases

4304

1732

18.29

307.65

4.6

2.9

4.58

4.80

pmol/l

10.57

3920

1590

Papillary adenocarcinoma of thyroid gland

1233

1127

26.48

307.65

7.4

3.1

4.50

4.51

pmol/l

0.11

1193

987

Hypopituitarism

685

1186

7.20

307.65

3.3

4.34

4.65

pmol/l

9.01

633

1071

Disorders of the thyroid gland

12753

9260

11.17

307.65

4.5

1.6

4.55

4.50

pmol/l

3.28

11562

8137

Abnormalities of breathing

4823

14976

1.95

307.65

3.3

3.4

4.46

4.57

pmol/l

8.48

4312

13471

Nontoxic multinodular goitre

1706

2307

8.92

307.65

3.5

1.6

4.50

4.39

pmol/l

3.39

1529

1992

Disorders of lacrimal system and orbit in diseases classified elsewhere

480

538

16.88

307.65

7.9

3.3

4.62

4.54

pmol/l

0.53

455

477

Graves ophthalmopathy, strict

449

500

18.24

307.65

8.0

3.2

4.60

4.54

pmol/l

0.36

426

433

Autoimmune hyperthyroidism

1450

1069

28.00

307.65

7.9

2.7

4.78

4.53

pmol/l

5.49

1368

965

Depression medications

1685

1797

5.03

307.65

3.2

2.9

4.55

4.82

pmol/l

12.92

1504

1652

Amiodarone users

1588

1335

19.19

307.65

4.4

3.1

4.01

4.48

pmol/l

28.49

1508

1142

Hypothyroidism (congenital or acquired)

4335

1742

18.30

307.65

4.6

2.9

4.59

4.80

pmol/l

9.95

3949

1599

Carbimazole or st.post thyroidectomy, condition for graves disease

5618

4914

25.70

307.65

7.3

2.3

4.77

4.41

pmol/l

53.62

5315

4309

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2402

3069

12.81

307.65

6.9

3.0

4.58

4.50

pmol/l

2.10

2262

2740

Cardiac arrhythmias

3683

11358

2.23

307.65

3.5

4.46

4.60

pmol/l

11.62

3353

10176

Abnormalities of heart beat

2065

8508

2.54

304.73

3.4

4.46

4.50

pmol/l

0.64

1801

7573

General symptoms and signs

5551

15933

1.81

300.39

3.2

3.4

4.46

4.58

pmol/l

10.76

4924

14305

Anxiety (asthma-related co-morbidities)

3546

14144

2.04

297.59

3.0

3.5

4.53

4.59

pmol/l

2.34

3089

12893

Follicular adenocarcinoma of thyroid gland, including Hilmo

246

180

35.92

294.78

8.6

3.5

4.62

4.53

pmol/l

0.47

241

156

Headache

3642

15206

2.00

293.96

3.0

3.4

4.47

4.58

pmol/l

7.62

3251

13649

Antihypertensive medication - note that there are other indications

3510

9305

2.09

291.87

3.8

3.1

4.65

4.62

pmol/l

0.77

3177

8337

Other heart diseases

2760

8424

2.26

289.73

3.5

3.4

4.45

4.61

pmol/l

11.30

2525

7577

Any reimbursement code in KELA

3220

7865

2.14

281.19

3.6

3.1

4.57

4.67

pmol/l

4.77

2936

7036

Paroxysmal tachycardia

1395

4180

3.02

275.99

3.9

3.4

4.27

4.58

pmol/l

21.74

1279

3727

All anxiety disorders

3615

15276

1.96

273.53

3.0

3.5

4.53

4.58

pmol/l

1.73

3154

13848

Cardiomyopathy

893

2531

3.84

271.04

3.9

3.2

4.19

4.52

pmol/l

14.08

828

2229

Symptoms and signs involving the circulatory and respiratory systems

5172

15011

1.78

269.36

3.3

3.4

4.52

4.57

pmol/l

1.62

4577

13502

Vocal cord dysfunction

936

2440

3.79

267.61

4.6

3.6

4.53

4.61

pmol/l

1.01

848

2209

Depression or dysthymia

3295

9234

2.05

264.37

3.0

3.7

4.47

4.54

pmol/l

3.11

2877

8445

Cardiomyopathies, Primary/intrinsic

661

1545

4.73

263.16

4.1

3.3

4.18

4.52

pmol/l

10.77

613

1368

Heart failure, not strict

3409

12144

1.99

263.05

3.4

3.3

4.21

4.51

pmol/l

46.98

3069

10722

Heart failure,strict

2279

7279

2.32

262.09

3.5

3.3

4.15

4.49

pmol/l

36.05

2063

6376

Pain in throat and chest

4234

14251

1.85

257.64

3.2

3.4

4.48

4.56

pmol/l

3.87

3770

12796

Autoimmune diseases related-to ILD

4355

21598

1.79

254.10

3.5

3.3

4.47

4.52

pmol/l

1.67

3883

19304

Sleep disorders (combined)

5628

17906

1.70

251.84

3.1

3.4

4.50

4.52

pmol/l

0.64

4967

16044

Medical observation and evaluation for suspected diseases and conditions

3264

8577

2.02

247.86

3.4

3.5

4.49

4.55

pmol/l

1.98

2864

7746

Pain in joint

2991

9710

2.05

247.52

3.2

3.5

4.52

4.57

pmol/l

1.71

2632

8758

Benzodiazepine use

5075

21081

1.71

245.44

3.0

3.4

4.38

4.53

pmol/l

18.12

4332

19026

Cardiomyopathy (excluding other)

670

1672

4.41

244.59

4.1

3.3

4.18

4.53

pmol/l

11.98

622

1470

Other soft tissue disorders, not elsewhere classified

4747

16365

1.76

243.96

3.1

3.5

4.45

4.56

pmol/l

8.38

4178

14689

Adjustment and management of implanted device

958

3045

3.42

243.19

3.8

3.1

4.14

4.39

pmol/l

10.00

891

2614

Hypothyroidism due to medicaments and other exogenous substances

185

107

30.11

241.27

6.1

1.5

4.36

4.49

pmol/l

0.42

170

Episodal and paroxysmal disorders

5501

17043

1.69

240.07

3.1

3.4

4.49

4.55

pmol/l

3.76

4875

15277

Neurological diseases, wide definition

1532

2865

2.81

238.17

3.1

2.6

4.57

4.58

pmol/l

0.21

1379

2562

Dyspnoea

4434

19358

1.75

235.39

3.3

4.37

4.51

pmol/l

16.75

3949

17260

Selective serotonin reuptake inhibitors

4755

14676

1.74

232.33

2.9

3.6

4.45

4.56

pmol/l

8.80

4141

13293

Heart failure, strict

2396

8233

2.14

228.78

3.5

3.2

4.15

4.44

pmol/l

31.02

2163

7198

Examination and observation for other reasons

2880

8542

2.03

227.72

3.2

3.5

4.45

4.55

pmol/l

4.82

2557

7717

Persons encountering health services for specific procedures and health care

5336

19998

1.65

218.06

3.4

3.3

4.42

4.56

pmol/l

17.63

4825

17841

Subacute thyroiditis

293

385

9.28

217.31

3.4

1.4

4.63

4.48

pmol/l

1.06

263

329

Sleep apnoea, including avohilmo

4779

18090

1.69

215.56

3.2

3.4

4.48

4.49

pmol/l

0.05

4245

16189

Other anxiety disorders

2683

12341

1.98

211.80

2.9

3.5

4.54

4.59

pmol/l

1.39

2353

11202

Asthma, excluding more controls

3701

10985

1.82

207.05

3.2

3.4

4.48

4.57

pmol/l

5.71

3319

9810

All-cause Heart Failure

2286

8080

2.08

202.64

3.4

3.2

4.15

4.45

pmol/l

29.14

2061

7055

Any mental disorder

5205

16352

1.64

200.66

3.0

3.6

4.44

4.54

pmol/l

7.12

4527

14850

Other nutritional deficiencies

3486

19223

1.78

200.65

3.1

3.4

4.48

4.52

pmol/l

1.71

3058

17284

Nontoxic diffuse goitre

244

288

10.31

197.30

4.2

1.6

4.63

4.40

pmol/l

2.74

210

246

Heart failure and coronary heart disease

1704

5461

2.32

196.35

3.6

3.3

4.11

4.42

pmol/l

25.03

1543

4732

Asthma (mode)

3771

11781

1.77

195.04

3.2

3.4

4.48

4.56

pmol/l

3.88

3374

10530

Asthma (only as main-diagnosis), excluding more controls

3368

10985

1.81

191.19

3.1

3.4

4.47

4.57

pmol/l

7.61

3010

9810

Pain in limb

3958

15965

1.71

190.93

3.1

3.5

4.42

4.54

pmol/l

10.48

3489

14332

First line medication for Crohn's disease

5338

18514

1.60

190.62

3.4

3.3

4.45

4.57

pmol/l

11.82

4783

16551

Asthma

3789

11698

1.75

188.57

3.2

3.4

4.48

4.55

pmol/l

4.28

3388

10453

Sleep apnoea

4360

17482

1.67

188.25

3.2

3.4

4.48

4.47

pmol/l

0.18

3863

15649

Persons encountering health services in other circumstances, wide

5507

18335

1.59

187.98

3.2

3.4

4.46

4.53

pmol/l

4.88

4935

16324

Oral corticosteroids

5119

19534

1.60

185.05

3.3

3.4

4.43

4.53

pmol/l

9.06

4587

17440

Pacemaker

1324

5493

2.43

180.72

3.5

3.2

4.13

4.36

pmol/l

9.22

1200

4728

General examination and investigation of persons without complaint and reported diagnosis

2960

8572

1.86

179.28

3.1

3.5

4.47

4.55

pmol/l

3.09

2664

7742

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5198

18299

1.59

178.49

3.1

3.4

4.46

4.54

pmol/l

5.97

4692

16296

ILD medications: prednisolone, methylprednisolone, prednisone

5242

19061

1.58

178.43

3.3

4.42

4.55

pmol/l

12.02

4677

17048

Dilated cardiomyopathy

605

1770

3.76

176.36

4.2

3.3

4.20

4.44

pmol/l

5.49

561

1553

Neurological diseases

4180

12919

1.67

174.53

3.1

3.6

4.52

4.58

pmol/l

3.14

3740

11658

Non-invasive ventilation

1170

4323

2.55

174.49

3.3

3.6

4.58

pmol/l

0.01

1085

3913

Behavioural syndromes associated with physiological disturbances and physical factors

4529

20545

1.61

174.14

3.2

3.4

4.51

4.53

pmol/l

0.67

4015

18407

Asthma (only as main-diagnosis)

3417

11698

1.74

171.31

3.1

3.4

4.46

4.55

pmol/l

5.63

3048

10453

Thyrotropin deficiency

201

241

15.47

171.02

4.0

3.8

4.21

4.64

pmol/l

4.79

188

214

Disorders of parathyroid gland

1119

4598

2.59

170.80

3.5

3.2

4.33

4.42

pmol/l

1.90

967

4009

Asthma, unspecified (mode), excluding more controls

2490

10230

1.89

170.15

3.2

3.4

4.41

4.55

pmol/l

10.32

2221

9134

Codeine

4554

15739

1.62

169.42

3.2

3.4

4.47

4.56

pmol/l

5.76

4075

14066

Disorders of eyelid, lacrimal system and orbit

4034

19254

1.64

169.15

3.9

3.2

4.46

4.48

pmol/l

0.86

3614

17156

Low back pain

3658

16070

1.69

169.02

3.1

3.5

4.47

4.53

pmol/l

2.39

3208

14450

Cardiovascular diseases

3236

10159

1.77

167.51

3.3

3.4

4.56

4.67

pmol/l

6.07

2916

9185

Disorders of calcium metabolism

444

1106

4.63

165.54

4.3

3.0

4.41

4.45

pmol/l

0.17

398

974

Disorders of mineral metabolism

531

1499

3.98

164.86

4.1

3.0

4.41

4.46

pmol/l

0.35

475

1326

Benign neoplasm: Pituitary gland, craniopharyngeal duct

435

1083

4.81

164.50

3.1

3.4

4.34

4.53

pmol/l

2.82

409

960

Cardiovascular diseases (excluding rheumatic etc)

3356

11541

1.73

162.22

3.3

3.4

4.53

4.64

pmol/l

7.28

3041

10390

Sleep disorders

4330

20164

1.60

161.82

3.2

3.4

4.52

4.53

pmol/l

0.13

3853

18059

Lower back pain or/and sciatica

4962

21442

1.55

160.94

3.2

3.4

4.46

4.52

pmol/l

3.59

4381

19205

Psychiatric diseases

4476

14303

1.61

160.66

3.1

3.6

4.46

4.54

pmol/l

4.56

3912

12999

Migraine

2780

13108

1.79

160.58

3.1

3.5

4.54

4.58

pmol/l

1.11

2500

11807

Dorsalgia

4719

16418

1.58

159.66

3.2

3.4

4.48

4.54

pmol/l

3.12

4167

14755

Fever of other and unknown origin

2517

12736

1.82

157.85

3.3

3.4

4.40

4.56

pmol/l

10.51

2253

11382

Codeine or tramadol medication

5339

19577

1.53

157.21

3.2

3.4

4.45

4.52

pmol/l

4.57

4770

17460

Tramadol

3672

13972

1.66

156.57

3.0

3.4

4.41

4.53

pmol/l

8.84

3233

12472

Disorders of lipoprotein metabolism and other lipidaemias

3308

12351

1.71

156.28

3.0

3.1

4.41

4.48

pmol/l

2.66

2907

10940

Personality disorders, excluding more controls

1399

6643

2.23

154.96

2.9

3.7

4.43

4.60

pmol/l

8.51

1206

6111

Neoplasms

3683

12037

1.67

154.27

3.8

3.1

4.56

4.62

pmol/l

2.44

3377

10749

Use of hypnotics and sedatives

4893

18634

1.55

152.81

3.2

3.4

4.39

4.53

pmol/l

14.66

4278

16770

Other headache syndromes

2195

12201

1.88

152.59

3.0

3.5

4.46

4.52

pmol/l

1.87

1924

10938

GASTRO-related operations

3899

12242

1.64

151.66

3.6

3.2

4.50

4.62

pmol/l

9.02

3473

11026

Any gastric operation

3899

12242

1.64

151.66

3.6

3.2

4.50

4.62

pmol/l

9.02

3473

11026

Thyroiditis, unspecified

154

141

14.42

151.25

4.0

1.4

4.44

4.50

pmol/l

0.17

138

124

Other specific joint derangements/joint disorders

3648

14766

1.65

150.71

3.3

3.5

4.53

4.57

pmol/l

1.30

3226

13286

Asthma, unspecified (mode)

2527

10895

1.81

150.51

3.2

3.4

4.41

4.53

pmol/l

8.04

2254

9732

Panhypopituitarism

208

290

9.96

150.45

3.3

3.4

4.05

4.63

pmol/l

8.18

194

258

Inflammatory bowel disease treatment related agents

5334

20207

1.51

149.71

3.3

4.43

4.55

pmol/l

10.68

4780

18054

Obesity and other hyperalimentation

3171

18904

1.68

148.35

3.1

3.4

4.48

4.52

pmol/l

1.48

2781

17007

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2395

13389

1.80

146.80

3.8

3.3

4.49

pmol/l

0.09

2167

11970

Other disorders of fluid, electrolyte and acid-base balance

1306

5838

2.23

146.51

3.1

3.0

4.12

4.43

pmol/l

19.52

1135

5116

Obesity

3152

18850

1.67

146.47

3.1

3.4

4.48

4.52

pmol/l

1.43

2763

16957

Insomnia

4232

20225

1.57

146.40

3.2

3.4

4.52

pmol/l

0.06

3774

18108

Opioids

4645

15945

1.55

144.21

3.2

3.4

4.48

4.57

pmol/l

6.72

4163

14259

ILD medications

5254

19359

1.51

143.96

3.3

4.45

4.56

pmol/l

9.47

4709

17322

Other special examinations and investigations of persons without complaint or reported diagnosis

2884

8577

1.75

142.86

3.2

3.5

4.49

4.55

pmol/l

1.96

2579

7746

Thyrotoxicosis with toxic single thyroid nodule

149

150

17.33

142.49

5.4

2.3

4.91

4.34

pmol/l

5.20

136

127

Emergency coronary revascularization (for ACS)

3475

13226

1.64

141.34

3.3

4.35

4.49

pmol/l

11.84

3121

11653

Percutaneous Coronary Intervention

3273

12447

1.66

138.66

3.3

3.4

4.36

4.50

pmol/l

11.88

2943

10992

Parasetamol

3469

10938

1.65

138.32

3.3

3.4

4.53

4.60

pmol/l

3.07

3110

9808

Hypocalcemia

237

415

7.59

137.78

5.5

3.4

4.54

4.61

pmol/l

0.20

221

367

Coronary revascularization (ANGIO or CABG)

3271

12457

1.66

137.10

3.3

3.4

4.36

4.50

pmol/l

12.19

2939

11001

Congenital iodine-deficiency syndrome/hypothyroidism

194

268

8.50

136.96

3.2

1.4

4.29

4.47

pmol/l

1.15

174

224

Cardiomyopathy, other and unspecified

410

1102

4.10

135.65

3.9

3.2

4.18

4.53

pmol/l

7.85

376

970

Asthma, including avohilmo

5399

21008

1.48

135.05

3.2

3.4

4.51

4.52

pmol/l

0.31

4825

18770

Infections, IBD-co-morbidities

651

1569

3.11

135.00

3.0

2.8

4.32

4.48

pmol/l

3.18

577

1391

Care involving use of rehabilitation procedures

2884

16355

1.67

134.78

3.2

3.3

4.45

4.53

pmol/l

3.41

2624

14541

Hypertensive diseases (excluding secondary)

2510

8479

1.78

134.57

3.3

3.5

4.50

4.59

pmol/l

4.01

2267

7624

Other disorders of adrenal gland

360

904

4.72

134.29

3.9

3.2

4.36

4.55

pmol/l

2.66

330

798

Adrenocortical insufficiency

311

701

5.42

134.15

3.9

3.3

4.29

4.54

pmol/l

3.57

286

621

Heart failure and bmi 25plus

1372

4475

2.17

133.36

3.6

3.3

4.15

4.46

pmol/l

20.61

1232

3893

Exclusions for E4_PCOS_CONSORTIUM

3912

16069

1.58

133.05

3.3

4.45

4.53

pmol/l

5.28

3513

14358

Diarrhoea and gastroenteritis of presumed infectious origin

4635

20774

1.51

131.85

3.3

4.49

4.52

pmol/l

1.14

4124

18576

Benign neoplasm of other and unspecified endocrine glands

749

2932

2.79

131.51

3.1

3.3

4.36

4.45

pmol/l

1.67

686

2609

Hypoparathyroidism

312

719

5.33

131.29

5.2

3.2

4.32

4.50

pmol/l

2.17

282

625

Implicit Sepsis

3539

16707

1.59

130.74

3.2

3.4

4.28

4.53

pmol/l

36.46

3090

14931

Other dorsopathies, not elsewhere classified

4654

16461

1.51

130.10

3.2

3.4

4.52

4.54

pmol/l

0.56

4124

14794

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1692

4330

2.02

130.01

3.3

3.5

4.55

4.64

pmol/l

2.49

1503

3924

Condition for Implicit Sepsis (Organ dysfunction codes)

3986

18233

1.55

128.85

3.1

3.4

4.32

4.55

pmol/l

35.00

3511

16333

Dysphagia

1137

5356

2.24

128.27

3.1

3.3

4.39

4.43

pmol/l

0.69

993

4748

Implicit Sepsis

3176

15188

1.62

127.87

3.1

3.3

4.25

4.51

pmol/l

35.53

2761

13532

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4397

20575

1.51

127.63

3.3

4.32

4.53

pmol/l

25.68

3881

18407

Malignant neoplasm, wide definition for exclusion

3996

15520

1.55

126.57

4.4

3.1

4.49

4.51

pmol/l

0.69

3678

13763

Other diseases of intestines

4879

19111

1.49

126.30

3.2

3.4

4.48

4.55

pmol/l

4.17

4339

17199

Intestinal infectious diseases

5172

20578

1.47

126.23

3.2

3.3

4.47

4.52

pmol/l

2.83

4581

18413

Symptoms and signs involving cognition, perception, emotional state and behaviour

4358

20177

1.51

125.57

3.1

3.4

4.38

4.52

pmol/l

16.57

3821

18101

Other pulmonary diagnosis

3650

11796

1.59

125.23

3.3

3.4

4.47

4.55

pmol/l

4.20

3275

10540

Excluding asthma or asthma-COPD overlap

3642

11796

1.59

123.76

3.3

3.4

4.47

4.55

pmol/l

3.96

3279

10540

Malignant neoplasm

3840

15007

1.55

123.41

4.5

3.1

4.48

4.50

pmol/l

0.48

3530

13303

Ischemic heart diseases

3412

13217

1.59

122.28

3.3

3.4

4.36

4.51

pmol/l

12.67

3069

11694

Other disorders of lacrimal gland

1732

9614

1.89

122.19

3.8

3.2

4.44

4.45

pmol/l

0.09

1539

8488

Major coronary heart disease event

3396

13213

1.59

122.00

3.2

3.4

4.35

4.50

pmol/l

11.75

3042

11662

Bipolar affective disorders

1056

4953

2.27

121.71

2.7

3.6

4.35

4.58

pmol/l

11.86

896

4509

Solid cancers, helper endpoint

3792

14818

1.55

120.75

4.5

3.1

4.47

4.50

pmol/l

0.71

3482

13128

Diseases of oesophagus, stomach and duodenum

4756

19710

1.48

120.49

3.0

3.4

4.42

4.53

pmol/l

10.00

4178

17694

Obesity due to excess calories

2335

14135

1.72

120.37

3.1

3.4

4.48

4.52

pmol/l

1.44

2049

12731

ILD differential diagnosis

3615

11781

1.57

119.53

3.3

3.4

4.47

4.56

pmol/l

4.42

3256

10530

Valvular heart disease excluding rheumatic fever

1715

6736

1.90

119.46

3.3

4.28

4.51

pmol/l

13.91

1532

5944

COPD differential diagnosis

3615

11786

1.57

119.32

3.3

3.4

4.47

4.56

pmol/l

4.42

3256

10535

Other functional intestinal disorders

2044

11056

1.78

118.78

2.9

3.4

4.36

4.49

pmol/l

6.79

1811

9844

Pain, not elsewhere classified

1357

7015

2.03

118.62

3.0

3.4

4.39

4.54

pmol/l

7.06

1211

6287

Condition for Implicit Sepsis (Organ dysfunction codes)

3676

17244

1.54

118.37

3.2

3.4

4.29

4.54

pmol/l

35.63

3225

15428

Asthma (diagnoses ohter than nonallergic)

3951

22243

1.51

118.12

3.2

3.4

4.45

4.52

pmol/l

4.37

3528

19856

Non-rheumatic valve diseases

1701

6687

1.90

117.87

3.3

4.28

4.50

pmol/l

13.33

1518

5896

Soft tissue disorders

4652

16499

1.48

117.65

3.1

3.4

4.50

4.56

pmol/l

2.88

4125

14808

Constipation

3841

17859

1.53

117.23

3.1

3.4

4.35

4.50

pmol/l

13.48

3350

16010

Nausea and vomiting

1288

6429

2.06

116.88

3.2

3.3

4.36

4.51

pmol/l

4.71

1157

5697

Any event in cancer register

4227

16963

1.50

116.76

4.4

3.1

4.49

4.52

pmol/l

0.89

3873

15074

Disorders of lacrimal system

2027

11903

1.77

116.01

3.7

3.2

4.43

4.45

pmol/l

0.30

1804

10500

Symptoms and signs involving the digestive system and abdomen

4299

14653

1.50

114.89

3.2

3.4

4.49

4.55

pmol/l

2.87

3807

13132

Presence of cardiac and vascular implants and grafts

1579

6324

1.92

114.01

3.6

3.3

4.22

4.45

pmol/l

11.64

1421

5521

Persons encountering health services in other circumstances

1871

10770

1.79

113.23

3.3

3.4

4.44

4.53

pmol/l

2.99

1674

9583

Hypertension, essential

3431

12729

1.57

113.19

3.3

3.4

4.47

4.52

pmol/l

1.86

3067

11419

Pure hypercholesterolaemia

2722

11144

1.63

111.14

3.0

4.43

4.47

pmol/l

0.74

2393

9850

Non-ischemic cardiomyopathy

1188

4762

2.10

110.49

3.3

4.25

4.45

pmol/l

7.56

1073

4146

Complications of surgical and medical care, not elsewhere classified

4378

20898

1.47

110.41

3.4

3.3

4.40

4.51

pmol/l

8.83

3895

18647

Abdominal and pelvic pain

4261

14653

1.49

110.36

3.2

3.4

4.50

4.55

pmol/l

2.41

3757

13132

Obesity related asthma

1610

9036

1.86

109.14

3.1

3.3

4.43

4.48

pmol/l

1.02

1428

8041

Irritable bowel syndrome

1459

7977

1.92

108.28

3.2

3.4

4.49

4.50

pmol/l

0.10

1267

7116

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4369

19890

1.46

107.38

3.3

3.4

4.38

4.55

pmol/l

20.26

3938

17779

Follow-up examination after treatment for conditions other than malignant neoplasms

1989

7698

1.76

107.20

3.3

3.5

4.49

4.54

pmol/l

1.00

1779

6945

Cystitis

3997

16320

1.49

106.54

3.2

3.4

4.44

4.50

pmol/l

2.62

3537

14659

Hard cardiovascular diseases

3428

13607

1.54

106.32

3.2

3.4

4.37

4.51

pmol/l

11.62

3085

12070

Other diseases of upper respiratory tract

4768

17535

1.45

106.30

3.4

3.3

4.51

4.50

pmol/l

0.13

4261

15627

Nonorganic sleeping disorders, excluding more controls

980

4701

2.20

106.03

3.2

3.6

4.51

4.59

pmol/l

1.69

857

4300

Symptoms and signs involving the skin and subcutaneous tissue

3160

20632

1.54

105.72

3.4

3.3

4.50

4.49

pmol/l

0.36

2822

18393

Unspecified mental disorder

1893

11212

1.75

105.54

2.5

3.4

4.38

4.55

pmol/l

10.55

1583

10085

Acute upper respiratory infections

4630

20210

1.44

104.52

3.3

4.49

4.50

pmol/l

0.17

4118

18024

Symptoms and signs involving speech and voice

1545

8709

1.86

103.39

3.6

3.3

4.41

4.44

pmol/l

0.45

1378

7714

Other reaction to severe stress, and adjustment disorders

1856

11022

1.75

102.95

3.3

3.5

4.45

4.58

pmol/l

5.94

1601

10010

Triptan medication for migraine, single purchase ok

3740

17439

1.49

101.34

3.3

3.4

4.54

pmol/l

0.05

3373

15603

Migraine, single triptan purchase ok & required. ICD-code if available is included

3740

17439

1.49

101.34

3.3

3.4

4.54

pmol/l

0.05

3373

15603

Sciatica+with lumbago

2285

13158

1.65

100.91

3.2

3.5

4.43

4.49

pmol/l

2.48

2044

11820

Dronedarone medication

191

358

6.28

100.68

3.7

3.2

4.28

4.46

pmol/l

0.92

172

310

Gastro-oesophageal reflux disease

2912

16586

1.56

100.39

3.0

3.4

4.46

4.50

pmol/l

1.08

2511

14853

Implicit viral Sepsis

1226

6476

1.97

100.23

3.2

3.3

4.22

4.49

pmol/l

16.86

1064

5718

Diseases of the eye and adnexa

3738

12749

1.50

99.82

3.4

3.3

4.55

4.59

pmol/l

1.48

3355

11505

Other disorders of urethra and urinary system

3217

15595

1.53

99.47

3.0

3.4

4.40

4.50

pmol/l

4.78

2838

14006

Voice disturbances

1306

7089

1.94

99.45

3.7

3.3

4.42

4.45

pmol/l

0.73

1168

6292

5060

18859

1.41

99.44

3.2

3.4

4.46

4.51

pmol/l

2.43

4483

16845

Disorder of thyroid, unspecified

111

116

12.03

98.94

4.1

1.4

4.75

4.39

pmol/l

1.69

106

103

Symptoms and signs involving the nervous and musculoskeletal systems

2504

16132

1.60

98.78

3.0

3.4

4.44

4.48

pmol/l

1.34

2229

14374

Schizophrenia or delusion, excluding more controls

1309

7039

1.91

97.76

2.3

3.6

4.39

4.58

pmol/l

8.62

1087

6397

Chronic lower respiratory diseases

5335

20768

1.39

97.37

3.2

3.4

4.48

4.54

pmol/l

3.30

4795

18566

Hypertensive diseases

3440

13150

1.51

97.17

3.3

3.4

4.47

4.53

pmol/l

2.43

3093

11805

Oedema, not elsewhere classified

1334

7204

1.90

97.11

3.2

3.3

4.34

4.50

pmol/l

6.26

1167

6395

Hypertension

3438

13140

1.51

97.10

3.3

3.4

4.47

4.53

pmol/l

2.32

3091

11795

Asthma, hospital admission 2, infections

2556

16252

1.58

96.91

3.2

3.3

4.44

4.52

pmol/l

2.92

2266

14458

Asthma-related infections

2556

16252

1.58

96.91

3.2

3.3

4.44

4.52

pmol/l

2.92

2266

14458

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1352

7458

1.88

95.44

2.8

3.7

4.50

4.60

pmol/l

2.41

1175

6843

Haemorrhage from respiratory passages

1257

6083

1.92

95.29

3.2

3.3

4.32

4.47

pmol/l

4.51

1094

5401

Hyperparathyroidism

843

3935

2.24

95.03

2.9

3.1

4.32

4.42

pmol/l

1.81

719

3415

Other diseases of urinary system

4398

17601

1.43

94.98

3.2

3.4

4.46

4.52

pmol/l

2.08

3910

15830

Personality disorders

1399

7865

1.87

94.82

2.9

3.5

4.43

4.57

pmol/l

6.53

1206

7122

Syncope and collapse

1759

8941

1.73

93.90

3.2

3.4

4.34

4.52

pmol/l

11.12

1540

7963

Fibromyalgia

611

2560

2.63

93.85

3.1

3.4

4.49

4.53

pmol/l

0.49

536

2309

Disorders of adult personality and behaviour

1461

8347

1.83

93.61

2.9

3.4

4.44

4.59

pmol/l

6.99

1256

7554

Kela-code for severe mental illness

1649

9733

1.76

93.27

2.4

3.4

4.36

4.55

pmol/l

11.15

1365

8736

Somatoform disorder

871

4211

2.20

93.15

2.8

3.4

4.44

4.52

pmol/l

1.83

749

3807

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1978

7671

1.72

92.93

3.6

3.4

4.59

4.60

pmol/l

0.04

1803

6940

Dermatitis and eczema

4817

21741

1.40

92.81

3.2

3.4

4.46

4.53

pmol/l

4.31

4248

19472

Other intervertebral disc disorders

3544

14705

1.48

92.61

3.0

3.5

4.48

4.50

pmol/l

0.59

3124

13196

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2587

15182

1.57

92.40

3.2

3.3

4.38

4.44

pmol/l

2.26

2287

13422

Persons encountering health services for examination and investigation

2661

8577

1.59

92.39

3.2

3.5

4.49

4.55

pmol/l

1.97

2374

7746

Hyperkinetic disorders, excluding more controls

629

2539

2.53

92.31

2.7

3.8

4.83

4.76

pmol/l

0.61

559

2352

Visual disturbances and blindness

2240

14299

1.62

92.21

3.4

3.3

4.42

4.48

pmol/l

1.86

2008

12672

Dental caries

1057

5243

2.02

91.90

3.5

3.6

4.37

4.53

pmol/l

3.78

952

4714

Pain (limb, back, neck, head abdominally)

2985

9877

1.54

91.81

3.3

3.5

4.48

4.57

pmol/l

4.02

2646

8900

Other obstetric conditions, not elsewhere classified

2008

7858

1.71

91.66

3.6

3.4

4.59

4.60

pmol/l

0.03

1833

7109

Cough

1701

9585

1.73

91.58

3.2

3.3

4.48

4.52

pmol/l

0.71

1517

8561

Nerve, nerve root and plexus disorders

4563

20222

1.41

91.22

3.0

3.4

4.43

4.50

pmol/l

4.62

4066

18073

Visual disturbances

2113

13363

1.63

90.90

3.4

3.3

4.44

4.48

pmol/l

1.12

1898

11867

Benign neoplasms

4222

16562

1.43

90.83

3.4

4.50

4.56

pmol/l

2.67

3810

14841

Implicit bacterial Sepsis

1624

8228

1.76

90.80

3.0

3.3

4.09

4.46

pmol/l

36.40

1417

7261

Dorsopathies

4528

16536

1.42

90.69

3.2

3.4

4.53

4.54

pmol/l

0.59

4029

14866

Non-selective monoamine reuptake inhibitors

1563

8806

1.77

90.60

2.8

3.5

4.31

4.48

pmol/l

9.79

1342

7904

Generalized anxiety disorder

894

4413

2.15

90.29

3.0

3.5

4.55

4.63

pmol/l

1.79

785

4026

Renal failure

1559

8037

1.77

89.35

3.1

3.2

3.93

4.45

pmol/l

66.00

1368

7055

Complications of procedures, not elsewhere classified

3493

20220

1.46

89.31

3.5

3.3

4.41

4.50

pmol/l

5.68

3119

18046

COPD/asthma/ILD related infections

4627

16766

1.41

88.86

3.2

3.4

4.43

4.54

pmol/l

9.32

4114

14996

COPD/asthma related infections

4627

16766

1.41

88.86

3.2

3.4

4.43

4.54

pmol/l

9.32

4114

14996

Dizziness and giddiness

3170

17274

1.49

88.29

3.1

3.4

4.37

4.49

pmol/l

8.76

2796

15467

Implicit bacterial Sepsis

1472

7517

1.79

88.20

3.0

3.3

4.07

4.46

pmol/l

35.74

1280

6635

Acute upper respiratory infections of multiple and unspecified sites

3367

17349

1.47

87.46

3.3

4.52

4.53

pmol/l

0.11

3005

15513

Oxycodone

1453

7600

1.78

86.38

3.5

3.3

4.27

4.45

pmol/l

6.21

1285

6714

1987

12425

1.64

86.35

3.2

3.3

4.49

4.54

pmol/l

1.11

1773

11060

Symptoms and signs concerning food and fluid intake

502

1972

2.72

86.26

3.2

3.3

4.36

4.54

pmol/l

3.37

435

1739

Nonischemic cardiomyopathy

424

1530

2.97

86.07

3.6

3.3

4.32

4.47

pmol/l

1.71

396

1340

Bronchitis

4678

21625

1.39

86.03

3.2

3.3

4.47

4.52

pmol/l

1.84

4151

19325

Covid-19 confirmed case

1506

8878

1.76

85.43

3.2

3.3

4.34

4.47

pmol/l

5.59

1367

7860

Conduction disorders

1021

4275

2.00

85.31

3.2

3.3

4.34

4.50

pmol/l

3.19

902

3767

Chronic kidney disease

1033

5321

1.97

85.08

3.1

3.2

3.86

4.43

pmol/l

56.82

906

4640

Hyperlipidaemia, other/unspecified

1296

6721

1.83

84.33

2.9

3.0

4.29

4.43

pmol/l

4.67

1146

5906

Intestinal infectious diseases

4057

22271

1.41

84.16

3.2

3.3

4.45

4.53

pmol/l

5.14

3592

19914

Spondylosis

2121

11047

1.61

83.96

3.1

3.4

4.41

4.45

pmol/l

0.99

1872

9878

Diarrhoea and gastroenteritis of presumed infectious origin

3052

19021

1.48

83.67

3.2

3.4

4.44

4.54

pmol/l

5.28

2706

16988

Continuous positive airway pressure

682

2575

2.32

83.46

3.0

3.6

4.35

4.56

pmol/l

5.41

589

2319

Spondylopathies

3157

12985

1.48

82.79

3.0

3.4

4.41

4.48

pmol/l

2.47

2781

11629

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3867

16764

1.42

82.12

3.2

3.4

4.36

4.54

pmol/l

17.72

3416

14994

3867

16764

1.42

82.12

3.2

3.4

4.36

4.54

pmol/l

17.72

3416

14994

724

3425

2.25

82.01

3.7

3.4

4.43

4.53

pmol/l

1.95

648

3072

Primary hyperparathyroidism

570

2463

2.51

81.13

2.8

3.2

4.43

4.42

pmol/l

0.11

492

2162

Other CVD (FINNGEN)

462

1349

2.81

81.12

2.8

3.3

4.15

4.55

pmol/l

12.82

385

1184

Migraine with aura

1302

7510

1.81

80.82

3.2

3.5

4.52

4.58

pmol/l

1.59

1195

6766

Viral Sepsis

831

4143

2.10

80.66

3.1

3.2

4.19

4.51

pmol/l

15.81

720

3642

Implicit viral Sepsis

828

4131

2.10

80.21

3.1

3.2

4.18

4.51

pmol/l

16.15

718

3630

Type 1 diabetes

1085

5922

1.90

79.85

3.0

3.4

4.36

4.59

pmol/l

9.86

960

5312

Bacterial Sepsis

1657

8651

1.68

79.36

3.0

3.3

4.12

4.47

pmol/l

32.32

1448

7644

Asthma, hospital admissions , main diagnosis only

3547

22474

1.42

78.74

3.1

3.4

4.47

4.53

pmol/l

2.86

3163

20064

Caries of dentine

915

4617

2.01

78.63

3.5

3.6

4.36

4.52

pmol/l

2.89

820

4145

Codes for special purposes

2268

15024

1.55

78.39

3.0

3.4

4.38

4.52

pmol/l

8.88

2043

13361

Provisional assignment of new diseases of uncertain etiology

2266

15011

1.55

78.32

3.0

3.4

4.38

4.52

pmol/l

8.87

2041

13350

Gastrointestinal diseases

2773

9372

1.51

77.70

3.3

3.5

4.51

4.62

pmol/l

5.93

2478

8463

Diabetes mellitus

4460

19275

1.38

77.44

3.2

3.4

4.42

4.54

pmol/l

11.63

3958

17243

Insulin, fast-acting

1436

8573

1.73

77.42

3.0

3.4

4.32

4.53

pmol/l

10.28

1264

7618

Specific personality disorders

1198

6841

1.83

77.18

2.7

3.4

4.42

4.57

pmol/l

6.03

1027

6200

Hypo-osmolality and hyponatraemia

670

3117

2.24

76.83

3.2

3.0

4.04

4.42

pmol/l

14.05

579

2703

Corticotropin deficiency

110

163

10.02

76.54

4.7

3.1

4.23

4.49

pmol/l

1.43

105

147

Other medical care

1735

9756

1.64

76.53

4.0

3.3

4.27

4.48

pmol/l

10.86

1560

8566

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

358

1280

3.16

76.36

3.8

3.2

4.28

4.42

pmol/l

2.17

312

1126

Type 1 diabetes, wide definition, subgroup 1

938

4968

1.97

76.27

3.1

3.4

4.38

4.61

pmol/l

7.79

836

4462

Persistent mood disorders

897

4709

2.00

75.46

2.9

3.5

4.35

4.53

pmol/l

6.32

746

4220

Complications of medical and surgical care

3084

20075

1.44

75.04

3.4

3.3

4.37

4.49

pmol/l

7.58

2742

17895

Myalgia

1153

6559

1.84

75.02

3.3

3.4

4.47

4.52

pmol/l

1.09

997

5866

Other/unspecified dorsalgia

1623

9995

1.66

74.99

3.2

3.5

4.43

4.49

pmol/l

1.74

1450

8929

Disturbances of skin sensation

1332

7919

1.75

74.10

3.4

4.52

4.51

pmol/l

0.16

1175

7103

Insulin, fast-acting or short human

1443

8729

1.71

73.94

3.0

3.4

4.32

4.52

pmol/l

10.20

1271

7749

Renal tubulo-interstitial diseases

3628

19610

1.41

73.79

3.2

3.4

4.26

4.53

pmol/l

38.01

3217

17511

Chronic rhinitis, nasopharyngitis and pharyngitis

1419

8577

1.72

73.56

3.1

3.3

4.52

4.49

pmol/l

0.44

1245

7661

Diabetes, varying definitions

4406

19260

1.37

72.49

3.2

3.4

4.42

4.54

pmol/l

11.15

3908

17231

Irregular menses

2618

14295

1.50

72.49

3.1

3.4

4.44

4.54

pmol/l

6.83

2370

12853

All kidney diseases

4192

21288

1.37

72.43

3.2

3.4

4.32

4.55

pmol/l

31.15

3740

19062

Panic disorder

790

4054

2.06

71.56

3.2

3.5

4.56

4.61

pmol/l

0.52

681

3696

Diseases of the skin and subcutaneous tissue

4309

16031

1.37

70.90

3.3

3.4

4.49

4.55

pmol/l

3.25

3802

14414

AV-block

558

2166

2.34

70.72

3.2

3.1

4.31

4.46

pmol/l

1.40

499

1877

Chronic sinusitis

1834

11881

1.59

70.68

3.3

4.44

4.49

pmol/l

1.14

1629

10597

Type 1 diabetes, wide definition

958

5241

1.90

70.26

3.1

3.4

4.37

4.60

pmol/l

8.14

853

4698

KRA_PSY_EATING, excluding more controls

507

2204

2.47

70.09

2.8

3.7

4.32

4.71

pmol/l

15.24

442

2032

Diseases of the respiratory system

2804

9699

1.48

70.00

3.3

3.4

4.48

4.54

pmol/l

2.02

2516

8634

Disorders of conjunctiva

3648

21554

1.39

69.04

3.2

3.3

4.50

4.53

pmol/l

1.19

3239

19281

Obesity, other/unspecified

1625

10330

1.63

69.01

3.0

3.4

4.47

4.52

pmol/l

1.30

1442

9320

Other symptoms and signs involving cognitive functions and awareness

1672

9676

1.62

68.96

2.9

3.3

4.29

4.44

pmol/l

8.03

1424

8578

Certain infectious and parasitic diseases

4309

16101

1.36

68.31

3.2

3.4

4.42

4.58

pmol/l

15.69

3818

14462

Thyrotoxicosis factitia

25.63

68.12

6.9

1.9

4.44

4.43

pmol/l

0.03

Hypogonadotropic hypogonadism

162

371

4.94

67.19

2.2

3.5

4.50

4.72

pmol/l

1.62

138

341

Other symptoms and signs involving the nervous and musculoskeletal systems

1781

11630

1.58

66.63

2.9

3.4

4.47

4.48

pmol/l

0.32

1599

10353

Nonorganic sleeping disorders

980

5545

1.85

65.25

3.2

3.4

4.51

4.55

pmol/l

0.79

857

4973

Other joint disorders

3839

14975

1.38

65.15

3.2

3.5

4.55

4.57

pmol/l

0.44

3412

13460

Special screening examination for infectious and parasitic diseases

1102

4660

1.80

65.01

3.1

3.6

4.52

4.65

pmol/l

4.02

904

4258

Undetermined asthma, excluding more controls

581

2752

2.22

64.94

3.3

4.38

4.54

pmol/l

3.28

518

2411

Shoulder lesions

3003

12995

1.43

64.77

3.1

3.5

4.45

4.49

pmol/l

1.24

2694

11629

Asthma/COPD (KELA code 203)

4021

20730

1.35

64.19

3.1

3.4

4.48

4.54

pmol/l

2.88

3610

18530

Influenza and pneumonia

4455

21584

1.33

64.01

3.2

3.4

4.38

4.56

pmol/l

21.29

3943

19346

Abnormal results of function studies

439

1875

2.52

63.94

3.0

3.3

4.46

4.51

pmol/l

0.36

390

1680

Diseases of the musculoskeletal system and connective tissue

2398

8197

1.50

63.81

3.3

3.6

4.55

4.62

pmol/l

2.36

2133

7440

Triptan medication for migraine, min. 3 purchases

2844

15560

1.43

63.61

3.3

3.4

4.54

4.55

pmol/l

0.19

2583

14033

Excessive, frequent and irregular menstruation

2021

7357

1.55

63.52

3.2

3.4

4.49

4.56

pmol/l

2.73

1793

6561

Cerebrovascular diseases (FINNGEN)

1190

4961

1.75

63.49

3.2

3.4

4.34

4.56

pmol/l

8.87

1058

4414

Heart failure and hypertrophic cardiomyopathy

122

233

6.22

63.35

4.3

3.1

3.97

4.38

pmol/l

3.00

113

200

Hyperfunction of pituitary gland

315

1161

3.02

63.20

2.9

3.2

4.35

4.58

pmol/l

4.07

292

1040

Autoimmune diseases excluding thyroid diseases

3219

12680

1.40

63.07

2.6

2.8

4.49

4.59

pmol/l

6.47

2860

11385

Polycystic ovarian syndrome, consortium definition

3706

16343

1.38

63.06

3.1

3.3

4.44

4.52

pmol/l

5.62

3301

14607

Lumbar disc prolapse

2569

13862

1.45

63.05

3.0

3.5

4.49

pmol/l

0.12

2280

12464

Osteopathies and chondropathies

2240

14399

1.48

63.02

3.2

3.3

4.39

4.47

pmol/l

3.03

1927

12778

All chronic kidney diseases

1947

10632

1.53

63.00

3.2

3.3

4.12

4.51

pmol/l

45.49

1731

9406

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

333

840

2.92

62.78

2.8

3.0

4.22

4.42

pmol/l

2.25

286

743

Dialysis, with operation codes

490

2209

2.34

62.11

3.4

3.87

4.52

pmol/l

29.21

449

1953

Myocarditis

235

733

3.47

61.96

3.7

3.5

4.36

4.61

pmol/l

3.11

228

654

Phobic anxiety disorders

679

3475

2.06

61.66

2.9

3.5

4.58

4.66

pmol/l

0.95

595

3179

Other disorders of thyroid

113

208

6.69

61.59

4.1

2.1

4.71

4.38

pmol/l

1.73

108

173

Nephropathy related operations

477

2139

2.36

61.35

3.4

3.87

4.50

pmol/l

27.16

439

1882

Type 2 diabetes, wide definition

2996

13865

1.41

60.82

3.1

3.4

4.34

4.48

pmol/l

9.45

2635

12314

Other endocrine disorders

285

965

3.10

60.62

3.4

3.3

4.61

4.73

pmol/l

0.73

255

860

Other and unspecified nonorganic psychotic disorders

882

4938

1.86

60.62

2.3

3.5

4.43

4.60

pmol/l

5.05

738

4448

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1017

5260

1.79

60.33

2.8

3.4

4.78

4.71

pmol/l

0.82

898

4776

Dentofacial anomalies [including malocclusion]

3163

18719

1.39

59.79

3.2

3.4

4.53

4.54

pmol/l

0.32

2800

16799

Spinal stenosis

1761

8819

1.55

59.77

3.0

3.4

4.32

4.41

pmol/l

3.03

1510

7844

Diverticular disease of intestine

2619

11854

1.44

59.53

3.1

3.4

4.40

4.45

pmol/l

1.92

2296

10579

Migraine without aura

1040

6155

1.76

59.09

3.0

3.5

4.56

4.61

pmol/l

0.57

934

5576

Undetermined asthma

581

2857

2.14

58.89

3.3

4.38

4.52

pmol/l

2.70

518

2508

Diseases of arteries, arterioles and capillaries (FINNGEN)

811

3014

1.92

58.65

3.0

3.4

4.25

4.57

pmol/l

12.48

722

2677

Nutritional anaemias

1897

12409

1.51

58.42

3.3

4.23

4.44

pmol/l

15.18

1655

10980

Chronic diseases of tonsils and adenoids

3344

15667

1.37

58.17

3.3

4.61

4.53

pmol/l

3.10

3023

14044

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2437

17127

1.44

58.15

3.4

3.3

4.38

4.47

pmol/l

4.77

2163

15243

Conjunctivitis

3328

20759

1.37

57.76

3.2

3.3

4.50

4.54

pmol/l

0.98

2966

18570

Coronary atherosclerosis

2155

9375

1.48

57.68

3.1

3.3

4.31

4.47

pmol/l

10.41

1911

8226

Insulin, intermediate and long-acting

1938

12873

1.50

57.33

3.0

3.4

4.32

4.48

pmol/l

9.59

1708

11441

Rheumatism, unspecified

694

3683

1.99

57.33

3.3

3.4

4.35

4.45

pmol/l

1.97

609

3284

Schizophrenia or delusion

1309

8256

1.64

57.17

2.3

3.4

4.39

4.55

pmol/l

6.69

1087

7407

Concussion

1976

11022

1.49

56.92

3.2

3.6

4.46

4.59

pmol/l

5.90

1764

9943

Other systemic involvement of connective tissue (FG)

1128

6783

1.70

56.88

2.9

3.4

4.38

4.46

pmol/l

1.81

993

6002

Other and unspecified iron deficiency

1342

8532

1.62

56.47

3.3

3.2

4.26

4.47

pmol/l

9.97

1168

7553

Iron deficiency anaemia

1662

10909

1.54

56.42

3.4

3.2

4.25

4.45

pmol/l

12.16

1449

9663

Schizophrenia, schizotypal and delusional disorders

1309

8284

1.63

56.36

2.3

3.4

4.39

4.55

pmol/l

6.46

1087

7436

Ischaemic heart disease, wide definition

2729

12179

1.41

56.31

3.1

3.3

4.32

4.47

pmol/l

9.66

2428

10760

All pneumoniae

4167

21432

1.32

56.21

3.2

3.4

4.36

4.55

pmol/l

22.77

3684

19206

Factors influencing health status and contact with health services

1003

2857

1.80

55.78

3.4

3.5

4.54

4.63

pmol/l

1.63

887

2564

Migraine with aura and triptan purchases

865

4956

1.84

55.78

3.3

3.4

4.52

4.57

pmol/l

0.65

791

4469

Pneumonia, organism unspecified

3660

19491

1.34

54.69

3.2

3.4

4.34

4.54

pmol/l

25.28

3229

17440

Type 2 diabetes

4057

18207

1.32

54.30

3.2

3.4

4.41

4.52

pmol/l

8.63

3578

16283

Primary adrenocortical insufficiency

110

225

6.30

54.20

3.7

3.5

4.34

4.56

pmol/l

1.29

199

Sub-endpoint used in defining T1D endpoints

1108

6678

1.68

54.04

3.0

3.4

4.35

4.54

pmol/l

7.32

977

5954

Pneumonias (Asthma/COPD co-morbidities)

4123

21389

1.31

54.01

3.2

3.4

4.36

4.55

pmol/l

22.04

3642

19167

Mycoses

3483

23008

1.34

53.90

3.1

3.4

4.45

4.53

pmol/l

4.21

3042

20627

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1860

7959

1.51

53.89

3.2

3.4

4.46

4.56

pmol/l

4.31

1693

7140

Disturbance of activity and attention

613

3117

2.03

53.79

2.7

3.5

4.83

4.74

pmol/l

0.83

544

2840

Hypokalaemia

478

2263

2.22

53.68

2.9

3.0

4.23

4.46

pmol/l

5.14

420

1994

Genitourinary diseases

2115

7292

1.48

53.68

3.2

3.5

4.53

4.67

pmol/l

5.82

1884

6596

Osteoporosis

1015

5720

1.72

52.82

3.3

3.2

4.27

4.40

pmol/l

3.67

850

4983

Chronic thyroiditis

19.95

52.67

4.1

1.7

4.34

4.35

pmol/l

0.03

Implicit fungal Sepsis

319

1294

2.66

52.10

3.3

4.12

4.50

pmol/l

8.40

267

1143

Non-allergic asthma (mode), excluding more controls

743

4084

1.86

52.02

3.1

3.3

4.54

pmol/l

0.03

663

3597

Abnormal findings on examination of blood, without diagnosis

1519

9252

1.54

51.73

3.1

3.3

4.40

4.46

pmol/l

1.22

1358

8218

Functional dyspepsia

1153

7245

1.65

51.49

3.0

3.4

4.43

4.48

pmol/l

1.05

1020

6460

Exposure to unspecified factor

4073

22794

1.31

51.38

3.1

3.4

4.43

4.53

pmol/l

8.02

3581

20427

Liquid cancers, helper endpoint

1278

7124

1.60

51.30

3.5

3.0

4.33

4.44

pmol/l

3.48

1145

6227

Endocrine disorders, other/unspecified

146

387

4.45

50.92

4.1

3.4

4.33

4.62

pmol/l

1.95

126

343

Certain infectious and parasitic diseases

3113

11582

1.37

50.90

3.2

3.5

4.42

4.57

pmol/l

12.36

2771

10439

Hypotension

560

2861

2.03

50.68

2.8

3.2

4.11

4.38

pmol/l

7.02

464

2461

Mouth breathing

1436

9489

1.55

50.50

3.2

3.4

4.52

4.51

pmol/l

0.21

1266

8503

Disorders of synovium and tendon

2163

13505

1.43

50.50

3.0

3.5

4.45

4.52

pmol/l

2.52

1937

12131

Candidiasis

1284

8321

1.60

50.37

3.3

4.36

4.50

pmol/l

5.85

1105

7400

Hypertrophic cardiomyopathy

199

641

3.41

50.30

4.1

3.5

4.08

4.50

pmol/l

5.28

185

564

Other arthrosis

1960

9449

1.47

50.25

3.1

3.5

4.44

4.47

pmol/l

0.48

1743

8422

Benign neoplasm of thyroid gland

205

679

3.42

50.23

4.5

3.2

4.44

4.48

pmol/l

0.20

187

593

Dental pulpitis, including avohilmo

3879

19484

1.31

50.22

3.4

4.59

4.53

pmol/l

2.01

3476

17516

Any operation in hilmo

158

183

4.56

50.19

3.9

3.2

4.79

4.85

pmol/l

0.14

138

161

Missing teeth due to accident, extraction or parodontitis

2138

14379

1.43

50.01

3.4

3.3

4.39

4.43

pmol/l

0.95

1844

12760

Hyperkinetic disorders

635

3345

1.96

49.93

2.8

3.4

4.83

4.74

pmol/l

0.92

565

3045

Poisoning by drugs, medicaments and biological substances

1064

6613

1.67

49.81

2.8

3.4

4.45

4.57

pmol/l

2.95

921

5972

Valvular operations

397

1788

2.30

49.80

3.7

3.1

4.30

4.52

pmol/l

2.74

363

1572

Other sleep disorders

456

2184

2.19

49.75

3.4

4.49

4.53

pmol/l

0.32

406

1945

Diseases of the ear and mastoid process

4909

19540

1.28

49.72

3.2

3.4

4.50

4.53

pmol/l

1.18

4343

17572

Aplastic and other anaemias

1541

9644

1.52

49.72

3.2

3.3

4.13

4.42

pmol/l

24.60

1356

8471

Pain and other conditions associated with female genital organs and menstrual cycle

1061

6055

1.68

49.61

3.1

3.5

4.56

4.59

pmol/l

0.34

946

5443

Endometriosis

1715

6829

1.52

49.39

3.1

3.4

4.46

4.53

pmol/l

2.67

1533

6073

Diabetes medication

4288

19945

1.29

49.02

3.1

3.4

4.43

4.52

pmol/l

7.33

3768

17860

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3978

21144

1.30

48.96

3.2

3.4

4.36

4.55

pmol/l

24.86

3511

18936

Insulin, combination of fast acting with intermediate-acting or long-acting

2154

14100

1.42

48.90

3.1

3.3

4.31

4.49

pmol/l

12.73

1897

12529

Other and unspecified anaemias

1413

8918

1.55

48.88

3.1

3.3

4.13

4.42

pmol/l

22.10

1245

7821

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1352

8918

1.57

48.83

2.8

3.4

4.50

4.56

pmol/l

1.19

1175

8059

Weight loss

424

1995

2.25

48.81

2.9

3.2

4.33

4.48

pmol/l

2.09

372

1754

Arthropathies

3841

14997

1.32

48.79

3.2

3.5

4.53

4.57

pmol/l

1.40

3426

13481

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2231

16116

1.41

48.77

3.4

3.3

4.37

4.46

pmol/l

3.67

1976

14339

Other anaemias

1426

8998

1.54

48.77

3.1

3.2

4.13

4.42

pmol/l

22.48

1257

7892

Drug-induced adrenocortical insufficiency

137

359

4.55

48.76

4.6

3.3

4.36

4.50

pmol/l

0.92

125

316

Other general symptoms and signs

272

1045

2.79

48.71

3.5

3.3

4.49

4.65

pmol/l

1.75

251

942

Symptoms and signs involving the urinary system

2807

15930

1.37

48.69

3.2

3.3

4.36

4.47

pmol/l

6.14

2428

14156

Diseases of pulp and periapical tissues, including avohilmo

4372

17776

1.29

48.42

3.4

3.3

4.53

4.52

pmol/l

0.23

3887

15906

Intracranial trauma

2236

11274

1.42

48.41

3.2

3.6

4.44

4.59

pmol/l

8.96

1992

10173

Abnormal involuntary movements

559

2920

2.01

48.08

3.1

3.4

4.36

4.49

pmol/l

2.64

484

2594

Other CVD

644

3508

1.90

47.97

2.9

3.2

4.13

4.38

pmol/l

7.29

540

3027

Temporomandibular joint disorders, including avohilmo

2090

14811

1.43

47.91

3.1

3.4

4.52

4.55

pmol/l

0.72

1863

13320

Rotator cuff syndrome

2245

11600

1.41

47.74

3.1

3.4

4.45

4.47

pmol/l

0.47

2003

10372

Acute renal failure

691

3852

1.85

47.72

3.3

3.2

3.95

4.43

pmol/l

23.70

612

3376

STROKE

2021

9706

1.44

47.63

3.2

3.4

4.34

4.52

pmol/l

12.03

1795

8573

Migraine without aura and triptan purchases

872

5234

1.75

47.49

2.9

3.4

4.55

4.58

pmol/l

0.39

779

4730

Menorrhagia

1678

6334

1.52

47.39

3.3

3.4

4.46

4.52

pmol/l

1.30

1477

5625

Other disorders of skin and subcutaneous tissue

2617

17287

1.37

47.18

3.2

3.3

4.35

4.46

pmol/l

5.87

2255

15407

Insulin medication

2151

13036

1.41

46.70

3.1

3.4

4.31

4.50

pmol/l

13.34

1894

11577

Emotional disorders starting during childhood or adolecense, excluding more controls

231

818

2.96

46.63

2.9

4.0

4.81

4.92

pmol/l

0.85

205

757

Cardiac arrest

219

644

3.05

46.58

3.9

3.3

4.09

4.60

pmol/l

9.35

199

564

Asthma-related pneumonia

1308

8612

1.55

46.56

3.1

3.3

4.33

4.46

pmol/l

4.23

1147

7578

Asthma-related pneumonia or sepsis

1310

8630

1.55

46.50

3.1

3.3

4.33

4.45

pmol/l

4.15

1149

7596

Asthma, hospital admissions 3, pneumonia

1310

8630

1.55

46.50

3.1

3.3

4.33

4.45

pmol/l

4.15

1149

7596

Finngen Rheumatological endpoints

4000

17795

1.30

46.44

3.1

3.5

4.47

4.55

pmol/l

4.69

3545

15985

Disease of hard tissues of teeth, NOS

2130

7910

1.43

46.44

3.3

3.5

4.52

4.49

pmol/l

0.68

1876

7078

Disorders of gallbladder, biliary tract and pancreas

3903

19236

1.30

46.42

3.2

3.4

4.38

4.49

pmol/l

8.44

3456

17198

Diseases of the digestive system

1593

10886

1.49

46.35

3.3

3.2

4.36

4.46

pmol/l

3.29

1404

9622

Poisoning by medicine

969

5996

1.68

46.30

2.8

3.4

4.45

4.57

pmol/l

3.26

835

5423

Autoimmune diseases excluding thyroid diseases, strict definition

2406

9545

1.39

46.07

1.7

1.9

4.51

4.59

pmol/l

3.78

2105

8448

Post-traumatic stress disorder

465

2323

2.13

46.01

3.0

3.6

4.55

4.65

pmol/l

1.30

410

2123

Inflammatory diseases of female pelvic organs

3029

16954

1.34

46.01

3.2

3.3

4.48

4.50

pmol/l

0.70

2668

15181

Abnormal weight loss

382

1770

2.29

45.76

2.9

3.3

4.33

4.49

pmol/l

2.13

331

1548

Chronic apical periodontitis

4603

20908

1.27

45.52

3.3

4.49

4.51

pmol/l

0.64

4064

18720

Acute sinusitis

2180

14691

1.40

45.42

3.2

3.4

4.51

4.54

pmol/l

0.39

1949

13164

Iron deficiency

203

712

3.26

45.39

3.3

3.4

4.49

4.60

pmol/l

0.86

187

637

Cholelithiasis

3366

17894

1.32

45.21

3.2

3.4

4.40

4.47

pmol/l

3.81

2974

15981

Systemic connective tissue disorders

1418

9597

1.52

45.08

2.9

3.3

4.35

4.44

pmol/l

2.88

1242

8460

Subjective visual disturbances

1053

6690

1.63

45.05

3.3

4.44

4.49

pmol/l

0.88

944

5925

Angina pectoris

1783

8286

1.46

44.89

3.1

3.3

4.29

4.46

pmol/l

9.87

1568

7271

Bacterial infection, other or unspecified

2012

12208

1.42

44.81

3.1

3.3

4.20

4.49

pmol/l

25.59

1787

10779

Non-allergic asthma (mode)

743

4269

1.78

44.81

3.1

3.3

4.54

4.51

pmol/l

0.25

663

3761

Cervical disc disorders

1323

8824

1.54

44.81

3.1

3.5

4.47

4.45

pmol/l

0.22

1164

7895

Other bacterial diseases

3580

18716

1.30

44.69

3.1

3.3

4.28

4.53

pmol/l

34.92

3164

16709

Monoamine oxidase A inhibitors

474

2403

2.07

44.39

2.9

3.6

4.41

4.51

pmol/l

1.09

403

2166

Caries of dentine, including avohilmo

3052

11798

1.34

44.35

3.2

3.4

4.48

4.50

pmol/l

0.28

2701

10570

Other systemic involvement of connective tissue

1138

7384

1.59

44.34

2.9

3.3

4.38

4.44

pmol/l

1.38

1001

6512

Emotionally unstable personality disorder

644

3623

1.87

44.28

2.7

3.4

4.45

4.61

pmol/l

3.91

554

3290

Extrapyramidal and movement disorders

1343

9016

1.53

44.17

3.0

3.3

4.40

4.41

pmol/l

0.08

1153

7956

Persons encountering health services for specific procedures, not carried out

375

1750

2.27

44.08

2.9

3.3

4.44

4.58

pmol/l

2.13

319

1563

Other neurological diseases

2590

15236

1.36

43.80

3.1

3.3

4.36

4.45

pmol/l

5.02

2296

13482

Substance abuse, excluding more controls

1865

11309

1.43

43.60

2.7

3.6

4.47

4.54

pmol/l

2.32

1580

10306

Hypothyroidism, autoimmune, DX-based

10.78

43.58

4.3

3.5

4.42

4.80

pmol/l

1.27

Urticaria and erythema

1574

10955

1.48

43.33

3.2

3.4

4.52

pmol/l

0.02

1394

9814

Dermatitis

2397

17803

1.37

43.26

3.0

3.4

4.40

4.50

pmol/l

5.45

2113

15922

Bacterial infection, other or unspecified

1828

11279

1.43

43.14

3.1

3.3

4.18

4.48

pmol/l

26.28

1618

9957

Cholelithiasis, broad definition with cholecystitis

3454

18101

1.30

42.92

3.2

3.4

4.39

4.47

pmol/l

4.28

3056

16171

Transplanted organ and tissue status

373

1753

2.24

42.87

3.4

4.10

4.57

pmol/l

15.45

348

1558

Other diseases of hard tissues of teeth

2158

8049

1.41

42.82

3.1

3.5

4.44

4.48

pmol/l

0.89

1889

7189

Ovarian cyst

1747

7056

1.47

42.80

3.3

3.4

4.49

4.54

pmol/l

1.57

1582

6279

Benign neoplasm of colon, rectum, anus and anal canal

2137

13581

1.39

42.47

3.0

3.3

4.35

4.42

pmol/l

2.19

1855

11996

Vasomotor and allergic rhinitis

1593

10931

1.46

42.44

3.0

3.3

4.60

4.56

pmol/l

0.70

1402

9817

Other bacterial diseases

3978

20001

1.28

42.35

3.2

3.4

4.31

4.55

pmol/l

37.36

3525

17881

Chronic gastritis

957

6021

1.63

42.24

2.9

3.4

4.26

4.42

pmol/l

5.51

823

5303

Hyperhidrosis

190

663

3.17

42.21

2.6

3.3

4.60

pmol/l

0.01

162

594

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3682

17404

1.29

42.20

3.1

3.4

4.38

4.52

pmol/l

12.76

3242

15549

Disorders of ocular muscles, binocular movement, accommodation and refraction

1947

13991

1.41

42.20

3.6

3.3

4.53

4.55

pmol/l

0.35

1757

12516

Pain in thoracic spine

670

3858

1.81

42.07

3.0

3.4

4.44

4.49

pmol/l

0.73

593

3449

Polyuria

744

4401

1.74

41.91

3.2

3.3

4.37

4.44

pmol/l

1.24

643

3901

Heartburn

465

2394

2.04

41.75

3.0

3.3

4.51

pmol/l

0.00

394

2148

Obsessive-compulsive disorder

347

1610

2.30

41.65

2.6

3.6

4.44

4.72

pmol/l

5.49

303

1469

Allergic asthma (mode), excluding more controls

985

6129

1.62

41.45

3.3

3.4

4.59

4.60

pmol/l

0.05

879

5457

Dental caries, including avohilmo

2799

10814

1.34

41.22

3.2

3.4

4.47

4.49

pmol/l

0.45

2479

9675

Other acute lower respiratory infections

1940

13413

1.40

41.21

3.2

3.3

4.46

4.51

pmol/l

1.21

1701

11930

Infections of the skin and subcutaneous tissue

2199

16157

1.37

40.87

3.3

3.4

4.46

4.55

pmol/l

3.61

1986

14448

Urticaria

1319

8986

1.51

40.78

3.3

4.54

4.53

pmol/l

0.03

1168

8053

Hernia of abdominal wall, postoperative

640

3658

1.80

40.72

3.0

3.1

4.32

4.54

pmol/l

7.60

556

3292

Enlarged lymph nodes

599

3363

1.85

40.69

3.6

3.4

4.48

4.55

pmol/l

1.22

528

2998

Other extrapyramidal and movement disorders in other diseases

892

5582

1.65

40.62

3.1

3.3

4.41

4.43

pmol/l

0.21

755

4915

Insulin, fast-acting (human)

598

3365

1.85

40.56

3.0

3.4

4.36

4.55

pmol/l

4.12

533

3011

Abnormal findings on diagnostic imaging of lung

1540

10327

1.46

40.41

3.3

4.33

4.40

pmol/l

1.57

1352

9110

Volume depletion

310

1381

2.34

40.31

3.0

3.98

4.44

pmol/l

4.86

268

1205

Other and unspecified dermatitis

2028

14907

1.39

40.28

3.0

3.4

4.40

4.49

pmol/l

4.23

1787

13328

Gout

759

3991

1.71

39.95

2.9

3.5

4.16

4.42

pmol/l

9.30

668

3515

Hyperkalaemia

200

730

2.90

39.93

3.0

3.1

3.95

4.41

pmol/l

5.43

172

642

Other eating disorders

309

1399

2.39

39.85

3.0

3.4

4.35

4.73

pmol/l

10.21

275

1256

Diplopia

519

2815

1.93

39.84

3.8

3.2

4.45

4.46

pmol/l

0.07

472

2500

Acute tubulo-interstitial nephritis

2410

15662

1.35

39.77

3.2

3.3

4.32

4.51

pmol/l

12.79

2135

13918

Amenorrhoea

403

2024

2.13

39.60

3.1

3.4

4.25

4.64

pmol/l

11.89

365

1818

Explicit Sepsis

1476

9612

1.46

39.27

3.0

3.3

4.20

4.50

pmol/l

20.38

1309

8538

Diseases of oral cavity, salivary glands and jaws

2148

8079

1.39

39.08

3.2

3.5

4.46

4.48

pmol/l

0.50

1898

7211

Cervicalgia

820

5076

1.67

39.00

3.0

3.4

4.47

4.46

pmol/l

0.17

722

4527

Statin medication

2859

12318

1.33

38.97

3.0

3.6

4.44

4.55

pmol/l

7.69

2552

11031

Fenamates

622

2379

1.84

38.94

3.1

3.6

4.42

4.41

pmol/l

0.03

563

2121

Gingivitis and periodontal diseases

4051

16693

1.27

38.93

3.2

3.4

4.48

4.51

pmol/l

0.66

3584

14937

Other and unspecified polyneuropathies, also in other diseases

606

3458

1.81

38.91

2.9

3.3

4.24

4.42

pmol/l

4.44

532

3045

Major coronary heart disease event excluding revascularizations

1816

8688

1.42

38.79

3.1

3.3

4.26

4.45

pmol/l

11.26

1602

7609

Eating disorder

509

2783

1.94

38.61

2.9

3.4

4.32

4.66

pmol/l

12.63

444

2517

Other gastritis (incl. Duodenitis)

787

4833

1.68

38.48

3.0

3.4

4.35

4.44

pmol/l

1.58

691

4289

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

756

4535

1.69

38.44

5.0

3.0

4.26

4.40

pmol/l

3.42

693

3966

Hypertensive heart and/or renal disease

743

3310

1.71

38.24

3.0

3.1

4.17

4.41

pmol/l

7.60

642

2896

Benign neoplasm: Colon

1768

12222

1.41

38.15

3.0

3.3

4.36

4.40

pmol/l

0.97

1528

10792

Hypercalcemia

201

762

2.87

38.03

2.9

3.2

4.17

4.46

pmol/l

2.90

174

660

Other disorders of eye and adnexa

621

3610

1.80

37.97

3.3

3.4

4.47

4.51

pmol/l

0.36

556

3232

Convulsions, not elsewhere classified

811

4966

1.65

37.78

3.0

3.4

4.42

4.62

pmol/l

5.66

722

4450

Other and unspecified mood [affective] disorders

353

1715

2.18

37.61

3.0

3.5

4.47

4.64

pmol/l

2.16

309

1550

Bleeding

2893

15949

1.31

37.50

3.2

3.3

4.35

4.48

pmol/l

8.08

2545

14146

Allergic asthma (mode)

985

6278

1.58

37.39

3.3

3.4

4.59

pmol/l

0.08

879

5596

Cardiomyopathy, Hypertrophic obstructive

223

4.71

37.36

4.2

3.4

3.95

4.68

pmol/l

8.28

198

Substance use, excluding alcohol

780

4834

1.67

36.97

2.8

3.4

4.45

4.56

pmol/l

2.15

661

4351

Glucagon-like peptide-1 (GLP-1) analogues

1076

7174

1.54

36.90

3.1

3.4

4.44

4.49

pmol/l

0.81

947

6448

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1076

7174

1.54

36.90

3.1

3.4

4.44

4.49

pmol/l

0.81

947

6448

Polyneuropathies and other disorders of the peripheral nervous system

685

4107

1.72

36.76

3.2

3.3

4.25

4.42

pmol/l

4.55

608

3630

Diaphragmatic hernia

1279

8828

1.48

36.69

2.9

3.3

4.42

4.41

pmol/l

0.10

1114

7812

Mycoses

1001

6584

1.56

36.62

3.1

3.3

4.33

4.49

pmol/l

5.16

859

5844

All influenza

869

5531

1.61

36.49

3.0

3.4

4.44

4.55

pmol/l

1.59

773

4899

Other bacterial intestinal infections

840

5313

1.63

36.46

3.2

3.3

4.33

4.48

pmol/l

5.17

724

4688

Cholecystectomy

2746

18399

1.31

36.26

3.2

3.3

4.43

4.45

pmol/l

0.29

2431

16386

Acute bronchitis

1461

10137

1.44

36.22

3.2

3.3

4.40

4.48

pmol/l

1.99

1274

8988

Certain disorders involving the immune mechanism

720

4413

1.69

35.81

3.6

3.3

4.38

4.50

pmol/l

2.11

648

3940

Hypertensive Heart Disease

663

3075

1.73

35.51

3.0

3.1

4.19

4.40

pmol/l

5.77

569

2683

Disorders of skin appendages

1934

14388

1.37

35.41

3.5

3.3

4.49

4.54

pmol/l

1.48

1714

12890

Dental operations

2209

8468

1.36

35.35

3.2

3.4

4.47

4.48

pmol/l

0.19

1964

7529

Allergic conjunctivitis

2512

18915

1.32

35.33

3.2

3.3

4.50

4.53

pmol/l

0.61

2227

16938

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2410

18010

1.33

35.23

3.2

3.3

4.50

4.53

pmol/l

0.76

2138

16129

Other diseases of blood and blood-forming organs, wide

804

5083

1.63

35.13

3.2

3.3

4.46

4.47

pmol/l

0.05

685

4506

Other septicaemia

1206

7962

1.49

35.11

2.9

3.3

4.14

4.48

pmol/l

20.44

1064

6992

Type 1 diabetes, definitions combined

438

2343

1.95

34.92

3.3

3.4

4.49

4.69

pmol/l

3.44

399

2117

Diseases of salivary glands

1274

8890

1.47

34.72

3.2

3.3

4.45

4.48

pmol/l

0.45

1138

7903

Diseases of pulp and periapical tissues and dental caries

2470

9625

1.33

34.72

3.2

3.4

4.47

4.49

pmol/l

0.51

2174

8605

Type 1 diabetes, strict (exclude DM2)

435

2331

1.95

34.52

3.3

3.4

4.49

4.69

pmol/l

3.49

396

2108

Type 2 diabetes, definitions combined

3670

17321

1.26

34.21

3.2

3.4

4.42

4.51

pmol/l

5.25

3243

15485

Chronic laryngitis and laryngotracheitis

531

3040

1.82

34.06

3.4

3.3

4.36

4.45

pmol/l

1.46

451

2688

Ocular pain

397

2088

2.01

34.05

3.5

3.4

4.53

4.51

pmol/l

0.15

361

1863

Type 2 diabetes, strict (exclude DM1)

3684

17409

1.26

33.98

3.2

3.4

4.42

4.51

pmol/l

4.92

3255

15566

Other specified and unspecified personality disorders

417

2228

1.97

33.93

2.6

3.4

4.41

4.55

pmol/l

2.13

355

2008

Polyarthropathies

2533

12759

1.32

33.82

3.0

3.5

4.35

4.52

pmol/l

10.69

2243

11452

Falls/tendency to fall

4490

18433

1.23

33.79

3.2

3.4

4.50

4.55

pmol/l

2.21

3961

16616

Type 2 diabetes, definitions combined, including avohilmo

3705

17386

1.26

33.76

3.2

3.4

4.43

4.51

pmol/l

3.99

3276

15549

Asthma and allergy, excluding more controls

582

3381

1.76

33.66

3.1

3.5

4.63

4.62

pmol/l

0.14

512

3033

Carpal tunnel syndrome

2361

16021

1.32

33.60

2.9

3.4

4.44

4.47

pmol/l

0.87

2099

14270

Presence of other functional implants

1895

9754

1.37

33.41

3.1

3.3

4.29

4.44

pmol/l

6.54

1665

8576

Viral infections characterized by skin and mucous membrane lesions

3368

23141

1.26

33.34

3.2

3.3

4.45

4.53

pmol/l

4.35

2983

20701

Other noninfective gastroenteritis and colitis

931

6149

1.55

33.28

3.5

3.2

4.38

4.52

pmol/l

4.00

820

5454

Eating disorders

550

3211

1.80

33.28

2.9

3.4

4.35

4.63

pmol/l

10.13

479

2898

Fall on same level

4621

20813

1.23

33.20

3.2

3.4

4.46

4.55

pmol/l

6.43

4084

18727

Congenital malformations, deformations and chromosomal abnormalities

2635

19010

1.30

33.05

3.4

4.53

4.56

pmol/l

0.43

2354

17061

Cervicobrachial syndrome

885

5802

1.57

32.97

3.1

3.4

4.51

4.48

pmol/l

0.35

806

5206

Cerebral cysts

262

1196

2.33

32.88

3.3

4.54

4.58

pmol/l

0.33

231

1067

Secondary hypertension

265

1191

2.29

32.81

2.6

3.4

4.10

4.61

pmol/l

10.39

242

1064

Asthma and allergy

582

3410

1.74

32.64

3.1

3.4

4.63

4.61

pmol/l

0.26

512

3066

Endometriosis of pelvic peritoneum

777

4736

1.62

32.54

3.0

3.5

4.51

4.54

pmol/l

0.42

690

4229

Other and unspecified urticaria

846

5522

1.58

32.43

3.3

3.4

4.57

4.53

pmol/l

0.49

749

4953

Localized swelling, mass and lump of skin and subcutaneous tissue

1165

8096

1.47

32.37

3.7

3.3

4.51

4.47

pmol/l

0.53

1059

7213

Social phobias

384

2025

1.99

32.32

2.7

3.7

4.64

4.69

pmol/l

0.33

328

1854

Gout, FINNGEN

759

4797

1.61

32.31

2.9

3.3

4.16

4.40

pmol/l

8.22

668

4225

Septicaemia

1339

8898

1.43

32.25

3.0

3.3

4.18

4.48

pmol/l

17.96

1186

7834

Psychotic depression

253

1144

2.33

32.18

2.9

3.6

4.35

4.55

pmol/l

2.83

216

1047

Problems related to lifestyle

417

2260

1.92

32.11

3.2

3.4

4.51

4.56

pmol/l

0.41

366

2022

ILD medications: immunosuppressive drugs

2397

17287

1.31

32.08

3.2

3.4

4.38

4.55

pmol/l

9.98

2160

15480

Viral hepatitis, IBD co-morbidity

178

684

2.71

32.01

2.4

2.7

4.52

4.55

pmol/l

0.12

147

609

Acetic acid derivatives and related substances

975

3315

1.56

31.94

3.2

3.6

4.49

4.46

pmol/l

0.31

868

2970

Implicit fungal Sepsis

169

641

2.85

31.93

2.9

3.2

4.04

4.53

pmol/l

6.12

142

562

Other retinal disorders

2083

12327

1.34

31.92

3.2

3.3

4.31

4.44

pmol/l

6.16

1817

10900

Disorder of lipoprotein metabolism, unspecified

387

2048

1.95

31.74

2.9

3.1

4.25

4.41

pmol/l

2.28

345

1779

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

486

2769

1.81

31.55

3.9

3.0

4.35

4.45

pmol/l

1.52

451

2413

Pulmonary heart disease, diseases of pulmonary circulation

1019

6936

1.50

31.33

3.2

4.25

4.41

pmol/l

5.72

888

6075

Diagnoses used for exclusion with ILD

815

5304

1.57

31.14

3.3

4.33

4.44

pmol/l

2.28

723

4679

Schizoaffective disorder

349

1811

2.04

31.11

2.1

3.4

4.29

4.57

pmol/l

5.34

294

1629

Inflammatory disease of uterus

719

4591

1.64

30.87

3.1

3.4

4.54

4.53

pmol/l

0.08

642

4140

Osteoporosis with pathological fracture (FG)

292

1425

2.17

30.83

2.8

3.0

4.19

4.39

pmol/l

2.74

232

1232

Other complications of surgical and medical care, not elsewhere classified

409

2241

1.91

30.66

3.6

3.3

4.37

4.50

pmol/l

1.44

364

2013

Hyperprolactinaemia

205

877

2.56

30.53

2.8

3.4

4.38

4.61

pmol/l

3.01

190

791

External causes of morbidity and mortality

2809

11083

1.29

30.43

3.3

3.4

4.48

4.57

pmol/l

4.18

2501

9999

Other maternal disorders predominantly related to pregnancy

2724

13517

1.29

30.19

3.3

3.4

4.52

4.51

pmol/l

0.35

2475

12123

Viral and other specified intestinal infections

1100

7383

1.47

30.15

3.2

3.4

4.59

4.66

pmol/l

1.27

991

6631

Myocardial infarction

1377

6949

1.42

29.96

3.1

3.3

4.25

4.47

pmol/l

11.17

1220

6075

Other diseases of anus and rectum

1025

7034

1.49

29.95

2.9

3.4

4.37

4.45

pmol/l

1.59

884

6231

Disorders of vitreous body and globe

1755

12680

1.35

29.91

3.1

3.3

4.36

4.41

pmol/l

1.46

1549

11211

Fungal Sepsis

174

692

2.70

29.83

3.0

3.3

4.02

4.54

pmol/l

7.04

146

606

Other symptoms and signs involving the digestive system and abdomen

688

4365

1.63

29.82

3.4

3.3

4.37

4.48

pmol/l

2.02

604

3885

Persons with potential health hazards related to communicable diseases

1600

11797

1.37

29.73

3.5

3.4

4.58

4.61

pmol/l

0.51

1466

10631

Other external causes of accidental injury

3403

13762

1.25

29.72

3.2

3.4

4.47

4.55

pmol/l

3.89

3029

12391

Care involving dialysis

264

1254

2.20

29.62

2.5

3.4

3.66

4.51

pmol/l

25.20

240

1103

Type 1 diabetes, strict definition, subgroup 1

347

1820

2.00

29.60

3.3

3.5

4.54

4.74

pmol/l

2.60

317

1646

Diabetes, insulin treatment (Kela reimbursement)

3800

18825

1.23

29.57

3.1

3.4

4.38

4.51

pmol/l

11.09

3354

16809

Congenital malformations, deformations and chromosomal abnormalities

2381

17793

1.29

29.55

3.4

4.54

4.56

pmol/l

0.36

2126

15977

Sequelae of external causes of morbidity and mortality

895

6022

1.53

29.44

3.2

3.4

4.41

4.45

pmol/l

0.46

799

5308

Disorders of vitreous body

1710

12412

1.36

29.40

3.1

3.3

4.36

4.41

pmol/l

1.27

1507

10971

Cervicocranial syndrome

443

2518

1.83

29.36

3.0

3.4

4.61

4.47

pmol/l

1.42

400

2244

Other menopausal disorders

1216

4816

1.46

29.36

3.3

3.4

4.43

4.48

pmol/l

0.83

1094

4265

Coxibs

959

3362

1.53

29.26

3.1

3.6

4.57

4.47

pmol/l

2.20

844

3014

Adenomyosis (Endometriosis of uterus)

591

3645

1.69

29.08

3.3

4.41

4.44

pmol/l

0.28

528

3195

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

373

2020

1.94

29.07

3.4

3.2

4.40

4.52

pmol/l

1.57

331

1799

Other bacterial intestinal infections

620

3854

1.66

29.06

3.1

3.2

4.27

4.47

pmol/l

6.05

539

3390

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1252

8893

1.43

29.05

3.4

4.60

pmol/l

0.01

1120

8034

Maternal care for other conditions predominantly related to pregnancy

1074

7387

1.47

29.01

3.2

3.4

4.56

4.55

pmol/l

0.11

960

6675

Other disorders of bladder

369

1984

1.93

28.99

3.3

4.33

4.43

pmol/l

1.18

326

1750

Gout, idiopatic and unspecified

634

3959

1.64

28.87

2.9

3.2

4.13

4.38

pmol/l

7.44

561

3476

Noninflammatory disorders of female genital tract

1954

7439

1.34

28.60

3.2

3.4

4.51

4.57

pmol/l

1.92

1754

6637

Mental disorders, not otherwise specified

385

2122

1.91

28.54

2.7

3.3

4.48

4.56

pmol/l

1.03

343

1913

Disorders of choroid and retina

2743

15536

1.27

28.54

3.2

3.3

4.34

4.45

pmol/l

6.65

2422

13772

Cutaneous abscess, furuncle and carbuncle

940

6431

1.50

28.43

3.2

3.4

4.44

4.53

pmol/l

1.57

844

5743

Disorders of vestibular function (Vertigo)

1675

12436

1.35

28.05

3.2

3.3

4.35

4.42

pmol/l

2.42

1475

10966

Deforming dorsopathies

1044

7305

1.46

28.02

3.0

3.4

4.47

4.49

pmol/l

0.19

917

6535

COPD (mode)

866

4551

1.52

27.93

3.1

3.3

4.26

4.46

pmol/l

6.23

750

3996

Disorders of pituitary gland, other and/or unspecified

6.72

27.72

2.7

3.2

4.10

4.65

pmol/l

2.28

Other disorders of eyelid

1443

10148

1.38

27.69

3.3

3.2

4.36

4.39

pmol/l

0.49

1276

8900

Injuries to the ankle and foot

2800

20038

1.26

27.63

3.0

3.4

4.54

4.55

pmol/l

0.35

2477

18026

Diabetes mellitus in pregnancy

1679

8097

1.36

27.38

3.4

3.5

4.59

4.58

pmol/l

0.26

1546

7350

Wide developmental disorders, excluding more controls

133

473

2.95

27.26

2.8

3.8

5.13

4.96

pmol/l

0.62

116

439

Cushing syndrome

212

4.34

27.21

2.7

3.2

4.21

4.53

pmol/l

1.71

186

Other and unspecified effects of external causes

1098

7802

1.44

27.19

3.1

3.4

4.52

4.55

pmol/l

0.44

980

7008

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

702

4576

1.59

27.17

2.8

3.4

4.48

4.57

pmol/l

1.68

599

4136

Emotional disorders and disorders of social functioning with onset specific to childhood

249

1181

2.20

27.14

3.3

3.5

4.80

4.83

pmol/l

0.16

219

1078

Accidents

3371

13762

1.24

27.02

3.2

3.4

4.48

4.55

pmol/l

3.78

3013

12391

Type 1 diabetes, strict definition

354

1925

1.92

27.01

3.3

3.5

4.54

4.73

pmol/l

2.70

324

1743

Elevated blood glucose level

313

1640

2.00

26.95

3.3

4.40

4.48

pmol/l

0.64

275

1459

Left bundle-branch block

233

1094

2.22

26.90

3.1

4.37

4.48

pmol/l

0.53

205

958

Suicide or other Intentional self-harm

961

6680

1.48

26.90

2.7

3.4

4.47

4.55

pmol/l

1.39

823

6022

Tonsillectomy and adenotomy

2443

13480

1.28

26.87

3.5

3.4

4.66

4.59

pmol/l

1.89

2201

12207

Extracorporeal dialysis

209

945

2.33

26.72

2.5

3.5

3.61

4.50

pmol/l

20.21

190

837

Soft tissue disorders related to use, overuse and pressure

943

6538

1.48

26.59

3.0

3.5

4.43

4.46

pmol/l

0.47

832

5810

Mixed and other personality disorders

358

1979

1.90

26.30

3.2

3.4

4.42

4.58

pmol/l

2.65

307

1794

Malignant neoplasm of urinary organs

270

1350

2.07

26.28

4.4

2.9

4.23

4.41

pmol/l

1.55

241

1160

Malignant neoplasm of kidney, except renal pelvis

252

1231

2.12

26.17

4.4

3.0

4.26

4.42

pmol/l

1.24

226

1053

Strabismus

1001

7034

1.45

26.01

3.9

3.3

4.52

4.54

pmol/l

0.26

913

6284

Deviated nasal septum

982

6871

1.45

25.99

3.2

3.3

4.47

4.49

pmol/l

0.31

872

6119

False labour

1514

7056

1.37

25.98

3.4

3.5

4.58

4.57

pmol/l

0.13

1378

6400

Other strabismus

858

5858

1.50

25.94

4.0

3.3

4.54

4.56

pmol/l

0.24

782

5245

Early onset COPD, excluding more controls

574

3592

1.63

25.91

3.2

3.5

4.31

4.51

pmol/l

5.18

500

3188

Gout, unspecified

515

3141

1.68

25.89

2.9

3.2

4.13

4.38

pmol/l

6.77

452

2766

Anosmia

151

4.47

25.84

3.1

2.7

4.37

4.64

pmol/l

1.62

136

Meniscus derangement

1923

9998

1.31

25.82

3.1

3.5

4.45

4.48

pmol/l

0.46

1731

8930

Epilepsy

999

7012

1.45

25.72

2.8

3.4

4.34

4.53

pmol/l

6.47

895

6230

Other diseases of pericardium

155

624

2.62

25.71

3.2

3.3

4.18

4.57

pmol/l

3.28

136

548

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3556

18837

1.22

25.70

3.2

3.4

4.40

4.48

pmol/l

3.77

3159

16832

Other viral diseases

1484

11072

1.36

25.69

3.0

3.4

4.56

4.59

pmol/l

0.42

1323

9994

Other and unspecified drugs and medicaments

347

1914

1.90

25.63

3.3

4.38

4.50

pmol/l

1.30

306

1706

Anankastic personality disorder

205

945

2.34

25.54

2.9

3.4

4.44

4.55

pmol/l

0.88

173

849

Tinnitus

842

5770

1.50

25.43

3.1

3.3

4.48

4.45

pmol/l

0.36

735

5132

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

288

1491

2.00

25.40

4.4

2.9

4.28

4.42

pmol/l

1.13

258

1287

Intracranial injury

2044

15166

1.29

25.34

3.1

3.3

4.43

4.52

pmol/l

3.53

1794

13511

Sequelae with surgical and medical care as external cause

695

4588

1.56

25.22

3.2

3.3

4.41

4.45

pmol/l

0.45

622

4042

Unstable angina pectoris

970

5341

1.46

25.21

3.2

3.3

4.26

4.43

pmol/l

5.24

849

4639

Bacterial intestinal infections, IBD co-morbidities

616

3959

1.60

25.16

3.0

3.2

4.26

4.45

pmol/l

5.48

541

3501

Postmenopausal bleeding

1060

3979

1.46

25.15

3.2

3.3

4.41

4.42

pmol/l

0.10

920

3488

Restless leg syndrome

512

3160

1.68

25.12

3.4

3.3

4.45

4.46

pmol/l

0.17

440

2805

Procreative management

1266

7748

1.39

25.09

3.3

3.4

4.59

pmol/l

0.07

1152

6920

Neuromuscular dysfunction of bladder

320

1728

1.93

25.07

3.2

4.28

4.48

pmol/l

3.36

282

1543

Gout, strict definition

444

2629

1.73

25.02

3.0

3.2

4.13

4.38

pmol/l

5.01

394

2307

Retention of urine

908

5154

1.47

24.95

3.2

3.3

4.21

4.42

pmol/l

7.25

800

4572

Venous thromboembolism

1763

13152

1.31

24.82

3.1

3.3

4.32

4.42

pmol/l

4.25

1540

11624

Arthrosis

2565

11264

1.26

24.75

3.1

3.5

4.49

pmol/l

0.06

2286

10096

Benign neoplasm: Adrenal gland

292

1542

1.99

24.74

3.2

3.4

4.36

4.42

pmol/l

0.53

258

1361

Manic episode

143

569

2.70

24.64

2.5

3.5

4.32

4.65

pmol/l

3.68

119

513

L04AD Calcineurin inhibitors

400

2327

1.79

24.53

3.4

4.12

4.57

pmol/l

14.63

368

2090

Atypical facial pain

238

1178

2.15

24.51

3.2

3.3

4.34

4.47

pmol/l

1.39

209

1045

Diseases of inner ear

1884

14226

1.30

24.50

3.2

3.3

4.37

4.44

pmol/l

2.50

1659

12578

Speech and linguistic disorders, excluding more controls

276

1340

2.01

24.36

2.9

3.8

4.86

4.83

pmol/l

0.11

249

1223

Exposure to other specified factors

2842

21343

1.24

24.25

3.0

3.4

4.49

4.54

pmol/l

1.69

2497

19170

Other disorders of kidney and ureter

420

2481

1.75

24.20

3.1

3.3

4.17

4.44

pmol/l

6.33

383

2183

Injury, poisoning and certain other consequences of external causes

2286

9058

1.28

24.15

3.2

3.5

4.47

4.57

pmol/l

4.46

2039

8166

Internal derangement of knee

1316

9758

1.36

24.09

3.3

3.5

4.47

4.50

pmol/l

0.79

1164

8738

Injuries to the knee and lower leg

4651

21959

1.19

24.03

3.2

3.4

4.49

4.52

pmol/l

1.46

4145

19633

Pulmonary embolism

911

6399

1.45

23.88

3.1

3.2

4.27

4.42

pmol/l

4.29

790

5623

Emotional disorders starting during childhood or adolescence

236

1163

2.13

23.88

3.0

3.4

4.83

pmol/l

0.03

210

1059

Atopic dermatitis

2414

15923

1.26

23.82

3.1

3.4

4.57

pmol/l

0.01

2125

14368

Viral infections characterized by skin and mucous membrane lesions

1482

11251

1.34

23.82

3.2

3.4

4.43

4.51

pmol/l

2.46

1313

10014

Excessive attrition of teeth

2176

17373

1.27

23.74

3.2

3.4

4.48

4.54

pmol/l

2.23

1931

15602

Other diseases of the digestive system

914

6431

1.45

23.63

3.2

4.31

4.43

pmol/l

2.29

797

5636

Abnormal findings on diagnostic imaging of other body structures

508

3176

1.66

23.62

3.2

4.41

4.45

pmol/l

0.46

457

2824

Stomatitis and related lesions

732

4960

1.52

23.52

2.8

3.3

4.52

4.51

pmol/l

0.06

649

4427

Pulmonary heart disease

911

6421

1.45

23.45

3.1

3.2

4.27

4.41

pmol/l

4.11

790

5643

Viral pneumonia

424

2535

1.72

23.30

3.3

4.35

4.53

pmol/l

1.67

379

2240

Dissociative [conversion] disorders

194

907

2.29

23.25

3.0

3.4

4.28

4.62

pmol/l

6.29

169

817

Diseases of the myoneural junction and muscle

393

2305

1.76

23.25

2.9

3.2

4.34

4.46

pmol/l

1.45

336

2030

Unspecified haematuria

1172

7118

1.39

23.21

3.1

3.3

4.34

4.45

pmol/l

2.12

1029

6321

Benign neoplasm: Colon, unspecified

745

5071

1.50

23.17

2.9

3.3

4.33

4.38

pmol/l

0.91

628

4461

Vitamin deficiency, wide

195

913

2.26

23.08

3.9

3.2

4.32

4.51

pmol/l

1.51

166

811

Vitamin deficiency

195

913

2.26

23.08

3.9

3.2

4.32

4.51

pmol/l

1.51

166

811

Disorders of refraction and accommodation

1040

7505

1.41

23.07

3.3

4.55

4.57

pmol/l

0.24

929

6732

Candidiasis

540

3449

1.62

23.02

3.3

4.30

4.48

pmol/l

4.43

458

3069

Use of pramipexole

745

5090

1.50

22.90

3.0

3.3

4.39

4.41

pmol/l

0.29

635

4468

Sleep disorders, other/unspecified

177

803

2.37

22.90

3.6

3.2

4.52

4.67

pmol/l

1.24

153

717

Other diseases of liver

647

4303

1.55

22.79

2.9

3.4

4.46

4.48

pmol/l

0.18

569

3832

GI-bleeding

905

6401

1.44

22.73

3.2

4.30

4.42

pmol/l

2.47

797

5616

Haemorrhoids and perianal venous thrombosis

1042

7540

1.40

22.70

3.2

3.4

4.40

4.44

pmol/l

0.48

907

6680

Caries of enamel

3474

20983

1.21

22.66

3.3

3.4

4.53

pmol/l

0.04

3065

18853

Adverse effects, not elsewhere classified

800

5562

1.48

22.61

3.2

3.3

4.50

4.53

pmol/l

0.48

724

4982

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

552

3547

1.60

22.59

4.9

3.0

4.33

4.41

pmol/l

1.05

512

3093

Paracetamol or NSAID medication

588

1869

1.61

22.58

3.5

4.66

4.60

pmol/l

0.58

525

1684

Other abnormal uterine and vaginal bleeding

939

4771

1.45

22.55

3.0

3.3

4.45

4.47

pmol/l

0.17

810

4191

Myocardial infarction, strict

1216

6386

1.37

22.54

3.1

3.3

4.25

4.47

pmol/l

9.54

1080

5576

Diseases of liver

1125

8282

1.38

22.43

3.0

3.4

4.36

4.47

pmol/l

2.66

989

7360

Autism spe, excluding more controls

106

379

2.99

22.39

2.7

3.9

5.22

4.97

pmol/l

0.82

351

Other (not insulin) diabetes medications

3652

18192

1.20

22.31

3.1

3.4

4.43

4.50

pmol/l

3.26

3181

16281

Erysipelas

1733

11962

1.30

22.29

3.1

3.3

4.25

4.49

pmol/l

17.53

1520

10556

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1683

10465

1.31

22.23

3.0

3.3

4.29

4.41

pmol/l

5.57

1462

9236

Other enthesopathies

1087

7975

1.39

22.22

3.0

3.5

4.47

4.49

pmol/l

0.24

980

7135

Sicca syndrome [Sjögren]

366

2147

1.79

22.11

3.0

3.2

4.36

4.46

pmol/l

1.23

316

1916

Ovarian dysfunction

399

2403

1.75

22.02

3.4

4.62

4.59

pmol/l

0.24

358

2168

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

270

1444

1.95

21.93

2.3

3.4

4.58

4.69

pmol/l

0.84

228

1295

Other specified/unspecified arthritis

961

6931

1.41

21.82

3.1

3.4

4.42

4.49

pmol/l

1.54

869

6189

Benign neoplasm of other and ill-defined parts of digestive system

613

4073

1.55

21.73

3.3

3.2

4.38

4.42

pmol/l

0.50

543

3579

Sarcoidosis

469

2937

1.65

21.67

3.4

3.3

4.40

4.46

pmol/l

0.62

420

2619

Isolated growth hormone deficiency

109

5.33

21.63

2.9

3.4

4.89

5.21

pmol/l

0.98

100

Unspecified/other endometriosis

452

2816

1.67

21.62

3.0

3.5

4.55

4.60

pmol/l

0.51

417

2517

Radiculopathy

531

3419

1.59

21.58

3.1

3.4

4.40

4.42

pmol/l

0.16

481

3029

Polyarthrosis

693

4377

1.51

21.53

3.2

3.4

4.34

4.41

pmol/l

0.67

620

3846

Hypermobility syndrome

281

1545

1.93

21.45

2.8

3.4

4.58

4.56

pmol/l

0.06

257

1388

Disorders of lens

2171

10853

1.26

21.40

3.1

3.3

4.32

4.46

pmol/l

7.29

1914

9677

Substance abuse

1865

13887

1.28

21.34

2.7

3.4

4.47

4.53

pmol/l

1.58

1580

12504

Transient ischemic attack

1562

9779

1.31

21.32

3.1

3.3

4.29

4.40

pmol/l

4.27

1386

8601

Viral and other specified intestinal infections

782

5328

1.46

21.31

3.1

3.3

4.62

4.69

pmol/l

1.03

707

4765

Noninfective enteritis and colitis

1660

12979

1.30

21.31

3.4

3.3

4.47

4.53

pmol/l

1.48

1476

11587

Allergic rhinitis

1266

9464

1.35

21.27

2.9

3.4

4.65

4.59

pmol/l

0.86

1114

8560

Status post-ami

614

3084

1.54

21.25

3.6

3.2

4.16

4.42

pmol/l

7.59

542

2668

Coeliac disease

475

3005

1.64

21.13

3.6

3.2

4.43

4.52

pmol/l

1.09

428

2686

Mental and behavioural disorders due to psychoactive substance use

1930

14242

1.27

21.12

2.7

3.4

4.47

4.52

pmol/l

1.26

1640

12817

Other symptoms and signs involving the circulatory and respiratory systems

229

1173

2.03

21.07

2.9

3.3

4.44

4.52

pmol/l

0.54

199

1051

Trochanteric bursitis

554

3631

1.57

21.06

3.0

3.4

4.39

4.44

pmol/l

0.64

487

3225

Pain associated with micturition

425

2620

1.68

20.97

3.5

3.2

4.46

4.48

pmol/l

0.14

368

2330

Other and unspecified disorders of vitreous body

1392

10532

1.33

20.96

3.3

4.37

4.40

pmol/l

0.63

1215

9288

Misadventures to patients during surgical and medical care

505

3244

1.60

20.92

3.2

3.3

4.34

4.48

pmol/l

2.07

445

2884

Diabetic maculopathy, excluding more controls

351

2058

1.76

20.82

3.0

3.3

4.29

4.53

pmol/l

3.59

301

1827

DVT of lower extremities and pulmonary embolism

1292

9778

1.34

20.71

3.1

3.3

4.29

4.42

pmol/l

4.53

1132

8601

Malignant melanoma, including Hilmo

509

3278

1.59

20.66

3.9

3.0

4.37

4.42

pmol/l

0.52

466

2856

Oral lichen planus and hypothyroidism or thyroxine medication

100

371

3.02

20.31

3.1

3.3

4.10

4.49

pmol/l

4.33

315

Malignant melanoma

429

2667

1.65

20.29

3.9

2.9

4.36

4.43

pmol/l

0.75

390

2315

Other or ill-defined heart diseases

169

783

2.24

20.28

3.4

3.5

4.26

4.67

pmol/l

5.33

150

697

Need for other prophylactic measures

220

1132

2.04

20.21

3.2

4.48

4.55

pmol/l

0.48

198

1001

Benign paroxysmal vertigo

1018

7520

1.38

20.08

3.2

3.3

4.35

4.43

pmol/l

2.06

895

6636

Type1 diabetes, definitions combined, early onset

290

1628

1.86

20.07

3.3

3.5

4.57

4.76

pmol/l

2.15

265

1467

Malignant melanoma of skin

331

1930

1.77

20.05

3.9

2.9

4.38

4.43

pmol/l

0.39

306

1671

Mental and behavioural disorders due to sedatives or hypnotics

263

1438

1.91

20.05

2.6

3.3

4.35

4.60

pmol/l

2.99

214

1292

Recurrent aphthous stomatitis , including avohilmo

520

3402

1.58

19.91

2.9

3.3

4.48

4.52

pmol/l

0.34

460

3024

Other inflammation of eyelid

480

3085

1.60

19.89

3.2

4.41

4.49

pmol/l

1.03

418

2749

Erysipelas

2383

14885

1.23

19.87

3.2

3.3

4.28

4.51

pmol/l

23.45

2091

13219

Noninfectious colitis NAS

494

3197

1.59

19.83

3.3

3.2

4.39

4.51

pmol/l

1.96

430

2836

Injuries to the thorax

1384

10681

1.31

19.73

3.1

3.3

4.41

4.47

pmol/l

1.40

1205

9470

Other symptoms and signs involving the urinary system

312

1798

1.79

19.70

3.3

4.33

4.48

pmol/l

2.32

288

1588

Other disorders of glucose regulation and pancreatic internal secretion

296

1684

1.82

19.67

2.7

3.3

4.26

4.52

pmol/l

4.32

265

1492

Delirium, not induced by alcohol and other psychoactive substances

321

1861

1.77

19.59

2.7

3.2

4.16

4.39

pmol/l

3.20

272

1601

Other viral diseases, not elsewhere classified

1006

7409

1.38

19.50

3.0

3.4

4.58

pmol/l

0.00

902

6674

Gonarthrosis,primary

2958

15218

1.21

19.37

3.1

3.3

4.43

pmol/l

0.05

2643

13491

Other noninflammatory disorders of vulva and perineum

412

2578

1.66

19.36

3.1

3.4

4.40

4.52

pmol/l

1.88

371

2282

Other and unspecified nerve root and plexus disorders, also in other diseases

686

4771

1.47

19.30

2.9

3.5

4.50

4.51

pmol/l

0.07

611

4256

L01XE Protein kinase inhibitors

194

973

2.10

19.23

4.0

3.3

4.25

4.41

pmol/l

1.39

176

853

Symptoms and signs involving emotional state

142

633

2.40

19.20

3.8

3.3

4.49

4.63

pmol/l

0.82

124

572

Other diseases of intestine

444

2822

1.62

19.18

3.5

3.3

4.41

4.46

pmol/l

0.39

386

2492

Nonalcoholic fatty liver disease

367

2241

1.70

18.97

2.7

3.3

4.52

4.51

pmol/l

0.12

325

2016

Acute and transient psychotic disorders

429

2721

1.63

18.87

2.5

3.4

4.33

4.53

pmol/l

3.90

358

2453

Diseases of male genital organs

1102

4109

1.37

18.86

3.1

3.5

4.61

4.62

pmol/l

0.12

978

3705

Gonarthrosis

2171

10031

1.25

18.84

3.1

3.5

4.49

4.46

pmol/l

0.47

1939

8972

Melanocytic naevi

1088

8200

1.35

18.81

3.5

3.3

4.50

pmol/l

0.09

998

7309

Other diseases of pleura

1226

8204

1.33

18.68

3.5

3.2

4.21

4.41

pmol/l

9.34

1071

7227

Astigmatism

235

1268

1.94

18.64

3.6

3.3

4.66

4.63

pmol/l

0.15

213

1134

Pure hyperglyceridaemia

293

3.06

18.63

2.6

3.2

4.19

4.50

pmol/l

1.92

260

Benign neoplasm of meninges

375

2314

1.68

18.61

3.1

3.2

4.28

4.43

pmol/l

1.93

337

2034

Gonarthrosis [arthrosis of knee](FG)

2565

12325

1.22

18.60

3.1

3.5

4.47

pmol/l

0.03

2287

11012

Contact with and exposure to communicable diseases

1282

9856

1.32

18.59

3.6

3.4

4.61

4.62

pmol/l

0.09

1180

8912

Other diseases of the respiratory system

546

3651

1.53

18.58

3.1

3.2

4.24

4.40

pmol/l

2.57

478

3187

Other respiratory disorders and diseases

546

3651

1.53

18.58

3.1

3.2

4.24

4.40

pmol/l

2.57

478

3187

Anorexia (incl.atypical)

275

1566

1.84

18.46

2.5

3.3

4.26

4.65

pmol/l

8.11

239

1410

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1460

11414

1.29

18.45

3.1

3.4

4.57

4.59

pmol/l

0.24

1305

10291

Other problems related to primary support group, including family circumstances

485

3097

1.58

18.40

3.7

3.3

4.63

pmol/l

0.01

431

2782

Other disorders of ear

3275

18176

1.19

18.34

3.1

3.4

4.47

4.48

pmol/l

0.18

2858

16271

Hypoglycaemia, other or unspecified

239

1304

1.91

18.31

2.6

3.3

4.25

4.55

pmol/l

4.66

215

1155

Unspecified kidney failure

268

1509

1.83

18.28

2.9

3.2

3.81

4.43

pmol/l

16.36

234

1319

Invasive ventilation

236

1283

1.91

18.27

2.6

3.3

4.18

4.49

pmol/l

4.29

207

1133

Faecal incontinence

347

2111

1.71

18.20

3.0

3.2

4.49

4.43

pmol/l

0.36

294

1860

Disorders resulting from impaired renal tubular function

131

576

2.41

18.16

2.4

3.5

3.81

4.57

pmol/l

11.59

117

512

Artrosis, including avohilmo

3024

13909

1.20

18.15

3.2

3.4

4.49

4.48

pmol/l

0.05

2687

12470

Cluster headache, wide

163

786

2.19

18.03

2.4

3.3

4.45

4.59

pmol/l

1.19

143

706

Polyp of the female genital tract

1282

5653

1.33

18.01

3.4

4.48

4.49

pmol/l

0.11

1136

4995

Postmenopausal osteoporosis with pathological fracture

236

1294

1.91

18.00

3.0

2.9

4.22

4.35

pmol/l

1.13

184

1109

Testicular dysfunction

108

435

2.60

17.99

3.0

3.7

4.75

4.67

pmol/l

0.42

401

Other arthritis (FG)

1075

8135

1.34

17.98

3.1

3.4

4.42

4.50

pmol/l

1.30

965

7267

Bacterial pneumonia, not elsewhere classified

1199

8085

1.32

17.96

2.9

3.3

4.32

4.49

pmol/l

6.79

1068

7145

Immunodeficiencies

195

1007

2.04

17.91

3.7

3.3

4.30

4.56

pmol/l

3.00

180

890

Female genital prolapse

1175

5038

1.34

17.87

3.4

4.50

4.47

pmol/l

0.39

1057

4449

COPD-related respiratory insufficiency

297

1734

1.76

17.86

2.8

3.3

4.12

4.36

pmol/l

4.03

259

1496

Disorders of psychological development

432

2572

1.60

17.76

2.8

3.3

4.94

4.76

pmol/l

1.23

386

2324

Acute pharyngitis

541

3621

1.52

17.76

3.6

3.4

4.78

4.65

pmol/l

1.63

483

3279

Secondary right heart disease

136

612

2.33

17.75

3.5

3.3

4.03

4.40

pmol/l

4.89

122

526

Neuralgia and neuritis, unspecified

207

1093

1.99

17.73

2.9

3.3

4.40

4.48

pmol/l

0.50

185

989

Contraceptive management

1557

8636

1.28

17.72

3.4

3.5

4.52

4.55

pmol/l

0.64

1422

7771

Benign neoplasm: Cerebral meninges

343

2097

1.70

17.71

3.1

3.2

4.28

4.43

pmol/l

1.76

307

1841

Injuries to the abdomen, lower back, lumbar spine and pelvis

1284

9860

1.31

17.68

3.1

3.3

4.35

4.49

pmol/l

5.16

1120

8721

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

254

1427

1.85

17.67

2.7

3.2

4.21

4.42

pmol/l

2.56

220

1248

All influenza (not pneumonia)

464

3034

1.57

17.66

2.9

3.4

4.44

4.58

pmol/l

1.29

422

2705

Other disorders of veins

1479

11636

1.28

17.63

3.1

3.3

4.40

4.44

pmol/l

0.68

1282

10335

Malignant melanoma of skin, including Hilmo

419

2683

1.60

17.56

4.0

3.0

4.38

4.43

pmol/l

0.41

388

2335

Senile cataract

1892

9351

1.25

17.55

3.1

3.3

4.30

4.43

pmol/l

6.57

1667

8317

Pruritus

421

2709

1.61

17.51

3.1

3.3

4.32

4.49

pmol/l

2.81

366

2405

Later onset COPD, excluding more controls

516

2646

1.53

17.50

3.2

4.23

4.39

pmol/l

2.63

444

2268

Collagenous colitis

332

2019

1.71

17.47

3.6

3.2

4.27

4.47

pmol/l

3.44

289

1796

Other and unspecified tonsillitis

1238

8035

1.31

17.45

3.4

3.5

4.73

4.64

pmol/l

1.45

1138

7253

Cramp and spasm

186

953

2.06

17.45

3.1

3.4

4.45

4.55

pmol/l

0.73

169

847

Vitamin D deficiency

352

2.85

17.43

3.4

3.2

4.35

4.58

pmol/l

1.00

316

Coxarthrosis

1530

7970

1.28

17.41

3.1

3.4

4.38

4.45

pmol/l

1.93

1350

7075

Gestational diabetes (for exclusion)

1807

10158

1.26

17.39

3.5

3.4

4.62

4.56

pmol/l

1.40

1651

9212

Necrosis of pulp, including avohilmo

2139

17587

1.23

17.37

3.4

4.52

4.53

pmol/l

0.38

1894

15826

Clear cell adenocarcinoma of kidney

135

611

2.31

17.36

4.8

3.0

4.28

4.47

pmol/l

1.01

124

524

Bacterial pneumoniae

1261

8618

1.31

17.24

3.0

3.3

4.33

4.49

pmol/l

6.26

1125

7629

Impingement syndrome of shoulder

758

5472

1.41

17.24

3.2

3.5

4.46

pmol/l

0.04

684

4895

Erectile dysfunction

175

874

2.06

17.23

5.5

3.5

4.41

4.38

pmol/l

0.15

157

764

Fentanyl

295

1738

1.74

17.09

3.0

3.2

4.16

4.43

pmol/l

4.41

259

1508

Enterocolitis due to Clostridium difficile

331

2017

1.69

17.09

3.3

3.2

4.12

4.41

pmol/l

6.46

294

1766

Other cataract

1335

7881

1.30

17.07

3.1

3.3

4.31

4.43

pmol/l

3.77

1181

6993

Schizophrenia

532

3610

1.51

17.06

2.0

3.5

4.37

4.55

pmol/l

3.51

434

3248

Arthropathies in other diseases classified elsewhere

139

644

2.28

17.03

3.3

3.5

4.15

4.48

pmol/l

4.07

125

578

Oligomenorrhoea

177

902

2.09

17.02

2.6

3.2

4.41

4.57

pmol/l

1.37

159

796

Other mental disorders due to brain damage and dysfunction and to physical disease

333

2037

1.68

16.92

2.8

3.2

4.28

4.41

pmol/l

1.70

281

1760

Pleural effusion

398

2539

1.60

16.89

3.9

3.2

4.18

4.39

pmol/l

4.14

334

2219

Oxicams

714

2858

1.44

16.88

3.1

3.6

4.42

4.40

pmol/l

0.23

641

2555

Use of cabergoline

280

3.10

16.85

2.7

3.6

4.52

4.61

pmol/l

0.40

248

Cluster headache, strict

153

740

2.19

16.84

2.5

3.3

4.46

4.60

pmol/l

1.09

137

668

Disorders of sclera, cornea, iris and ciliary body

1910

15620

1.24

16.83

3.2

3.3

4.46

4.50

pmol/l

0.98

1691

13912

Agoraphobia

153

743

2.19

16.74

3.1

3.6

4.53

4.66

pmol/l

0.60

136

673

Other diseases of blood and blood-forming organs

230

1277

1.87

16.73

3.0

3.4

4.45

pmol/l

0.01

191

1128

Primary_lymphoid and hematopoietic malignant neoplasms

679

4838

1.43

16.65

3.1

3.2

4.32

4.42

pmol/l

2.31

608

4246

Brachial plexus disorders

389

2491

1.62

16.65

2.8

3.5

4.52

4.54

pmol/l

0.14

359

2241

L04AA Selective immunosuppressants

796

5836

1.39

16.62

3.2

3.3

4.28

4.51

pmol/l

6.00

725

5204

Appendectomy

2474

19844

1.21

16.59

3.4

4.49

4.53

pmol/l

1.22

2243

17755

Diseases of arteries, arterioles and capillaries

1954

11795

1.24

16.52

3.1

3.3

4.24

4.43

pmol/l

14.29

1729

10401

SLE (Finngen)

129

587

2.32

16.51

2.6

3.1

4.15

4.56

pmol/l

5.25

114

527

Congenital malformations and deformations of the musculoskeletal system

429

2794

1.58

16.49

3.3

4.70

4.64

pmol/l

0.46

385

2513

Benign neoplasm: Stomach

328

2019

1.68

16.45

3.6

3.2

4.39

4.41

pmol/l

0.19

283

1768

Lactose intolerance

127

577

2.33

16.37

3.4

3.0

4.59

4.57

pmol/l

0.07

106

510

Myocardial infarction, without ST-elevation

983

6768

1.34

16.26

3.1

3.2

4.18

4.37

pmol/l

7.06

867

5902

Fracture of rib(s), sternum and thoracic spine

835

6176

1.37

16.25

3.0

3.3

4.38

4.44

pmol/l

0.98

720

5447

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

331

2048

1.67

16.24

3.2

3.3

4.35

4.47

pmol/l

1.45

299

1817

Erosion of teeth , including avohilmo

932

7032

1.35

16.12

3.2

3.4

4.47

4.55

pmol/l

1.90

831

6342

Abnormalities of gait and mobility

342

2133

1.65

16.11

3.1

3.3

4.32

4.44

pmol/l

1.33

302

1876

Female infertility

1320

6280

1.30

16.07

3.3

3.5

4.45

4.57

pmol/l

4.99

1211

5614

Other pulmonary heart/vessel disease

145

697

2.17

16.07

3.7

3.3

4.04

4.41

pmol/l

4.65

129

606

Other diseases of lip and oral mucosa

1411

11237

1.28

16.00

3.1

3.3

4.44

4.47

pmol/l

0.52

1234

9984

Zoster [herpes zoster]

574

4010

1.46

15.85

3.2

4.28

4.44

pmol/l

3.27

507

3515

Mechanical strabismus

7.03

15.84

8.4

3.7

4.31

4.64

pmol/l

1.11

Coxarthrosis [arthrosis of hip](FG)

1667

9464

1.25

15.84

3.1

3.4

4.36

4.44

pmol/l

2.63

1475

8409

Enthesopathies of lower limb, excluding foot

773

5685

1.39

15.78

3.2

3.5

4.48

4.49

pmol/l

0.17

683

5090

Short stature, not elsewhere classified

100

385

2.58

15.67

2.6

3.5

4.94

5.01

pmol/l

0.25

347

Other symptoms and signs involving general sensations and perceptions

146

712

2.15

15.66

2.7

3.3

4.31

4.55

pmol/l

2.05

128

625

Infections with a predominantly sexual mode of transmission

1624

12258

1.25

15.66

3.3

3.4

4.55

4.60

pmol/l

0.79

1420

11085

Thoracic aortic aneurysm

342

2146

1.63

15.62

3.4

4.30

4.42

pmol/l

1.08

308

1897

Cellulitis

687

4966

1.41

15.57

3.1

3.3

4.36

4.51

pmol/l

2.83

614

4404

Seborrhoeic dermatitis

301

1840

1.69

15.45

3.0

3.4

4.37

4.49

pmol/l

1.39

265

1625

Failure and rejection of transplanted organs and tissues

199

3.35

15.43

2.3

3.4

4.17

4.67

pmol/l

2.60

180

Other disorders starting during childhood or adolecense, excluding more controls

162

785

2.05

15.43

2.7

3.9

4.98

4.90

pmol/l

0.22

149

728

Bacterial pneumonia (organism specified)

1332

9568

1.28

15.42

3.0

3.3

4.32

4.46

pmol/l

5.50

1186

8442

Immunodeficiency with predominantly antibody defects

117

530

2.37

15.37

3.2

3.3

4.20

4.67

pmol/l

4.81

109

467

Visual field defects

271

1616

1.73

15.35

3.2

4.29

4.43

pmol/l

1.16

246

1418

Other and unspecified visual disturbances

361

2315

1.61

15.31

3.4

3.3

4.48

4.47

pmol/l

0.07

332

2056

Unspecified fall

1637

13117

1.24

15.19

3.0

3.3

4.40

4.50

pmol/l

3.73

1400

11644

Hypersomnia

273

2.98

15.17

4.3

3.7

4.27

4.67

pmol/l

2.83

248

Spondylolisthesis/Spondylolysis

608

4329

1.44

15.15

3.1

3.4

4.45

pmol/l

0.00

535

3869

Unspecified acute lower respiratory infection

458

3091

1.51

15.12

3.3

4.47

4.51

pmol/l

0.33

411

2737

Endocarditis

416

2.48

15.10

3.0

3.5

4.04

4.60

pmol/l

3.40

366

Other viral diseases

1050

8099

1.31

15.07

3.1

3.4

4.54

4.60

pmol/l

0.70

933

7293

Zoster [herpes zoster]

1629

13052

1.24

15.04

3.1

3.3

4.35

4.44

pmol/l

2.61

1418

11517

Adhesive capsulitis of shoulder

543

3797

1.46

14.96

3.8

3.5

4.43

4.46

pmol/l

0.23

494

3394

Injuries to the neck

794

5925

1.37

14.80

3.7

3.3

4.49

4.54

pmol/l

0.78

719

5307

Aortic aneurysm

500

3372

1.48

14.78

3.3

4.22

4.39

pmol/l

2.69

453

2971

Heterophoria

312

1953

1.66

14.75

4.0

3.2

4.61

4.58

pmol/l

0.20

280

1735

Mental and behavioural disorders due to opioids

150

758

2.08

14.68

2.4

3.4

4.37

4.72

pmol/l

2.61

124

688

Other shoulder lesions

340

2172

1.61

14.64

3.2

3.5

4.45

4.50

pmol/l

0.53

308

1969

Conjunctivitis (acute, non atopic)

986

7569

1.32

14.64

3.1

3.4

4.51

4.54

pmol/l

0.52

896

6768

Testicular hypofunction

380

2.53

14.61

3.1

3.7

4.75

4.68

pmol/l

0.30

349

Diseases of external ear

1084

8457

1.30

14.56

3.0

3.3

4.47

4.48

pmol/l

0.17

924

7524

Ventral hernia

750

5561

1.37

14.54

3.2

3.4

4.34

4.43

pmol/l

1.83

656

4929

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

254

1515

1.74

14.50

2.8

3.3

4.48

4.59

pmol/l

0.97

233

1348

Ganglion

786

5882

1.36

14.42

3.0

3.4

4.51

4.52

pmol/l

0.08

700

5272

Dermatophytosis

2061

17231

1.21

14.33

3.1

3.4

4.45

4.51

pmol/l

1.44

1813

15418

Superficial injury of head

766

5714

1.36

14.24

2.8

3.3

4.52

4.50

pmol/l

0.13

665

5037

Vitamin B12 deficiency anaemia

298

1853

1.65

14.24

3.1

3.2

4.12

4.42

pmol/l

6.08

260

1608

Dysplasia of cervi uteri

1052

5915

1.31

14.22

3.3

3.5

4.56

pmol/l

0.07

933

5290

Oter anti-inflammatory and antirheumatic agents, non-steroids

623

2439

1.43

14.20

3.1

3.5

4.40

4.35

pmol/l

0.53

543

2178

Primary gonarthrosis, bilateral

1539

10711

1.24

14.19

3.1

3.3

4.42

4.39

pmol/l

0.57

1363

9432

Flat foot [pes planus] (acquired)

351

2278

1.59

14.16

3.6

3.5

4.42

4.49

pmol/l

0.78

311

2034

Gonarthrosis, primary, with knee surgery

1696

11086

1.23

14.01

3.1

3.3

4.37

4.39

pmol/l

0.29

1502

9756

Ptosis of eyelid

335

2154

1.60

14.00

3.4

3.2

4.34

4.42

pmol/l

0.78

300

1898

Anaemia in chronic diseases classified elsewhere

311

2.69

14.00

3.4

3.1

3.83

4.55

pmol/l

5.87

271

Left ventricular outflow tract obstruction (LVOTO), broad definition

308

1943

1.63

13.97

3.6

3.4

4.44

4.55

pmol/l

0.92

276

1753

Iron deficiency anaemia secondary to blood loss (chronic)

489

3399

1.47

13.93

3.5

3.2

4.23

4.45

pmol/l

4.71

422

2986

ILD, hospital admission 2, with pulmonary infections

249

1487

1.72

13.92

2.7

3.1

4.20

4.45

pmol/l

2.58

212

1296

Congenital malformations and deformations of the musculoskeletal system

335

2149

1.60

13.91

3.2

3.3

4.74

4.66

pmol/l

0.59

297

1936

Chronic periodontitis, including avohilmo

3424

19971

1.16

13.85

3.1

3.4

4.46

4.48

pmol/l

0.68

2982

17893

Ulcer of lower limb, not elsewhere classified

375

2473

1.55

13.85

2.9

3.3

4.02

4.42

pmol/l

9.04

314

2157

Periodontitis

3435

19996

1.16

13.84

3.1

3.4

4.46

4.48

pmol/l

0.68

2993

17913

Non-Hodgkin lymphoma, all, including Hilmo

344

2227

1.58

13.83

2.6

2.9

4.24

4.42

pmol/l

3.25

307

1920

Vertical strabismus

136

680

2.12

13.82

4.8

3.2

4.47

4.58

pmol/l

0.47

123

599

Coagulation defects, purpura and other haemorrhagic conditions

636

4638

1.40

13.80

3.4

3.3

4.34

4.50

pmol/l

3.37

568

4123

Rash and other nonspecific skin eruption

339

2196

1.59

13.80

3.0

3.2

4.44

4.46

pmol/l

0.19

304

1956

Keratitis

1200

9548

1.27

13.76

3.3

3.4

4.48

4.49

pmol/l

0.17

1054

8497

Postprocedural disorders of nervous system

314

2007

1.63

13.73

3.2

3.4

4.49

4.56

pmol/l

0.63

281

1809

Other noninflammatory disorders of uterus, except cervix

796

4020

1.36

13.72

3.0

3.3

4.36

4.44

pmol/l

0.99

701

3520

Disorders of tooth development and eruption

581

3363

1.43

13.71

3.2

3.6

4.57

4.58

pmol/l

0.04

509

3024

Aortic valve malfunction, age under 60 years

287

1790

1.65

13.68

3.5

3.4

4.43

4.53

pmol/l

0.78

259

1609

Excessive vomiting in pregnancy

381

2546

1.55

13.67

2.8

3.4

4.48

4.53

pmol/l

0.53

347

2276

Congenital malformations of the circulatory system

475

3198

1.48

13.66

3.8

3.4

4.63

4.59

pmol/l

0.26

429

2888

Respiratory insufficiency

200

1125

1.82

13.66

2.9

3.2

4.04

4.45

pmol/l

6.34

173

974

Superficial injury of lower leg

876

6709

1.33

13.65

2.8

3.3

4.47

4.53

pmol/l

0.60

780

5985

Special screening examination for other diseases and disorders

333

2145

1.59

13.65

3.3

3.6

4.52

4.55

pmol/l

0.16

304

1906

Cerebrovascular diseases

2230

13211

1.20

13.60

3.1

3.3

4.30

4.43

pmol/l

7.22

1970

11675

Other coagulation defects

281

1753

1.66

13.53

3.2

3.3

4.32

4.53

pmol/l

3.00

250

1567

Plantar fascial fibromatosis

358

2358

1.56

13.52

3.1

3.5

4.52

4.50

pmol/l

0.08

315

2130

Abnormal serum enzyme levels

678

4873

1.37

13.43

3.2

3.5

4.47

4.43

pmol/l

0.44

610

4370

Other noninflammatory disorders of vagina

320

2063

1.61

13.41

3.5

3.3

4.49

4.51

pmol/l

0.14

278

1815

Other diseases of stomach and duodenum

204

1169

1.81

13.41

2.9

3.4

4.37

4.44

pmol/l

0.31

176

1023

Polycystic ovarian syndrome

278

1740

1.67

13.41

3.3

3.4

4.64

4.60

pmol/l

0.25

249

1572

Postmenopausal atrophic vaginitis

981

4174

1.32

13.38

3.0

3.3

4.37

4.44

pmol/l

1.37

860

3674

Other disorders of bone

678

5023

1.38

13.34

3.2

3.3

4.55

4.52

pmol/l

0.34

587

4511

Propionic acid derivatives

924

3534

1.33

13.32

3.4

3.6

4.57

4.51

pmol/l

0.99

819

3178

Pregnancy examination and test

761

3540

1.37

13.23

3.4

3.5

4.61

4.58

pmol/l

0.46

702

3176

Maternal care for other known or suspected fetal problems

1145

5737

1.29

13.22

3.3

3.5

4.58

pmol/l

0.03

1030

5201

Cluster headache, wide,, including avohilmo

211

1231

1.79

13.20

2.7

3.3

4.50

4.56

pmol/l

0.48

190

1106

Other neurotic disorders

160

857

1.94

13.16

2.8

3.3

4.39

4.50

pmol/l

0.78

141

759

Fracture of foot, except ankle

850

6520

1.33

13.13

3.2

3.4

4.48

4.54

pmol/l

0.94

750

5859

Trigeminal neuralgia

219

1292

1.76

13.10

2.9

3.3

4.43

4.49

pmol/l

0.35

201

1143

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

729

5490

1.36

13.08

3.5

3.4

4.50

4.53

pmol/l

0.40

639

4937

Abnormal blood-pressure reading, without diagnosis

159

852

1.94

13.07

3.4

3.5

4.41

4.53

pmol/l

0.89

141

762

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

562

3930

1.42

13.07

3.7

3.3

4.53

4.58

pmol/l

0.46

507

3533

Dislocation, sprain and strain of joints and ligaments at neck level

561

4050

1.42

13.07

3.7

3.4

4.53

4.56

pmol/l

0.28

513

3637

Endometriosis ASRM stages 1,2

794

6060

1.34

13.03

3.0

3.4

4.51

4.50

pmol/l

0.05

705

5451

conjunctival haemorrhage

239

1445

1.71

12.96

3.5

3.3

4.41

4.44

pmol/l

0.13

202

1268

Trigger finger

494

3492

1.45

12.96

3.0

3.5

4.39

4.47

pmol/l

1.31

441

3135

Disorders of muscles

333

2179

1.57

12.90

3.0

3.5

4.39

4.51

pmol/l

1.59

293

1957

Autonomic disorders

406

2.41

12.86

4.4

3.2

4.56

4.63

pmol/l

0.25

353

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

529

3667

1.43

12.85

3.7

3.3

4.54

4.59

pmol/l

0.40

481

3304

Bulimia nervosa (incl. atypical)

180

1016

1.88

12.83

3.2

3.5

4.32

4.62

pmol/l

4.40

150

909

Secondary and unspecified malignant neoplasm of lymph nodes

225

1341

1.73

12.78

2.9

4.30

4.47

pmol/l

2.10

202

1154

Salpingitis and oophoritis

718

5415

1.36

12.77

3.3

4.40

4.45

pmol/l

0.71

621

4834

Dermatographic urticaria

278

1758

1.64

12.76

3.4

3.3

4.44

4.54

pmol/l

0.85

254

1565

Disorders of breast

2110

16247

1.19

12.75

3.2

3.3

4.46

4.48

pmol/l

0.36

1883

14486

Fibroblastic disorders

656

4863

1.37

12.74

3.0

3.4

4.41

4.43

pmol/l

0.24

578

4339

Female infertility, cervical, vaginal, other or unspecified origin

1181

6124

1.28

12.73

3.4

3.5

4.48

4.56

pmol/l

2.56

1080

5480

Secondary parkinsonism, excluding more controls

295

2.62

12.72

2.8

3.2

4.13

4.50

pmol/l

2.86

265

Other disorders of white blood cells

182

1027

1.84

12.71

2.9

3.5

4.55

4.50

pmol/l

0.11

154

912

Other disorders of the musculoskeletal system and connective tissue

461

3230

1.46

12.70

3.0

3.3

4.48

4.45

pmol/l

0.30

412

2863

Endometriosis of ovary

684

4994

1.37

12.69

3.3

3.4

4.45

4.51

pmol/l

0.93

621

4436

Sequelae of injuries, of poisoning and of other consequences of external causes

747

5654

1.34

12.69

3.0

3.3

4.46

4.51

pmol/l

0.84

661

5055

COPD

1168

7620

1.27

12.63

3.2

3.3

4.27

4.40

pmol/l

4.10

1012

6711

Ehlers-Danlos syndrome

327

2.66

12.61

4.5

3.7

4.71

4.65

pmol/l

0.13

293

Other and unspecified myopathies

240

1461

1.69

12.59

2.8

3.3

4.38

4.44

pmol/l

0.38

203

1279

Secondary uncertain malignant neoplasm

333

2188

1.55

12.55

2.9

4.23

4.43

pmol/l

3.67

297

1876

Wide developmental disorders

133

681

2.04

12.52

2.8

3.2

5.13

4.87

pmol/l

1.09

116

618

Intestinal malabsorption

170

946

1.88

12.50

3.3

3.4

4.32

4.57

pmol/l

2.48

150

842

Cluster headache, strict, including avohilmo

201

1176

1.79

12.49

2.8

3.3

4.51

4.56

pmol/l

0.34

184

1061

Bursitis of shoulder

102

476

2.27

12.47

2.9

3.4

4.36

4.54

pmol/l

1.10

424

Other disorders of conjunctiva

419

2893

1.48

12.47

3.3

3.2

4.40

4.44

pmol/l

0.38

357

2554

Other specified/unspecified soft tissue disorders

173

968

1.86

12.43

3.1

3.3

4.38

4.46

pmol/l

0.58

148

859

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

160

878

1.92

12.39

3.0

3.4

4.19

4.59

pmol/l

5.31

145

793

Benign lipomatous neoplasm

933

7302

1.30

12.36

3.1

3.3

4.44

pmol/l

0.01

832

6464

Mental and behavioural disorders due to use of other stimulants, including caffeine

117

578

2.14

12.31

2.2

3.5

4.62

4.72

pmol/l

0.31

527

Cardiac murmurs and other cardiac sounds

315

2034

1.57

12.29

3.2

3.4

4.59

4.62

pmol/l

0.28

286

1841

Other skin changes

555

4037

1.40

12.28

3.5

3.3

4.47

4.43

pmol/l

0.26

490

3555

Congenital malformations of heart and great arteries

413

2764

1.48

12.27

3.8

3.4

4.61

pmol/l

0.01

371

2496

Other abnormal findings of blood chemistry

160

879

1.90

12.25

2.7

3.4

4.34

4.51

pmol/l

1.33

143

773

Ethmoidectomy

433

3023

1.47

12.23

3.4

4.50

4.49

pmol/l

0.02

384

2712

109

528

2.21

12.22

3.5

3.2

4.53

4.63

pmol/l

0.42

103

469

Varicose veins

2053

13122

1.19

12.21

3.2

3.3

4.39

4.42

pmol/l

0.71

1834

11625

COPD related to multimorbidity

961

6358

1.29

12.19

3.2

4.25

4.37

pmol/l

3.11

835

5587

113

555

2.17

12.18

3.2

3.5

4.45

4.57

pmol/l

0.79

102

497

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

132

681

2.01

12.12

3.2

2.8

4.14

4.43

pmol/l

2.68

121

573

Persistent delusional disorders

245

1517

1.67

12.12

2.3

3.4

4.36

4.50

pmol/l

1.24

204

1348

Gastric ulcer

460

3244

1.44

12.09

3.2

3.3

4.22

4.41

pmol/l

3.82

403

2834

Complications of internal orthopaedic prosthetic devices, implants and grafts

638

4755

1.36

12.05

2.8

3.2

4.36

4.41

pmol/l

0.52

554

4149

Mixed hyperlipidaemia

112

546

2.13

12.04

2.8

3.2

4.30

4.42

pmol/l

0.63

477

Haemorrhage in early pregnancy

1207

9521

1.26

12.02

3.2

3.4

4.52

4.51

pmol/l

0.10

1074

8548

Anti-inflammatory and antirheumatic products, non-steroids

912

3534

1.31

12.02

3.3

3.6

4.58

4.51

pmol/l

1.05

813

3178

Fissure and fistula of anal and rectal regions

758

5795

1.33

11.99

3.4

4.46

4.50

pmol/l

0.43

652

5175

Glucosamine medication

1411

9231

1.23

11.97

3.0

3.3

4.33

4.36

pmol/l

0.57

1214

8056

Hyperplasia of prostate

668

2803

1.37

11.95

3.3

3.6

4.44

4.45

pmol/l

0.01

595

2534

Pollen allergy

733

5519

1.34

11.92

2.8

3.4

4.71

4.64

pmol/l

0.60

640

5003

Lung diseases due to external agents

334

2223

1.53

11.84

3.0

3.2

4.23

4.40

pmol/l

2.05

293

1940

Papulosquamous disorders

1263

10285

1.24

11.83

3.1

3.3

4.47

4.46

pmol/l

0.04

1120

9129

Lactose intolerance, other/unspecified

104

500

2.19

11.75

3.7

2.9

4.53

pmol/l

0.02

439

FESS (DNB20)

421

2950

1.46

11.69

3.4

4.49

4.50

pmol/l

0.04

374

2648

Diabetic retinopathy, strict definition

540

3478

1.40

11.69

2.9

3.2

4.28

4.42

pmol/l

2.30

470

3081

Other bursopathies

389

2683

1.48

11.65

3.3

3.4

4.53

4.47

pmol/l

0.33

348

2387

Haemorrhage, not elsewhere classified

113

560

2.10

11.65

3.7

3.2

4.11

4.55

pmol/l

4.19

102

494

Other chronic obstructive pulmonary disease

1108

7317

1.26

11.62

3.2

3.3

4.26

4.40

pmol/l

4.04

957

6441

Blepharochalasis

886

6946

1.29

11.62

3.0

3.2

4.36

4.39

pmol/l

0.39

780

6084

Glomerular diseases

502

3625

1.41

11.60

2.9

3.3

4.09

4.48

pmol/l

11.15

447

3216

Hyperaldosteronism

463

2.23

11.60

3.0

3.2

4.25

4.48

pmol/l

1.61

412

Other disorders of patella

629

4714

1.36

11.57

3.3

3.5

4.58

4.52

pmol/l

0.48

558

4247

Dermatophytosis

374

2565

1.49

11.56

3.2

3.3

4.37

4.48

pmol/l

1.18

322

2258

Diseases of tongue

200

1190

1.74

11.56

2.8

3.4

4.41

4.45

pmol/l

0.29

170

1061

Cerebral palsy and other paralytic syndromes

356

2420

1.51

11.55

2.9

3.3

4.39

4.50

pmol/l

1.41

322

2149

Peritonsillar abscess

708

5394

1.33

11.53

3.5

3.3

4.59

4.54

pmol/l

0.64

642

4837

Childhood asthma (age<16), excluding more controls

485

2730

1.42

11.53

2.9

3.5

4.80

4.69

pmol/l

1.21

439

2458

Persons encountering health services in circumstances related to reproduction

1972

11257

1.19

11.42

3.3

3.4

4.60

4.58

pmol/l

0.61

1814

10077

Other disorders of skin and subcutaneous tissue, not elsewhere classified

433

3064

1.44

11.32

3.2

4.26

4.46

pmol/l

3.55

363

2724

Drug-induced osteoporosis with pathological fracture

285

2.61

11.32

2.3

2.9

4.03

4.39

pmol/l

2.04

245

Acute laryngitis and tracheitis

424

2940

1.45

11.30

3.4

4.68

pmol/l

0.02

369

2654

Mental and behavioural disorders due to cannabinoids

114

576

2.07

11.25

2.1

3.6

4.56

4.84

pmol/l

1.54

525

Paralytic ileus and intestinal obstruction

717

5482

1.32

11.25

3.1

3.4

4.35

4.43

pmol/l

1.37

618

4833

Other pleural conditions

248

1566

1.62

11.21

3.6

3.2

4.04

4.40

pmol/l

5.37

212

1351

Familial hypercholesterolemia

354

2412

1.49

11.21

3.2

3.0

4.33

4.38

pmol/l

0.48

305

2093

Autism

109

544

2.11

11.20

2.7

3.4

5.18

4.83

pmol/l

1.38

495

Other viral diseases, not elsewhere classified

614

4597

1.36

11.13

3.2

3.3

4.55

4.56

pmol/l

0.14

552

4128

Otitis externa

725

5573

1.32

11.12

3.0

3.3

4.48

4.51

pmol/l

0.38

626

4982

Degeneration of macula and posterior pole

1260

8188

1.24

11.08

3.3

3.2

4.31

4.36

pmol/l

1.13

1077

7154

Intestinal stricture

870

6842

1.29

11.07

3.1

3.3

4.34

4.41

pmol/l

1.53

756

6015

Nail disorders

275

1791

1.58

11.03

3.7

3.3

4.44

4.52

pmol/l

0.51

242

1599

Extreme obesity with alveolar hypoventilation

141

771

1.91

11.03

2.9

3.5

4.29

4.49

pmol/l

1.17

118

681

Childhood asthma (age<16)

485

2755

1.41

11.00

2.9

3.5

4.80

4.69

pmol/l

1.24

439

2482

Benign neoplasm: Rectum

490

3560

1.40

10.97

3.2

3.3

4.31

4.40

pmol/l

1.45

432

3131

Mixed disorders of conduct and emotions, excluding more controls

394

2.29

10.95

2.6

3.7

4.74

4.97

pmol/l

1.34

362

Focal epilepsy

634

4790

1.34

10.94

2.8

3.3

4.30

4.50

pmol/l

5.01

569

4234

Benign neoplasm: Rectum, anus and anal canal

546

4042

1.37

10.84

3.0

3.3

4.34

4.40

pmol/l

0.74

479

3550

Unknown and unspecified causes of morbidity

223

1387

1.65

10.83

3.6

3.3

4.48

4.53

pmol/l

0.24

211

1243

Calcific aortic valvular stenosis, including rheumatic fever

672

4958

1.33

10.80

3.0

3.2

4.23

4.32

pmol/l

1.43

588

4270

Pregnancy hypertension

1838

14015

1.19

10.78

3.5

3.3

4.53

4.51

pmol/l

0.26

1683

12597

Other diseases of arteries and capillaries

268

1744

1.58

10.75

2.9

3.2

4.24

4.46

pmol/l

3.20

239

1540

Acute appendicitis, no complications

1981

16890

1.18

10.66

3.3

3.4

4.53

pmol/l

0.14

1816

15163

Operations 2 for CAVS

668

4939

1.33

10.65

3.0

3.2

4.24

4.32

pmol/l

1.35

584

4251

Calcific aortic valvular stenosis, diagnosis (helper)

668

4939

1.33

10.65

3.0

3.2

4.24

4.32

pmol/l

1.35

584

4251

Fracture of lumbar spine and pelvis

611

4603

1.35

10.65

2.8

3.2

4.25

4.42

pmol/l

3.82

522

3987

Corneal ulcer

591

4446

1.35

10.61

3.4

4.49

4.51

pmol/l

0.19

515

3988

Calcific aortic valvular stenosis, operated

669

4951

1.33

10.60

3.0

3.2

4.24

4.32

pmol/l

1.45

585

4262

Calcific aortic valvular stenosis

669

4951

1.33

10.60

3.0

3.2

4.24

4.32

pmol/l

1.45

585

4262

Preparatory care for dialysis

126

674

1.94

10.51

2.2

3.4

3.51

4.49

pmol/l

18.69

111

604

Chondrocostal junction syndrome [Tietze]

143

799

1.87

10.51

2.9

3.2

4.51

4.50

pmol/l

0.03

119

702

Disorders of myoneural junction and muscle in diseases classified elsewhere

140

3.34

10.46

3.9

3.4

4.04

4.57

pmol/l

2.27

119

Agranulocytosis

357

2481

1.48

10.43

3.5

3.3

4.45

4.46

pmol/l

0.05

312

2202

Dystonia

203

1252

1.68

10.40

3.2

3.3

4.48

4.50

pmol/l

0.11

190

1108

Rosacea

410

2927

1.44

10.37

3.6

3.4

4.41

4.46

pmol/l

0.50

361

2619

Covid-19 suspected case

797

6265

1.29

10.35

2.8

3.4

4.43

4.56

pmol/l

3.85

704

5620

Myeloproliferative diseases

239

1530

1.61

10.34

2.9

3.2

4.40

4.41

pmol/l

0.11

197

1331

Alcohol abuse, main dg, excluding more controls

388

2735

1.44

10.32

2.5

3.6

4.46

4.57

pmol/l

1.13

335

2496

Unspecified privation

334

2296

1.49

10.31

2.8

3.3

4.33

4.48

pmol/l

1.96

281

2043

Other and unspecified coagulation defects

194

1187

1.70

10.29

3.2

3.4

4.36

4.55

pmol/l

2.07

172

1063

Maternal care for known or suspected abnormality of pelvic organs

1150

6393

1.25

10.28

3.4

3.5

4.54

pmol/l

0.02

1056

5775

Unspecified misadventure during surgical and medical care

178

1063

1.74

10.27

3.2

3.3

4.28

4.49

pmol/l

2.19

164

938

Injuries to the head

4092

22557

1.12

10.27

3.1

3.4

4.46

4.53

pmol/l

3.77

3602

20217

Visual impairment including blindness (binocular or monocular)

197

1205

1.68

10.27

2.4

3.1

4.23

4.49

pmol/l

2.95

172

1056

Melanocytic naevi of trunk

399

2840

1.44

10.23

3.8

3.3

4.37

4.51

pmol/l

2.07

376

2540

Hypertrophic disorders of skin

227

1445

1.63

10.22

3.8

3.2

4.53

4.55

pmol/l

0.14

203

1296

Personal history of other diseases and conditions

452

3275

1.41

10.21

3.7

3.3

4.63

4.62

pmol/l

0.02

407

2951

Alcohol use disorder, ICD-based

1139

9317

1.23

10.20

2.6

3.5

4.46

4.52

pmol/l

0.97

947

8420

Congenital malformations of the musculoskeletal system, not elsewhere classified

451

2.20

10.18

4.4

3.5

4.77

4.68

pmol/l

0.23

402

Infections with a predominantly sexual mode of transmission

1207

9942

1.23

10.14

3.3

3.4

4.51

4.57

pmol/l

1.11

1062

8985

Autism spe

106

544

2.05

10.13

2.7

3.5

5.22

4.87

pmol/l

1.32

493

Speech and linguistic disorders

286

1833

1.53

10.13

2.9

3.2

4.87

4.79

pmol/l

0.38

258

1656

Bruxism

486

2.15

10.11

2.4

3.6

4.46

4.64

pmol/l

1.59

434

Herpesviral [herpes simplex] infections

923

7406

1.27

10.11

3.4

4.48

4.53

pmol/l

0.74

819

6659

Biguanides

3375

18261

1.13

10.11

3.1

3.4

4.43

4.49

pmol/l

2.70

2944

16340

Other benign neoplasms of skin

1167

9589

1.23

10.10

3.3

3.2

4.40

4.42

pmol/l

0.46

1029

8476

Other disorders of penis

188

1137

1.68

10.09

2.8

3.5

4.56

4.55

pmol/l

0.04

172

1009

Inflammatory diseases of prostate (prostatitis)

235

1501

1.59

10.08

3.4

3.7

4.59

4.44

pmol/l

1.19

203

1339

Small fibre neuropathy

462

2.14

10.08

3.0

3.5

4.28

4.51

pmol/l

1.46

408

Hallux valgus (acquired)

1174

6914

1.24

10.07

2.8

3.4

4.40

4.45

pmol/l

0.68

1012

6137

Hypertension, Pulmonary Arterial

132

3.31

10.06

4.3

3.1

4.07

4.57

pmol/l

2.42

118

Artificial opening status

151

865

1.80

10.05

3.4

3.3

4.15

4.52

pmol/l

4.21

135

755

Gastroduodenal ulcer

644

4919

1.32

10.04

3.2

3.3

4.25

4.41

pmol/l

3.14

567

4329

Parkinson's disease, excluding more controls

300

1903

1.51

10.03

2.6

3.8

4.39

4.43

pmol/l

0.35

252

1703

Speech disturbances, not elsewhere classified

249

1620

1.58

10.02

3.4

3.2

4.39

4.43

pmol/l

0.20

217

1422

Other disorders of nervous system

199

1230

1.67

10.01

2.8

3.2

4.31

4.47

pmol/l

1.52

170

1087

Benign neoplasm: Sigmoid colon

509

3781

1.37

9.95

3.0

3.3

4.36

4.41

pmol/l

0.53

455

3319

Hypertrophic scar

210

1322

1.65

9.94

3.9

3.3

4.53

4.55

pmol/l

0.11

189

1179

Parkinson's disease, strict definition, excluding more controls

278

1759

1.53

9.93

2.5

3.7

4.42

4.43

pmol/l

0.05

233

1573

Other degenerative diseases of the nervous system

776

4535

1.29

9.90

2.9

3.6

4.32

4.47

pmol/l

4.40

658

4037

Medical abortion

2774

13214

1.15

9.90

3.4

3.3

4.51

4.49

pmol/l

0.24

2468

11758

Renal tubulo-interstitial disorders in diseases classified elsewhere

161

3.06

9.87

3.2

3.4

4.13

4.62

pmol/l

1.99

141

Myopia

465

3418

1.39

9.86

3.4

3.3

4.57

4.59

pmol/l

0.13

420

3047

Otalgia

276

1847

1.54

9.85

2.9

3.3

4.47

4.53

pmol/l

0.49

244

1646

1068

7979

1.24

9.85

2.9

3.3

4.30

4.35

pmol/l

0.76

897

6954

Nasal polyp

500

3708

1.37

9.83

3.2

3.3

4.53

4.46

pmol/l

0.61

445

3280

Sequelae of other external causes

183

1115

1.70

9.79

3.0

3.4

4.39

4.52

pmol/l

1.15

164

987

Eosinophilic disease (BM)

236

2.62

9.78

2.5

3.5

4.58

4.56

pmol/l

0.03

211

Respiratory conditions due to other external agents

323

2.36

9.76

3.1

2.9

4.15

4.43

pmol/l

1.31

275

Suppurative and unspecified otitis media

1313

9692

1.21

9.74

3.2

3.4

4.58

4.62

pmol/l

0.77

1170

8735

Other respiratory diseases principally affecting the interstitium

438

3186

1.40

9.74

2.8

3.2

4.19

4.38

pmol/l

2.82

379

2767

Ischaemic Stroke, excluding all haemorrhages

1513

9473

1.20

9.71

3.0

3.3

4.26

4.40

pmol/l

6.30

1338

8325

Other postsurgical states

197

1224

1.66

9.71

2.8

3.3

4.40

4.52

pmol/l

0.85

173

1076

Otitis media, unspecified

383

2510

1.43

9.69

3.2

3.4

4.70

4.71

pmol/l

0.03

350

2275

Malignant neoplasm of skin

1400

8012

1.21

9.68

3.2

3.0

4.36

4.42

pmol/l

1.14

1219

6995

Haemangioma and lymphangioma, any site

304

2087

1.50

9.55

3.1

3.3

4.45

4.49

pmol/l

0.33

275

1865

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2006

15099

1.17

9.50

3.4

4.53

4.50

pmol/l

0.68

1844

13529

Right bundle-branch block

477

2.06

9.50

4.1

3.2

4.38

4.54

pmol/l

0.88

417

Other follicular disorders

252

1668

1.56

9.49

3.1

3.3

4.36

4.54

pmol/l

2.10

221

1496

Transport accidents

1639

11994

1.19

9.48

3.5

3.4

4.58

4.57

pmol/l

0.23

1470

10795

Hallux rigidus

423

3079

1.40

9.48

3.2

3.4

4.39

4.43

pmol/l

0.38

364

2724

Secondary polycythaemia

333

2.30

9.46

3.3

3.5

4.63

4.60

pmol/l

0.10

300

Lesion of ulnar nerve

402

2902

1.41

9.45

2.9

3.4

4.49

pmol/l

0.00

360

2599

Non-follicular lymphoma

244

1602

1.56

9.43

2.6

3.3

4.23

4.41

pmol/l

2.66

220

1388

Artificial joint operation, meniscal resection

2927

16808

1.14

9.42

3.1

3.3

4.43

4.46

pmol/l

0.59

2610

14901

Diffuse large B-cell lymphoma, including Hilmo

120

655

1.89

9.41

2.7

3.0

4.26

4.46

pmol/l

1.53

105

560

Diffuse large B-cell lymphoma, helper endpoint

120

655

1.89

9.41

2.7

3.0

4.26

4.46

pmol/l

1.53

105

560

Diffuse large B-cell lymphoma

120

655

1.89

9.41

2.7

3.0

4.26

4.46

pmol/l

1.53

105

560

Acute pancreatitis

523

3933

1.35

9.40

3.2

3.3

4.38

4.45

pmol/l

0.74

446

3511

Skin changes due to chronic exposure to nonionizing radiation

984

7371

1.24

9.40

2.8

3.2

4.31

4.33

pmol/l

0.29

828

6399

Other abnormal products of conception

1509

8440

1.20

9.39

3.6

3.4

4.56

4.55

pmol/l

0.18

1390

7630

Disorders of adrenal gland, other and/or unspecified

3.84

9.39

5.4

3.3

4.84

4.46

pmol/l

1.08

Malnutrition

335

2.30

9.37

4.0

3.0

4.19

4.65

pmol/l

2.03

287

Traumatic subdural haemorrhage

285

1850

1.50

9.36

2.9

3.4

4.18

4.38

pmol/l

2.20

233

1617

Abnormal findings on diagnostic imaging of central nervous system

171

1038

1.71

9.36

3.4

3.2

4.42

4.54

pmol/l

0.86

155

928

Benign neoplasm: Caecum

288

1962

1.50

9.35

3.0

3.2

4.35

4.39

pmol/l

0.22

255

1711

Anomalies of dental arch relationship, including avohilmo

704

4972

1.30

9.34

3.0

3.4

4.63

4.61

pmol/l

0.15

622

4496

Explicit bacterial Sepsis

273

1837

1.52

9.34

3.5

3.3

4.38

4.54

pmol/l

1.31

248

1615

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1947

9844

1.17

9.29

3.3

3.4

4.56

4.53

pmol/l

0.68

1769

8878

Focal epilepsy, strict definition

566

4314

1.33

9.28

2.8

3.3

4.28

4.50

pmol/l

4.89

508

3813

Lateral epicondylitis

439

3230

1.39

9.23

3.2

3.5

4.48

4.49

pmol/l

0.13

399

2928

Actinic keratosis

946

7099

1.25

9.23

2.8

3.2

4.30

4.33

pmol/l

0.31

794

6151

Hernia of abdominal wall

1338

11236

1.20

9.20

3.1

3.3

4.38

4.47

pmol/l

2.49

1166

10003

Unspecified urinary incontinence

292

2005

1.50

9.19

3.1

3.2

4.35

4.43

pmol/l

0.50

227

1762

Atopic conjunctivitis

169

1029

1.71

9.16

3.3

3.2

4.58

4.60

pmol/l

0.05

150

911

Renal cell carcinoma of kidney

403

2.13

9.11

4.4

2.9

4.25

4.43

pmol/l

0.59

343

Early onset COPD

574

4396

1.32

9.09

3.2

3.4

4.31

4.45

pmol/l

2.87

500

3919

Sexual dysfunction

257

2.48

9.09

3.0

3.9

4.66

4.71

pmol/l

0.13

235

Other congenital malformations

309

2149

1.48

9.08

3.3

4.69

4.60

pmol/l

0.49

288

1927

Fall on and from stairs and steps

807

6457

1.27

9.05

2.9

3.3

4.40

4.48

pmol/l

1.13

690

5721

Hernia

3242

19396

1.13

9.02

3.0

3.4

4.43

4.50

pmol/l

3.23

2841

17316

Polymyalgia rheumatica

345

2447

1.44

9.00

2.7

3.1

4.20

4.36

pmol/l

2.77

296

2097

Alzheimer disease, excluding more controls

406

1928

1.41

8.97

2.6

3.6

4.25

4.40

pmol/l

2.34

342

1710

Other diseases of oesophagus

254

1700

1.53

8.97

2.9

3.4

4.33

4.46

pmol/l

1.46

225

1492

706

4832

1.29

8.95

3.2

3.1

4.30

pmol/l

0.00

589

4152

Other/unspecified enthesopathies of lower limb, excluding foot

247

1651

1.54

8.90

3.1

3.4

4.46

4.52

pmol/l

0.50

219

1487

Scoliosis

302

2101

1.47

8.87

2.8

3.2

4.55

4.56

pmol/l

0.12

264

1878

Striking against or struck by other objects

999

8184

1.23

8.87

3.1

3.4

4.48

4.60

pmol/l

2.98

875

7352

Vitreous haemorrhage

280

1918

1.49

8.86

2.9

3.3

4.33

4.45

pmol/l

1.04

254

1687

Chronic periodontitis, complicated

1649

14011

1.18

8.85

3.3

4.40

4.45

pmol/l

1.17

1440

12474

Mental and behavioural disorders due to alcohol

1446

11781

1.19

8.84

2.7

3.4

4.48

4.53

pmol/l

0.82

1222

10622

Haemangioma, any site

282

1939

1.49

8.84

3.2

4.47

4.48

pmol/l

0.12

255

1725

Budesonide

456

3400

1.37

8.81

3.1

3.4

4.44

4.55

pmol/l

1.52

394

3032

Congenital malformations of cardiac septa

217

1367

1.58

8.81

3.8

3.4

4.76

4.71

pmol/l

0.19

196

1227

Leiomyoma of uterus

2618

13100

1.14

8.74

3.5

3.3

4.46

4.45

pmol/l

0.17

2348

11651

Atopic dermatitis, strict definition with reimbursement

1147

9222

1.22

8.73

3.0

3.5

4.63

4.61

pmol/l

0.23

1009

8360

Idiopathic gout

199

1270

1.60

8.71

2.5

3.3

4.10

4.39

pmol/l

2.98

183

1111

Periapical abscess

1446

12294

1.19

8.68

3.1

3.4

4.59

4.50

pmol/l

1.64

1286

10982

Supervision of high-risk pregnancy

915

4466

1.25

8.63

3.7

3.5

4.62

4.55

pmol/l

1.15

830

4023

Other chronic obstructive pulmonary disease, including avohilmo

1403

9813

1.19

8.59

3.3

4.30

4.40

pmol/l

3.12

1212

8667

Stroke, excluding SAH

1620

10116

1.18

8.57

3.1

3.3

4.25

4.42

pmol/l

8.16

1427

8918

Calcific tendinitis of shoulder

202

1305

1.60

8.57

3.2

3.5

4.40

4.48

pmol/l

0.66

179

1186

Other misadventures during surgical and medical care

416

2.10

8.54

2.9

3.4

4.38

4.58

pmol/l

0.86

365

Other enthesopathy of foot (+metatarsalgia)

349

2509

1.42

8.54

2.7

3.5

4.52

4.50

pmol/l

0.10

312

2265

Impotence

108

587

1.88

8.54

3.0

3.6

4.47

4.51

pmol/l

0.09

516

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1207

10061

1.20

8.53

2.6

3.5

4.46

4.51

pmol/l

0.91

1009

9083

Abrasion of teeth

1178

9864

1.21

8.53

3.4

3.3

4.43

4.47

pmol/l

0.96

1033

8802

Use of disulfiram, acamprosate or naltrexone

244

1641

1.52

8.49

2.3

3.5

4.46

4.53

pmol/l

0.43

202

1476

Other congenital malformations

446

3336

1.36

8.48

3.2

3.3

4.60

4.57

pmol/l

0.12

412

3003

Ehlers-Danlos syndrome

256

2.50

8.47

4.9

4.0

4.80

4.66

pmol/l

0.24

230

Other and unspecified local infections of skin and subcutaneous tissue

291

2029

1.47

8.44

3.3

3.4

4.38

4.51

pmol/l

1.72

267

1802

ILD, hospital admissions 3, with pneumonia sepsis

199

1281

1.59

8.43

2.6

3.2

4.19

4.42

pmol/l

1.65

168

1109

Essential (haemorrhagic) thrombocythaemia

116

651

1.85

8.42

3.1

3.0

4.33

4.53

pmol/l

1.59

561

Malignant neoplasm of bladder, including Hilmo

219

1427

1.55

8.42

3.3

2.9

4.20

4.35

pmol/l

1.59

194

1230

Other/unspecified synovitis and tenosynovitis

364

2641

1.41

8.39

2.8

3.5

4.40

4.49

pmol/l

1.08

322

2370

Retinal detachments and breaks

967

7950

1.23

8.39

3.3

4.39

4.42

pmol/l

0.33

860

7025

Mental retardation, excluding more controls

109

582

1.88

8.38

2.0

3.5

4.88

4.85

pmol/l

0.04

101

533

502

3585

1.33

8.37

3.4

3.0

4.27

4.29

pmol/l

0.18

407

3062

Lung cancer and mesothelioma

438

2787

1.36

8.37

3.9

3.3

4.24

4.41

pmol/l

3.08

397

2433

Glomerular disorders in diseases classified elsewhere

302

2121

1.45

8.37

2.6

3.4

3.94

4.49

pmol/l

11.01

260

1878

Atrophic disorders of skin

517

3962

1.33

8.36

3.4

3.3

4.42

4.47

pmol/l

0.58

462

3509

COPD, hospital admissions

1109

7792

1.21

8.36

3.2

3.3

4.27

4.38

pmol/l

3.24

960

6871

Fracture of lower leg, including ankle

1809

15530

1.16

8.35

3.1

3.3

4.47

4.49

pmol/l

0.35

1607

13790

Melanocytic naevi, other sites/unspecified

269

1855

1.49

8.34

3.8

3.3

4.53

4.51

pmol/l

0.15

247

1663

Myeloproliferative diseases (CML excluded)

213

1399

1.56

8.33

2.8

3.2

4.36

4.41

pmol/l

0.41

174

1216

Other blood glucose lowering drugs, excl. Insulins

431

3215

1.36

8.29

3.0

3.3

4.31

4.41

pmol/l

1.03

366

2800

Kela reimbursement Agammaglobulinemia (D80-84)

160

2.88

8.27

3.3

3.6

4.14

4.59

pmol/l

2.68

142

Hyperosmolality and hypernatraemia

147

2.86

8.22

3.2

2.8

4.22

4.37

pmol/l

0.43

129

Viral pneumonia (unknown virus, not influenza)

204

1332

1.57

8.20

3.8

3.4

4.32

4.54

pmol/l

2.41

183

1182

Conductive and sensorineural hearing loss

2481

14798

1.14

8.19

3.1

3.3

4.42

4.45

pmol/l

0.50

2148

13169

Diseases of appendix

2619

20991

1.13

8.18

3.4

3.3

4.51

pmol/l

0.01

2387

18779

Status epilepticus

105

576

1.88

8.17

2.6

3.4

4.09

4.56

pmol/l

4.55

513

Acute pancreatitis (for exclusion)

523

4017

1.32

8.17

3.2

3.3

4.38

4.44

pmol/l

0.59

446

3566

Other local infections of skin and subcutaneous tissue

305

2158

1.44

8.17

3.3

3.4

4.38

4.51

pmol/l

1.65

280

1917

ILD, hospital admissions

356

2583

1.40

8.15

2.7

3.3

4.20

4.40

pmol/l

2.46

305

2245

Primary ovarian failure

504

1.99

8.12

3.8

3.4

4.52

4.59

pmol/l

0.25

453

Phlebitis and thrombophlebitis (not including DVT)

687

5469

1.27

8.12

3.1

3.3

4.34

4.46

pmol/l

2.67

619

4841

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

417

3110

1.37

8.12

3.1

3.3

4.48

4.47

pmol/l

0.10

368

2782

Decubitus ulcer and pressure area

151

919

1.68

8.11

2.5

3.2

3.90

4.44

pmol/l

7.51

125

806

Other specified/unspecified bacterial intestinal infections

201

1313

1.57

8.10

3.0

3.3

4.44

4.47

pmol/l

0.20

178

1159

Injuries to the elbow and forearm

2478

19316

1.14

8.10

3.1

3.3

4.47

4.52

pmol/l

1.67

2173

17218

Superficial injury of wrist and hand

682

5430

1.27

8.08

3.1

3.4

4.50

4.58

pmol/l

1.16

598

4891

Vulvovaginal ulceration/inflammation in other diseases

265

1843

1.49

8.01

3.1

3.4

4.50

4.52

pmol/l

0.19

234

1656

Speech therapy

804

6526

1.25

7.99

2.9

3.3

4.38

4.44

pmol/l

0.92

740

5759

Sensorineural hearing loss

2301

13768

1.14

7.97

3.1

3.3

4.41

4.43

pmol/l

0.53

1991

12233

Deficiency of other B group vitamins

331

2.18

7.97

4.2

3.3

4.25

4.53

pmol/l

1.79

289

Appendicitis, broad definition

2595

20896

1.13

7.97

3.4

4.51

4.52

pmol/l

0.02

2365

18695

Septal defects

203

1307

1.56

7.92

3.8

3.4

4.72

4.70

pmol/l

0.08

184

1173

Acute suppurative otitis media

950

7319

1.23

7.92

3.0

3.4

4.61

4.65

pmol/l

0.76

854

6631

Disorders of oesophagus in diseases classified elsewhere

312

2.22

7.91

3.0

3.2

3.98

4.54

pmol/l

4.16

265

COPD, early/later onset

1115

7858

1.21

7.89

3.2

3.3

4.26

4.38

pmol/l

3.45

963

6929

Other and unspecified disorders of white blood cells

126

739

1.77

7.89

3.0

3.5

4.52

4.56

pmol/l

0.06

107

653

Anogenital herpesviral [herpes simplex] infection

427

3217

1.36

7.86

3.1

3.4

4.47

4.59

pmol/l

1.93

374

2897

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

188

1196

1.59

7.85

2.6

3.5

4.99

4.82

pmol/l

0.56

173

1087

Metatarsalgia

320

2302

1.42

7.85

2.7

3.5

4.51

4.50

pmol/l

0.06

285

2075

Diabetic retinopathy, excluding more controls

822

3726

1.25

7.83

2.9

3.3

4.28

4.48

pmol/l

6.25

723

3291

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2325

16294

1.14

7.83

3.2

3.4

4.52

4.50

pmol/l

0.53

2090

14630

Memory loss

235

1596

1.50

7.83

2.5

3.2

4.30

4.38

pmol/l

0.61

196

1384

Somnolence, stupor and coma

125

732

1.76

7.82

3.0

3.5

4.35

4.48

pmol/l

0.75

106

645

Hodgkin lymphoma, hilmo

507

1.93

7.81

3.6

3.4

4.33

4.61

pmol/l

2.22

444

Non-small cell lung cancer, including Hilmo

332

2256

1.41

7.78

4.0

2.9

4.24

4.37

pmol/l

1.72

310

1935

Non-small cell lung cancer

207

1357

1.54

7.76

3.9

2.8

4.25

4.35

pmol/l

0.69

192

1148

Other disorders of optic [2nd] nerve and visual pathways

197

1295

1.56

7.75

2.9

3.3

4.48

4.54

pmol/l

0.16

180

1148

Acute gastritis

214

1431

1.53

7.71

2.8

3.4

4.23

4.44

pmol/l

2.48

189

1253

Benign neoplasm of mouth and pharynx

315

2266

1.42

7.70

3.4

3.3

4.43

4.45

pmol/l

0.14

276

2017

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

958

7949

1.22

7.67

3.3

3.4

4.56

pmol/l

0.05

843

7169

Injuries to unspecified part of trunk, limb or body region

297

2116

1.43

7.67

2.7

3.3

4.41

4.50

pmol/l

0.72

268

1874

Pneumonia due to other infectious organisms, not elsewhere classified

100

553

1.87

7.65

3.2

3.5

4.09

4.58

pmol/l

5.24

487

Coxarthrosis, primary

1658

12164

1.16

7.63

3.1

3.3

4.36

4.38

pmol/l

0.53

1463

10691

Idiopathic urticaria

492

1.95

7.62

3.0

3.5

4.58

4.62

pmol/l

0.13

440

Sequelae of cerebrovascular disease

879

6224

1.23

7.61

3.0

3.2

4.30

4.38

pmol/l

1.39

770

5440

Disorders of optic nerve and visual pathways

313

2257

1.42

7.60

3.1

3.3

4.52

pmol/l

0.02

284

2015

Superficial injury of abdomen, lower back and pelvis

468

3582

1.33

7.60

3.1

3.3

4.45

4.53

pmol/l

1.03

412

3192

Arterial embolism and thrombosis

139

842

1.69

7.60

2.9

3.2

4.26

4.47

pmol/l

1.40

126

735

Lichen simplex chronicus and prurigo

193

1269

1.56

7.59

3.5

3.3

4.41

4.47

pmol/l

0.39

172

1124

Prurigo nodularis

456

1.98

7.58

4.7

3.2

4.43

4.52

pmol/l

0.33

400

Interstitial lung disease

357

2624

1.38

7.58

2.7

3.2

4.20

4.39

pmol/l

2.43

306

2282

Interstitial lung disease endpoints

357

2624

1.38

7.58

2.7

3.2

4.20

4.39

pmol/l

2.43

306

2282

Pre-eclampsia or eclampsia

913

7567

1.23

7.58

3.4

4.52

4.50

pmol/l

0.20

828

6782

Pre-eclampsia or poor fetal growth

1328

11329

1.18

7.56

3.6

3.4

4.55

4.53

pmol/l

0.29

1202

10201

Other interstitial pulmonary diseases

357

2625

1.38

7.56

2.7

3.2

4.20

4.39

pmol/l

2.35

306

2282

Pericarditis

482

1.92

7.55

3.3

3.2

4.26

4.60

pmol/l

2.21

425

Hemiplegia

154

962

1.65

7.55

3.4

3.2

4.26

4.50

pmol/l

2.74

139

844

Glaucoma

1598

11902

1.16

7.49

3.1

3.3

4.40

4.38

pmol/l

0.26

1399

10469

Assault

407

3061

1.35

7.49

2.6

3.4

4.53

4.62

pmol/l

1.20

358

2766

Chondropathies

486

3750

1.32

7.47

3.1

3.4

4.58

4.51

pmol/l

0.80

418

3352

Colonic or urogenital fistula

806

6593

1.24

7.47

3.4

3.3

4.46

4.48

pmol/l

0.17

696

5875

Benign neoplasm of eye and adnexa

299

2146

1.42

7.45

3.3

4.38

4.44

pmol/l

0.60

265

1894

Spondyloarthritis

510

3957

1.31

7.43

2.9

3.3

4.51

4.52

pmol/l

0.03

454

3532

Follow-up examination after treatment for malignant neoplasms

262

1834

1.45

7.42

3.4

4.34

4.42

pmol/l

0.64

244

1606

Pustulosis palmaris et plantaris

150

938

1.66

7.42

3.8

3.4

4.55

4.51

pmol/l

0.19

138

833

Disorder of the sleep-wake schedule

342

2.13

7.39

5.0

3.4

4.60

4.77

pmol/l

0.75

304

Secondary parkinsonism+Parkinsonism in other disease

382

2.04

7.35

2.8

3.2

4.10

4.45

pmol/l

2.61

329

Follicular cysts of skin and subcutaneous tissue

532

4160

1.30

7.35

3.4

3.3

4.49

pmol/l

0.06

476

3702

Seborrhoeic keratosis

625

4983

1.27

7.34

3.2

3.3

4.36

4.41

pmol/l

0.66

533

4378

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

265

2.32

7.33

3.5

3.8

4.56

4.66

pmol/l

0.35

243

Hypertrophy of breast in women and men

753

6141

1.25

7.31

3.4

3.3

4.47

4.49

pmol/l

0.24

669

5502

Abnormal findings on antenatal screening of mother

373

2791

1.37

7.30

3.7

3.5

4.69

4.58

pmol/l

1.19

350

2521

Scar conditions and fibrosis of skin

153

967

1.64

7.27

3.9

3.2

4.40

4.54

pmol/l

0.94

137

862

Herpesviral [herpes simplex] infections

382

2864

1.36

7.26

3.3

3.4

4.41

4.49

pmol/l

0.79

339

2558

Intentional self-harm by sharp object

557

1.86

7.25

2.5

3.4

4.54

4.68

pmol/l

0.85

499

Multiple myeloma, including Hilmo

108

620

1.79

7.25

3.8

2.9

4.38

4.44

pmol/l

0.26

101

527

Hypertrophy of breast

711

5774

1.25

7.25

3.4

3.3

4.47

4.48

pmol/l

0.15

638

5168

Acne

368

2741

1.37

7.22

3.3

3.4

4.62

4.70

pmol/l

0.94

327

2480

Benign lipomatous neoplasm of other sites/unspecified

237

1640

1.48

7.22

3.0

3.3

4.31

4.43

pmol/l

1.08

216

1432

Other and unspecified rosacea

290

2085

1.43

7.22

3.9

3.3

4.43

4.46

pmol/l

0.22

253

1878

Spontaneous abortion

1973

11710

1.15

7.21

3.3

4.51

4.50

pmol/l

0.19

1777

10479

Allergic urticaria

287

2060

1.43

7.21

3.3

4.54

pmol/l

0.00

251

1845

Dialysis

107

615

1.80

7.19

2.3

3.5

3.79

4.64

pmol/l

12.82

102

550

Viral infections of the central nervous system

247

1727

1.46

7.17

2.9

3.3

4.31

4.53

pmol/l

3.64

222

1544

Secondary parkinsonism

379

2.03

7.15

2.8

3.1

4.13

4.45

pmol/l

2.35

326

Radial styloid tenosynovitis [de Quervain]

209

1418

1.52

7.15

3.3

3.4

4.44

4.53

pmol/l

0.80

188

1295

Morphin

245

2.29

7.14

3.2

3.0

4.26

4.47

pmol/l

0.70

211

Other predominantly sexually transmitted diseases, not elsewhere classified

789

6482

1.23

7.11

3.6

3.4

4.58

4.61

pmol/l

0.28

691

5881

Sequelae of injuries of lower limb

291

2097

1.42

7.11

2.9

3.3

4.42

4.51

pmol/l

0.86

263

1886

Superficial injury of thorax

415

3154

1.34

7.11

3.1

3.3

4.47

4.49

pmol/l

0.21

357

2795

Specific development disorders of scholastic skills

148

918

1.64

7.10

2.6

3.4

4.99

4.84

pmol/l

0.76

134

830

Ulcer of oesophagus

162

1038

1.59

7.10

3.0

3.4

4.28

4.42

pmol/l

1.05

131

907

Intestinal adhesions without obstruction

226

1555

1.48

7.08

3.5

3.2

4.44

4.47

pmol/l

0.18

196

1355

Alzheimer’s disease (Atypical or mixed), excluding more controls

166

843

1.59

7.08

2.9

3.2

4.21

4.34

pmol/l

0.96

140

727

Pregnancy with abortive outcome

2845

13338

1.12

7.07

3.3

4.51

4.50

pmol/l

0.26

2535

11865

Hypertensive Renal Disease

457

1.91

7.05

2.5

3.2

3.88

4.44

pmol/l

5.45

390

Problems related to social environment

524

1.86

7.05

3.4

3.2

4.63

4.57

pmol/l

0.15

458

Convalescence

176

1155

1.57

7.04

3.6

3.3

4.47

4.50

pmol/l

0.14

149

1028

Non-small cell lung cancer, adenocarcinoma

135

830

1.66

7.02

3.2

3.0

4.19

4.40

pmol/l

1.59

126

703

Benign neoplasm: Ascending colon

351

2609

1.37

7.02

3.3

3.2

4.34

4.39

pmol/l

0.48

294

2281

Other and unspecified trigeminal disorders

295

2.19

7.01

3.0

3.4

4.26

4.57

pmol/l

1.56

257

Other disorders of cornea

281

2019

1.42

6.98

3.3

3.4

4.51

4.48

pmol/l

0.14

240

1801

Hypermetropia

217

1487

1.49

6.97

3.3

3.2

4.59

4.63

pmol/l

0.22

196

1314

Other disorders of the genitourinary system

407

3100

1.34

6.97

3.1

4.46

4.42

pmol/l

0.31

364

2705

Viral warts

318

2334

1.39

6.96

3.2

3.4

4.53

4.55

pmol/l

0.13

288

2091

Anomalies of pupillary function

456

1.94

6.96

3.0

3.4

4.50

4.62

pmol/l

0.51

401

Injuries to the wrist and hand

3603

22741

1.10

6.95

3.2

3.4

4.50

4.52

pmol/l

0.51

3169

20403

Other abnormal immunological findings in serum

435

1.96

6.95

3.4

3.3

4.48

4.66

pmol/l

0.88

387

Other female pelvic inflammatory diseases

609

4887

1.27

6.93

3.2

3.3

4.45

4.47

pmol/l

0.20

535

4353

Fall on same level involving ice and snow

1884

16623

1.14

6.90

3.3

4.50

4.48

pmol/l

0.39

1672

14792

Malignant neoplasm of eye, brain and central nervous system

117

698

1.72

6.89

2.9

3.0

4.21

4.59

pmol/l

2.95

105

611

Chronic tubulo-interstitial nephritis

124

753

1.70

6.88

2.9

3.4

4.10

4.50

pmol/l

4.20

111

655

Biomechanical lesions, not elsewhere classified

152

971

1.61

6.86

3.4

4.40

4.49

pmol/l

0.59

138

849

Charcot foot

250

2.26

6.86

3.4

3.9

3.99

4.62

pmol/l

4.99

224

Car occupant injured in other and unspecified transport accidents

618

4968

1.26

6.82

4.0

3.3

4.59

4.55

pmol/l

0.55

565

4432

Other and unspecified disorders of orbit

3.68

6.82

3.6

4.32

4.49

pmol/l

0.50

Superficial injury of forearm

314

2308

1.39

6.81

3.3

3.2

4.51

4.55

pmol/l

0.41

276

2053

Acute appendicitis

2416

20224

1.12

6.80

3.4

4.51

4.52

pmol/l

0.12

2209

18104

ILD, hospital admissions 1, main diag only

312

2288

1.38

6.79

2.6

3.3

4.22

4.39

pmol/l

1.75

267

1991

Other hearing loss

708

5645

1.24

6.77

3.2

4.39

4.36

pmol/l

0.34

610

4952

Other specified/unspecified systemic involvement of connective tissue

202

1378

1.51

6.76

3.0

3.2

4.31

4.47

pmol/l

1.43

188

1228

Benign neoplasm: salivary glands, exclude unknown (D119)

243

1713

1.45

6.75

3.7

3.3

4.30

4.44

pmol/l

1.82

221

1508

Injuries to the hip and thigh

1346

10511

1.17

6.75

2.8

3.3

4.35

4.44

pmol/l

2.98

1163

9270

Mixed connective tissue disease

223

1552

1.48

6.74

2.9

3.3

4.32

4.46

pmol/l

1.16

202

1370

Maltreatment syndromes

185

1240

1.53

6.73

3.0

3.4

4.62

4.67

pmol/l

0.23

159

1118

Open wound of head

1520

12751

1.16

6.72

3.2

3.3

4.41

4.50

pmol/l

2.66

1319

11347

Macular pucker

378

2860

1.34

6.72

3.3

3.2

4.35

4.36

pmol/l

0.05

331

2486

Psoriasis

848

7050

1.22

6.71

3.1

3.3

4.50

4.49

pmol/l

0.11

754

6282

Female infertility, associated with anovulation

343

2567

1.37

6.71

3.1

3.6

4.57

4.66

pmol/l

1.01

307

2320

Cyst of kidney

181

1207

1.53

6.68

3.3

4.36

4.41

pmol/l

0.36

162

1040

Postpartum care and examination

625

3177

1.27

6.68

4.1

3.5

4.63

4.59

pmol/l

0.62

568

2833

Vasomotor rhinitis (mode)

230

1611

1.46

6.67

3.1

3.3

4.37

4.47

pmol/l

1.25

203

1433

Streptococcal septicaemia

216

1491

1.48

6.67

3.5

3.4

4.36

4.57

pmol/l

1.61

193

1288

Benign neoplasm: Parotid gland

220

1527

1.47

6.66

3.9

3.3

4.32

4.44

pmol/l

1.37

199

1343

All dysplastic lesions of the vulva

173

1151

1.56

6.64

2.9

3.3

4.34

4.48

pmol/l

0.79

146

1026

Viral warts

691

5640

1.24

6.63

3.0

3.3

4.50

4.57

pmol/l

0.95

621

5049

Hidradenitis suppurativa

142

903

1.63

6.63

2.7

3.3

4.41

4.58

pmol/l

1.15

120

818

Other and unspecified glaucoma

174

1152

1.54

6.62

2.8

3.2

4.26

4.36

pmol/l

0.68

152

989

Premature rupture of membranes

950

5707

1.21

6.62

3.8

3.5

4.58

4.56

pmol/l

0.33

850

5154

Excessive earwax

1598

13644

1.15

6.61

3.0

3.3

4.49

4.45

pmol/l

0.96

1387

12098

Benign neoplasm of breast

438

3400

1.32

6.60

3.2

4.46

4.45

pmol/l

0.16

387

2996

Eosinophilia

282

2.17

6.59

2.5

3.3

4.58

4.57

pmol/l

0.02

251

Otitis externa, unspecified

354

2665

1.35

6.58

3.1

3.4

4.50

4.53

pmol/l

0.20

312

2388

Entropion and trichiasis of eyelid

186

1250

1.51

6.56

3.6

3.0

4.15

4.36

pmol/l

1.99

160

1069

Other necrotizing vasculopathies (FG)

162

1060

1.57

6.55

2.9

3.4

4.29

4.47

pmol/l

1.24

140

933

Alcohol dependence

654

5308

1.24

6.54

2.5

3.5

4.45

4.50

pmol/l

0.57

539

4781

Other and unspecified injuries of head

198

1352

1.50

6.52

2.7

3.3

4.33

4.53

pmol/l

2.02

167

1189

Stroke, including SAH

1714

10912

1.15

6.51

3.1

3.3

4.27

4.42

pmol/l

7.98

1516

9635

Organic, including symptomatic, mental disorders

1282

7846

1.17

6.48

2.7

3.3

4.30

4.37

pmol/l

1.70

1080

6865

Pre-eclampsia

842

7039

1.22

6.46

3.4

3.3

4.52

4.50

pmol/l

0.24

762

6315

Other peripheral vascular diseases

254

1821

1.43

6.46

2.8

3.3

4.40

4.47

pmol/l

0.54

223

1619

Benign neoplasm of other and unspecified sites

102

599

1.76

6.45

3.5

4.32

4.54

pmol/l

1.38

530

Other disorders of breast

497

3932

1.29

6.45

3.6

3.3

4.44

4.49

pmol/l

0.55

436

3501

Diseases of middle ear and mastoid

2030

14763

1.13

6.43

3.2

3.4

4.55

4.57

pmol/l

0.26

1802

13239

Causalgia

348

2.03

6.39

3.1

3.7

4.39

4.60

pmol/l

0.99

306

Gluteal tendinitis

141

903

1.62

6.38

3.0

3.4

4.40

4.48

pmol/l

0.52

118

803

Dermatitis due to substances taken internally

174

1165

1.53

6.37

3.0

3.2

4.46

4.55

pmol/l

0.50

155

1037

Diseases of peritoneum

280

2043

1.40

6.37

3.1

3.2

4.21

4.43

pmol/l

2.69

238

1806

Calculus of kidney and ureter

746

6157

1.22

6.35

3.3

4.44

4.45

pmol/l

0.18

657

5478

Benign neoplasm of urinary organs

135

855

1.63

6.34

3.1

3.2

4.37

4.44

pmol/l

0.21

115

745

Abnormal findings on examination of urine, without diagnosis

126

785

1.65

6.33

3.3

3.4

4.37

4.55

pmol/l

1.04

113

690

Pustular psoriasis

157

1033

1.57

6.29

3.7

3.3

4.54

4.50

pmol/l

0.15

145

913

Non-Hodgkin lymphoma, all

504

1.81

6.29

2.2

2.8

3.83

4.45

pmol/l

6.11

426

Focal epilepsy, mode (most common among epilepsy diagnosis)

520

4136

1.27

6.28

2.9

3.3

4.28

4.51

pmol/l

5.15

470

3664

Other disorders of amniotic fluid and membranes

597

4724

1.26

6.27

3.3

3.5

4.61

4.56

pmol/l

0.55

539

4257

Cytomegalovirus infection, IBD co-morbidity

392

1.94

6.25

3.2

4.18

4.67

pmol/l

2.89

347

Malignant neoplasm of small intestine, including Hilmo

441

1.88

6.25

2.8

3.1

4.11

4.49

pmol/l

2.92

380

Bronchiectasis

203

1405

1.48

6.24

3.4

3.2

4.26

4.41

pmol/l

0.80

172

1207

Other specified/unspecified dorsopathies

115

704

1.69

6.24

2.3

3.4

4.40

4.50

pmol/l

0.60

101

622

Benign neoplasm: Skin of lower limb, including hip

546

1.79

6.23

3.7

3.3

4.43

4.56

pmol/l

0.66

485

Alcohol use disorder, Swedish definition

1508

12092

1.15

6.23

2.6

3.4

4.44

4.51

pmol/l

1.86

1272

10870

Superficial injury of ankle and foot

393

3028

1.32

6.21

2.9

3.4

4.59

4.58

pmol/l

0.08

342

2729

Suggestive for eosinophilic asthma

252

1817

1.41

6.18

3.1

3.4

4.51

4.45

pmol/l

0.32

222

1612

1168

0.52

6.17

2.1

3.4

3.82

4.39

pmol/l

2.88

1019

Congenital malformations of the musculoskeletal system, not elsewhere classified

368

2.00

6.16

4.7

3.6

4.84

4.70

pmol/l

0.29

328

Glomerulonephritis

262

1902

1.40

6.16

3.2

3.3

4.23

4.49

pmol/l

3.68

240

1692

Schizotypal disorder

460

1.86

6.12

1.7

3.7

4.43

4.64

pmol/l

1.07

415

Urolithiasis

792

6599

1.21

6.12

3.3

3.4

4.43

4.45

pmol/l

0.20

697

5874

Use of biperiden

153

1006

1.56

6.11

2.3

3.4

4.33

4.50

pmol/l

1.17

127

890

Osteonecrosis

174

1176

1.52

6.09

2.8

3.3

4.38

4.47

pmol/l

0.64

157

1040

L01XX Other antineoplastic agents

149

974

1.57

6.09

2.9

3.1

4.24

4.38

pmol/l

1.24

121

841

Non-allergic asthma

248

1787

1.41

6.09

3.2

4.56

4.51

pmol/l

0.31

224

1589

Other disorders of binocular vision

320

2.06

6.09

3.7

3.3

4.75

4.57

pmol/l

0.55

283

LSIL lesion of the vulva

122

767

1.66

6.08

2.6

3.4

4.30

4.49

pmol/l

1.16

105

682

Peripheral arterial reconstruction

338

2552

1.34

6.07

2.9

3.1

4.05

4.34

pmol/l

5.48

301

2193

Left ventricular outflow tract obstruction, narrow definition

135

865

1.60

6.04

3.6

3.4

4.47

4.70

pmol/l

1.72

119

780

Other specified and unspecified retinal disorders

580

1.74

6.03

2.8

3.4

4.34

4.51

pmol/l

0.79

504

Kidney transplant status

139

897

1.59

6.03

2.2

3.6

3.84

4.64

pmol/l

16.34

132

796

Other infectious diseases

204

1425

1.46

5.99

3.3

4.25

4.45

pmol/l

2.19

176

1245

COPD, hospital admission 2, with asthma infections

722

5113

1.22

5.98

3.2

4.20

4.37

pmol/l

4.38

617

4485

Other embolism and thrombosis

355

2711

1.33

5.97

3.5

3.3

4.32

4.46

pmol/l

1.02

310

2396

Ingrowing nail

161

1076

1.53

5.97

3.2

3.3

4.47

4.59

pmol/l

0.67

141

960

Postprocedural musculoskeletal disorders, not elsewhere classified

197

1370

1.47

5.97

2.6

3.4

4.57

4.42

pmol/l

0.92

169

1204

Fracture of skull and facial bones

597

4854

1.24

5.95

3.0

3.4

4.50

4.54

pmol/l

0.29

513

4334

Open bite

195

1358

1.48

5.92

2.9

3.3

4.63

4.66

pmol/l

0.21

174

1220

Drug-induced cataract

436

1.87

5.92

2.5

3.0

4.22

4.60

pmol/l

2.22

383

Pneumonitis due to solids and liquids

176

1196

1.50

5.91

2.8

3.2

4.18

4.42

pmol/l

2.25

150

1028

Other and unspecified diseases of blood and blood-forming organs

443

1.85

5.90

3.0

3.4

4.39

4.51

pmol/l

0.49

389

Muscle strain

107

654

1.69

5.86

2.4

3.4

4.43

4.56

pmol/l

0.84

593

Atopic dermatitis, strict definition

1094

9221

1.17

5.85

3.0

3.4

4.64

4.61

pmol/l

0.43

968

8337

Benign neoplasm of major salivary glands

264

1937

1.39

5.85

3.7

3.3

4.28

4.43

pmol/l

2.11

240

1700

Other and unspecified corneal deformities and disorders

103

625

1.71

5.82

3.6

3.3

4.49

4.55

pmol/l

0.15

557

Other noninfective disorders of lymphatic vessels and lymph nodes

121

765

1.63

5.81

3.4

4.22

4.50

pmol/l

2.48

106

666

Benign neoplasm: Kidney

102

618

1.71

5.79

3.1

3.4

4.47

4.42

pmol/l

0.15

541

Benign neoplasm: Tongue

468

1.82

5.78

2.7

3.3

4.48

pmol/l

0.00

402

Complications of the puerperium, not elsewhere classified

191

1337

1.48

5.77

4.2

3.3

4.60

4.55

pmol/l

0.20

182

1201

Other/unspecified cytomegaloviral diseases

339

1.98

5.76

3.3

4.13

4.62

pmol/l

2.58

303

Fracture of femur

643

4787

1.23

5.74

2.8

3.1

4.24

4.37

pmol/l

2.25

549

4128

Postprocedural disorders of digestive system, not elsewhere classified

581

1.72

5.74

3.9

3.4

4.43

4.53

pmol/l

0.53

508

Hirsutism in women

540

1.78

5.74

3.1

3.3

4.54

4.61

pmol/l

0.34

490

Melanocytic naevi of other and unspecified parts of face

197

1383

1.46

5.73

3.7

3.3

4.50

4.51

pmol/l

0.03

174

1229

Trichomoniasis

172

2.43

5.72

3.2

4.16

4.50

pmol/l

1.67

147

Malignant neoplasm of small intestine

311

2.01

5.71

3.0

4.18

4.46

pmol/l

1.57

270

Impacted cerumen

247

1800

1.40

5.70

3.1

3.3

4.37

4.46

pmol/l

0.64

192

1568

Chronic ulcer of skin, not elsewhere classified

171

1167

1.50

5.69

2.9

3.3

4.16

4.46

pmol/l

2.91

147

1016

Chronic pancreatitis

288

2149

1.36

5.69

3.1

3.4

4.15

4.46

pmol/l

6.12

248

1921

Lichen planus, including avohilmo

558

4534

1.25

5.68

3.1

3.3

4.42

4.44

pmol/l

0.10

488

4013

Systemic lupus erythematosus

129

834

1.60

5.68

2.6

3.2

4.15

4.51

pmol/l

4.29

114

731

Sequelae of injuries of upper limb

284

2119

1.36

5.67

3.1

3.3

4.51

4.50

pmol/l

0.10

252

1901

Benign neoplasm: Skin of other and unspecified parts of face

298

2239

1.35

5.67

3.1

3.3

4.40

4.43

pmol/l

0.17

266

1969

Dislocation, sprain and strain of joints and ligaments of thorax

105

645

1.68

5.66

3.6

3.4

4.50

4.60

pmol/l

0.56

573

Intermittent heterotropia

191

1334

1.46

5.66

3.5

3.2

4.73

4.69

pmol/l

0.14

171

1185

Single delivery by caesarean section

806

3876

1.21

5.64

3.4

4.56

pmol/l

0.00

738

3459

Bell's palsy

338

2587

1.33

5.64

3.0

3.4

4.44

4.49

pmol/l

0.28

296

2302

Attention to artificial openings

575

1.71

5.63

3.6

3.4

4.19

4.50

pmol/l

1.75

509

Vascular disorders of the intestines

154

1030

1.52

5.63

3.0

3.1

4.09

4.41

pmol/l

3.30

138

877

Stenosis and insufficiency of lacrimal passages

275

2045

1.37

5.62

3.4

3.1

4.40

4.46

pmol/l

0.54

251

1810

Corns and callosities

193

1354

1.46

5.61

2.8

3.3

4.34

4.47

pmol/l

0.86

162

1203

Behavioural disorders, excluding more controls

340

1.94

5.60

3.9

3.8

4.65

4.96

pmol/l

1.42

313

Multiple myeloma and malignant plasma cell neoplasms

114

715

1.63

5.60

3.7

3.3

4.37

4.36

pmol/l

0.04

106

615

Acute drug-induced interstitial lung disorder

112

2.78

5.60

2.9

2.7

4.32

4.28

pmol/l

0.05

Other specified disorders of muscle

502

1.77

5.60

2.9

3.5

4.42

4.55

pmol/l

0.52

452

Redundant prepuce, phimosis and paraphimosis

365

2789

1.31

5.58

3.1

3.6

4.66

4.67

pmol/l

0.05

322

2493

Coronary artery bypass grafting

479

2837

1.27

5.58

2.9

3.2

4.09

4.42

pmol/l

11.68

418

2455

Degenerative macular diseases

289

2166

1.35

5.56

3.4

3.1

4.26

4.37

pmol/l

1.10

249

1863

Acne vulgaris

281

2101

1.36

5.56

3.4

4.61

4.71

pmol/l

0.97

250

1904

Suppurative and necrotic conditions of lower respiratory tract

124

794

1.60

5.56

3.3

3.4

4.27

4.49

pmol/l

1.36

110

696

Raynaud syndrome

293

2207

1.36

5.56

2.7

3.4

4.47

4.50

pmol/l

0.18

257

1982

Protozoal diseases

504

1.77

5.54

2.6

3.4

4.00

4.57

pmol/l

4.62

435

Benign neoplasm: Transverse colon

260

1920

1.38

5.54

3.0

3.2

4.44

4.38

pmol/l

0.48

231

1678

Atrial septal defect

118

745

1.62

5.54

3.1

3.2

4.48

4.76

pmol/l

1.85

106

672

Other/unspecified disorders of vestibular function

118

750

1.62

5.53

3.1

3.4

4.27

4.46

pmol/l

1.52

101

660

Congenital malformations of eye, ear, face and neck

212

1517

1.43

5.53

3.7

3.3

4.65

4.66

pmol/l

0.07

188

1346

Nephrotic syndrome

519

1.75

5.53

2.8

3.4

4.15

4.66

pmol/l

3.06

464

Sacrococcygeal disorders, not elsewhere classified

111

697

1.65

5.52

3.3

3.4

4.56

4.54

pmol/l

0.07

617

Lichen planus

368

2859

1.31

5.52

3.2

3.3

4.38

4.44

pmol/l

0.67

324

2522

Other infectious diseases

241

1760

1.39

5.51

3.3

4.24

4.46

pmol/l

3.11

211

1544

Mandibular retrognathia

227

1642

1.41

5.48

2.9

3.3

4.72

4.64

pmol/l

0.40

207

1481

Other predominantly sexually transmitted diseases, not elsewhere classified

643

5326

1.22

5.48

3.5

3.4

4.56

4.58

pmol/l

0.24

568

4830

Congenital deformities of feet

130

848

1.58

5.47

3.1

3.3

4.62

4.68

pmol/l

0.25

124

758

Giant cell arteritis

110

689

1.64

5.47

3.2

3.1

4.28

4.37

pmol/l

0.35

598

Other specified and unspecified strabismus

228

2.18

5.46

4.5

3.3

4.26

4.61

pmol/l

1.57

204

Inflammatory diseases of the central nervous system

241

1765

1.39

5.45

3.1

3.3

4.39

4.50

pmol/l

0.79

208

1576

Sudden idiopathic hearing loss

267

1988

1.37

5.41

3.2

3.3

4.31

4.43

pmol/l

1.24

229

1755

Inguinal or femoral hernia, bilateral

200

1417

1.43

5.41

3.5

3.6

4.43

4.42

pmol/l

0.04

179

1263

Other congenital malformations of face and neck

101

623

1.68

5.41

4.6

3.2

4.68

4.65

pmol/l

0.11

553

Familial hypercholesterolemia, with ischemic heart disease

187

1310

1.45

5.40

3.3

3.2

4.13

4.34

pmol/l

2.20

157

1128

Other necrotizing vasculopathies

189

1330

1.45

5.40

3.1

3.3

4.23

4.43

pmol/l

1.73

161

1173

malignant neoplasm of female genital organs

477

3813

1.26

5.40

4.5

2.9

4.44

4.42

pmol/l

0.12

435

3294

Other superficial mycoses

412

1.85

5.40

2.4

3.5

4.41

4.59

pmol/l

1.05

372

Malignant neoplasm of respiratory system and intrathoracic organs

434

2857

1.28

5.40

3.7

2.9

4.25

4.37

pmol/l

1.73

396

2456

Polycystic ovarian syndrome, broad definition

473

3808

1.27

5.38

3.3

3.4

4.60

pmol/l

0.00

420

3440

Rare circulating lymphoid malignancy, including Hilmo

396

1.84

5.37

3.2

2.9

4.46

4.63

pmol/l

0.67

341

Examination and encounter for administrative purposes

116

738

1.61

5.36

4.3

3.6

4.52

4.47

pmol/l

0.25

105

654

Cytomegaloviral disease

420

1.83

5.36

3.2

3.4

4.19

4.64

pmol/l

2.67

373

Complications predominantly related to the puerperium

1076

9332

1.17

5.34

3.6

3.4

4.48

4.53

pmol/l

0.78

977

8365

Viral infections of the central nervous system

222

1611

1.41

5.34

2.9

3.2

4.34

4.53

pmol/l

2.65

197

1441

Arterial embolism and thrombosis of lower extremity artery

470

1.77

5.34

3.2

4.21

4.44

pmol/l

0.96

406

Paranoid personality disorder

363

1.90

5.32

3.3

3.5

4.48

4.61

pmol/l

0.56

317

Tobacco use

160

1096

1.50

5.31

3.8

3.4

4.54

4.56

pmol/l

0.07

141

975

1614

12955

1.13

5.31

2.7

3.4

4.46

4.52

pmol/l

1.16

1368

11653

Diseases of spleen

299

1.99

5.29

4.0

3.6

4.22

4.55

pmol/l

2.12

267

Other diseases of peritoneum

139

927

1.54

5.29

3.3

4.48

4.46

pmol/l

0.05

113

818

Mental and behavioural disorders associated with the puerperium

302

2.02

5.28

3.5

3.7

4.56

4.70

pmol/l

0.49

271

Onycholysis

116

2.70

5.27

4.4

3.4

4.65

4.52

pmol/l

0.24

108

Tubulo-interstitial nephritis, not specified as acute or chronic

195

1386

1.43

5.27

2.8

3.3

4.31

4.51

pmol/l

1.11

177

1221

Family history of malignant neoplasm

399

3155

1.29

5.27

3.4

3.3

4.48

4.54

pmol/l

0.54

366

2812

Localized adiposity

111

2.79

5.25

3.1

3.3

4.30

4.41

pmol/l

0.29

100

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

124

809

1.58

5.25

3.0

3.4

4.58

4.62

pmol/l

0.15

115

728

Other/unspecified enthesopathies, not elsewhere classified

236

1733

1.39

5.24

3.4

4.38

4.45

pmol/l

0.56

217

1550

Benign leiomyoma with endometriosis

543

4447

1.24

5.24

3.2

3.3

4.43

4.42

pmol/l

0.06

488

3901

Other aneurysm

119

766

1.58

5.23

2.8

3.4

4.40

4.44

pmol/l

0.14

105

666

Purpura and other haemorrhagic conditions

364

2845

1.30

5.21

3.6

3.3

4.35

4.49

pmol/l

1.41

327

2518

Other benign neoplasms of connective and other soft tissue

293

2227

1.34

5.21

3.4

3.3

4.54

4.47

pmol/l

0.33

267

1988

Other specified and unspecified disorders of eye and adnexa

117

754

1.60

5.21

2.6

3.3

4.17

4.52

pmol/l

3.61

102

661

Diabetic nephropathy

406

3175

1.28

5.20

2.8

3.3

4.02

4.39

pmol/l

7.93

356

2809

DVT of lower extremities

498

4037

1.25

5.19

3.1

3.3

4.32

4.44

pmol/l

1.86

445

3548

Open wound of lower leg

417

3315

1.27

5.18

3.5

3.2

4.34

4.50

pmol/l

2.50

364

2951

Embolic stroke with flimmer

237

2.07

5.17

2.9

3.1

4.23

4.43

pmol/l

0.76

204

Beningn neoplasm: Meninges, unspecified

274

2.03

5.16

4.0

2.9

4.04

4.50

pmol/l

3.20

231

Disorders of iron metabolism

239

2.10

5.16

3.1

2.9

4.59

4.47

pmol/l

0.48

212

Diabetic neuropathy

280

2105

1.35

5.16

2.5

3.3

4.11

4.37

pmol/l

3.20

247

1860

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

332

2579

1.32

5.15

3.5

3.4

4.61

4.52

pmol/l

0.79

312

2314

Artificial joint re-operation

180

1268

1.45

5.15

3.1

4.33

4.38

pmol/l

0.26

153

1108

Scleritis and episcleritis

203

1463

1.42

5.14

3.2

3.3

4.49

4.51

pmol/l

0.15

178

1312

Meralgia paraesthetica

108

686

1.63

5.13

2.9

3.3

4.50

4.51

pmol/l

0.04

605

Adrenomedullary hyperfunction

3.76

5.13

4.3

3.6

4.38

4.55

pmol/l

0.25

Other lesions of median nerve

478

1.75

5.12

2.8

3.0

4.24

4.48

pmol/l

1.11

409

Other or unspecified ileus, impaction or obstruction

449

3601

1.26

5.11

3.0

3.3

4.30

4.43

pmol/l

2.27

386

3149

Giant cell arteritis with polymyalgia rheumatica

600

1.66

5.11

2.9

3.1

4.36

4.37

pmol/l

0.02

515

Spondylopathies (FG)

424

3387

1.27

5.08

2.9

3.5

4.57

4.55

pmol/l

0.09

376

3043

Carrier of infectious disease

495

1.74

5.08

3.4

4.38

4.60

pmol/l

0.97

437

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

152

1041

1.50

5.08

3.0

3.5

4.53

4.56

pmol/l

0.13

140

942

Other benign neoplasm of uterus: Other parts/unspecified

115

743

1.59

5.07

3.1

2.8

4.59

4.37

pmol/l

0.42

103

630

Brain meningioma

145

984

1.51

5.07

3.2

2.9

4.25

4.44

pmol/l

1.28

133

847

Other disorders affecting eyelid function

149

2.43

5.06

6.3

3.4

4.22

4.53

pmol/l

1.31

132

Other and unspecified erythematous conditions

579

1.68

5.06

2.4

3.3

4.32

4.52

pmol/l

0.97

508

Temporal arteritis

602

1.66

5.05

2.9

3.1

4.36

4.38

pmol/l

0.05

520

Toxic liver disease

305

1.96

5.04

3.6

4.34

4.55

pmol/l

0.72

271

Other benign neoplasms of uterus

159

1101

1.48

5.04

3.1

4.55

4.38

pmol/l

0.44

142

941

Injury of unspecified body region

215

1567

1.40

5.04

2.8

3.3

4.41

4.50

pmol/l

0.65

194

1385

Episcleritis

175

1234

1.46

5.04

3.2

3.4

4.52

pmol/l

0.02

155

1111

Algoneurodystrophy

121

794

1.58

5.03

3.2

3.3

4.52

pmol/l

0.01

107

700

Retinal breaks without detachment

438

3517

1.26

5.02

3.5

3.3

4.52

4.45

pmol/l

0.77

393

3121

Achilles tendinitis

290

2213

1.33

5.00

3.3

3.4

4.59

4.49

pmol/l

0.84

257

1994

Other diseases of pancreas

202

1459

1.41

4.99

2.8

3.3

4.23

4.42

pmol/l

2.42

178

1292

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

235

1742

1.38

4.99

3.2

3.3

4.34

4.47

pmol/l

0.78

200

1536

Intentional self-harm by unspecified means

307

1.96

4.99

2.9

3.5

4.52

4.70

pmol/l

0.56

272

Hypertrichosis

616

1.67

4.98

2.9

3.3

4.55

4.58

pmol/l

0.10

559

Convergence insufficiency and excess

329

1.93

4.97

3.0

3.4

4.73

4.67

pmol/l

0.19

291

Other erythematous conditions

104

660

1.62

4.96

2.6

3.4

4.34

4.56

pmol/l

1.19

580

Polycythaemia vera

489

1.72

4.96

2.7

2.9

4.33

4.43

pmol/l

0.56

416

Diabetic nephropathy, excluding more controls

403

2635

1.28

4.95

2.8

3.3

4.02

4.48

pmol/l

11.44

354

2326

Other otitis externa (chronic)

193

1388

1.42

4.94

3.5

3.4

4.45

4.52

pmol/l

0.45

159

1234

Acute lymphadenitis

185

1321

1.43

4.94

3.2

3.4

4.54

4.60

pmol/l

0.38

169

1181

Dissocial personality disorder

250

2.04

4.94

2.9

3.8

4.47

4.77

pmol/l

1.32

227

Lichen ruber planus, wide definition including periferal and oral lichen planus

658

5517

1.21

4.93

3.1

3.3

4.41

4.44

pmol/l

0.40

580

4877

Brain meningioma, including Hilmo

148

1015

1.49

4.92

3.1

3.0

4.24

4.44

pmol/l

1.34

136

875

Chronic Coagulation defects

578

1.68

4.91

3.3

3.4

4.51

4.57

pmol/l

0.22

506

Peripheral artery operations in Hilmo

249

1859

1.35

4.91

3.3

3.2

3.95

4.38

pmol/l

9.58

223

1599

Enteropathic arthropathies

462

1.75

4.90

2.9

3.6

4.38

4.54

pmol/l

0.65

423

Assault by bodily force

234

1737

1.37

4.90

2.7

3.4

4.52

4.64

pmol/l

1.05

205

1557

Paralytic strabismus

179

1272

1.43

4.88

3.3

3.2

4.42

4.47

pmol/l

0.30

162

1108

Peripheral artery disease

991

6818

1.16

4.88

3.1

3.3

4.09

4.39

pmol/l

17.24

868

5955

1714

13527

1.12

4.87

2.7

3.4

4.47

4.52

pmol/l

1.23

1458

12179

Amputation

198

1429

1.40

4.86

3.0

3.2

3.83

4.39

pmol/l

11.63

177

1231

Viral haemorrhagic fevers, not elsewhere classified/unspecified

447

3610

1.25

4.85

3.3

4.47

4.51

pmol/l

0.34

411

3201

Other dialysis

486

1.72

4.83

1.9

3.5

3.63

4.59

pmol/l

12.62

430

Hypotension due to drugs

184

2.21

4.83

2.9

3.1

4.04

4.44

pmol/l

2.32

161

Infectious mononucleosis

291

2236

1.32

4.83

2.9

3.4

4.69

pmol/l

0.01

259

2014

Torsion of ovary, ovarian pedicle and fallopian tube

581

1.67

4.82

3.4

3.3

4.54

4.59

pmol/l

0.23

517

Other congenital malformations of the digestive system

124

818

1.54

4.81

2.6

3.3

4.69

4.75

pmol/l

0.21

110

736

Disorders of continuity of bone

298

2298

1.32

4.81

3.2

3.3

4.43

4.51

pmol/l

0.57

272

2052

Von Willebrand disease

297

1.96

4.79

3.3

3.8

4.45

4.66

pmol/l

0.87

262

Malignant neoplasm of other connective and soft tissue, including Hilmo

102

649

1.61

4.78

3.9

3.0

4.53

4.55

pmol/l

0.08

554

Other drug-induced secondary parkinsonism

140

2.42

4.78

2.2

3.3

3.88

4.50

pmol/l

2.79

119

Exposure to other and unspecified inanimate mechanical forces

209

1532

1.39

4.76

3.1

3.4

4.53

4.57

pmol/l

0.17

190

1369

Rheumatoid arthritis

964

7486

1.16

4.76

2.8

3.4

4.32

4.46

pmol/l

3.05

851

6639

Acute nasopharyngitis (common cold)

288

2194

1.32

4.76

3.5

3.4

4.61

4.62

pmol/l

0.01

264

1956

Anogenital herpesviral [herpes simplex] infection

234

1751

1.37

4.74

3.4

4.43

4.58

pmol/l

1.79

208

1579

Wet age-related macular degeneration

374

2876

1.27

4.73

3.4

3.1

4.32

4.28

pmol/l

0.34

320

2450

Presbycusis

282

2136

1.32

4.73

3.4

3.0

4.40

4.26

pmol/l

1.38

234

1814

Ménière disease

263

1998

1.34

4.73

3.3

4.38

4.43

pmol/l

0.37

233

1760

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1263

7539

1.14

4.73

3.1

3.0

4.36

4.41

pmol/l

0.76

1083

6575

Primary coxarthrosis, bilateral

719

6095

1.19

4.72

3.2

4.33

4.37

pmol/l

0.41

628

5329

Bicipital tendinitis

132

893

1.51

4.70

2.9

3.5

4.48

4.45

pmol/l

0.14

117

807

Other acquired deformities of musculoskeletal system and connective tissue

128

861

1.52

4.70

3.2

3.4

4.38

4.55

pmol/l

1.22

121

760

Cholecystitis

338

2654

1.29

4.67

3.0

3.2

4.31

4.43

pmol/l

1.53

303

2348

Progressive vascular leukoencephalopathy

505

1.68

4.67

2.7

2.9

4.11

4.29

pmol/l

1.11

425

Urethritis and urethral syndrome

454

1.74

4.66

4.0

3.2

4.46

4.59

pmol/l

0.51

395

Perioral dermatitis

540

1.68

4.66

3.0

3.4

4.39

4.55

pmol/l

1.02

479

Inguinal hernia, bilateral

190

1373

1.40

4.65

3.6

3.7

4.45

4.43

pmol/l

0.09

170

1226

Hyperkinetic disorders (excl. ADHD)

353

1.83

4.64

4.1

3.6

4.82

4.97

pmol/l

0.57

324

Prolapse and hernia of ovary and fallopian tube

100

632

1.61

4.64

2.3

2.7

4.24

4.29

pmol/l

0.20

517

Other disorders of binocular movement

525

1.68

4.62

3.0

3.4

4.59

4.64

pmol/l

0.19

472

Injuries involving multiple body regions

113

744

1.56

4.61

2.4

3.3

4.52

4.57

pmol/l

0.27

659

Benign neoplasm: Other parts of oropharynx

169

2.26

4.60

3.7

3.9

4.51

4.61

pmol/l

0.24

150

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

249

1885

1.34

4.60

3.1

3.5

4.47

4.58

pmol/l

1.06

213

1707

Late syphilis

257

1.99

4.60

3.0

3.4

4.10

4.68

pmol/l

3.80

229

Acquired absence of organs, not elsewhere classified

155

2.29

4.59

3.5

4.23

4.47

pmol/l

0.42

135

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

232

1729

1.35

4.59

2.4

2.8

4.22

4.33

pmol/l

0.71

190

1453

Congenital malformations of aortic and mitral valves

109

712

1.57

4.59

3.7

3.4

4.50

4.71

pmol/l

1.20

639

Herpesviral keratitis and keratoconjunctivitis

121

809

1.53

4.58

3.0

3.3

4.46

4.53

pmol/l

0.26

112

717

Uterine polyps

324

2545

1.30

4.58

3.3

4.57

4.47

pmol/l

0.58

292

2230

Spinal osteochondrosis

169

2.23

4.55

3.4

3.3

4.44

4.58

pmol/l

0.32

148

Fracture at wrist and hand level

991

8619

1.16

4.54

3.2

3.4

4.53

4.56

pmol/l

0.34

865

7726

Myeloid leukaemia

396

1.77

4.53

3.3

4.46

4.48

pmol/l

0.05

340

Other salmonella infections

109

715

1.57

4.53

2.3

3.3

4.35

4.51

pmol/l

0.74

620

Dependent personality disorder

413

1.76

4.52

2.4

3.5

4.08

4.61

pmol/l

3.95

367

Glaucoma suspect

1007

8793

1.15

4.52

3.2

3.3

4.42

4.38

pmol/l

0.48

878

7729

Encephalitis

550

1.65

4.51

3.1

3.4

4.34

4.57

pmol/l

1.14

486

Mental and behavioural disorders of puerperium, not classified elsewhere

319

1.90

4.51

3.5

3.6

4.56

4.68

pmol/l

0.41

283

Other and unspecified types of non-Hodgkin lymphoma, hilmo

100

643

1.59

4.51

2.7

3.4

4.06

4.43

pmol/l

3.54

559

Other inflammatory liver diseases

186

1352

1.40

4.50

4.1

3.3

4.39

4.49

pmol/l

0.60

173

1193

Achalasia of cardia

273

1.94

4.49

2.8

3.7

4.45

4.50

pmol/l

0.11

240

Olecranon bursitis

127

859

1.50

4.49

3.2

3.6

4.58

4.46

pmol/l

0.48

114

768

Malignant neoplasm of oropharynx

210

2.08

4.49

3.0

3.5

4.15

4.62

pmol/l

1.99

183

Other disorders of male genital organs

403

1.74

4.49

4.1

4.0

4.88

4.68

pmol/l

0.45

363

Superficial injury of hip and thigh

381

3051

1.26

4.48

2.9

3.2

4.39

4.47

pmol/l

0.76

321

2672

Other bursal cyst

274

1.94

4.47

2.7

3.2

4.36

4.48

pmol/l

0.54

242

Alzheimer’s disease (Late onset), excluding more controls

295

1488

1.31

4.47

2.4

3.5

4.32

4.35

pmol/l

0.19

241

1304

Intussusception

445

1.73

4.45

3.8

3.2

4.39

4.54

pmol/l

0.91

389

Open wound of ankle and foot

273

2103

1.32

4.44

2.8

3.4

4.37

4.53

pmol/l

1.45

245

1868

Benign neoplasm: Duodenum

399

1.76

4.44

3.0

3.1

4.21

4.45

pmol/l

1.47

343

Thiazolidinediones

259

1981

1.33

4.43

3.1

3.2

4.27

4.40

pmol/l

1.36

224

1745

Open wound of forearm

249

1895

1.33

4.42

2.9

3.3

4.39

4.54

pmol/l

1.77

211

1676

Specific development disorders of speech and language

157

1069

1.44

4.42

3.2

4.82

4.76

pmol/l

0.18

141

955

In situ neoplasms

1178

10413

1.14

4.41

3.2

3.3

4.43

4.42

pmol/l

0.22

1031

9183

Personal history of malignant neoplasm

224

1684

1.36

4.41

3.1

3.2

4.46

4.50

pmol/l

0.27

198

1490

Contusion of other and unspecified parts of foot

161

1147

1.44

4.41

2.9

3.3

4.54

4.62

pmol/l

0.60

141

1030

ILD-related respiratory insufficiency

429

1.72

4.41

2.3

3.4

4.07

4.33

pmol/l

1.26

370

Additional codes for the location of defect, injury or illness

168

1206

1.42

4.40

2.9

3.3

4.47

4.52

pmol/l

0.22

152

1069

Emphysema

147

1027

1.45

4.40

2.9

3.3

4.22

4.42

pmol/l

1.54

124

879

Effects of foreign body entering through natural orifice

621

5233

1.20

4.40

3.2

3.4

4.58

4.55

pmol/l

0.31

553

4681

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2115

14570

1.11

4.40

3.2

3.4

4.54

4.51

pmol/l

0.48

1905

13105

Vascular dementia (mixed)

184

2.13

4.39

2.1

2.6

4.14

pmol/l

0.00

162

Schizoid personality disorder

290

1.90

4.38

2.1

3.6

4.50

4.66

pmol/l

0.60

257

Type of accident

857

7416

1.17

4.38

2.9

3.3

4.42

4.52

pmol/l

2.15

754

6588

Hydronephrosis

283

2194

1.31

4.38

3.3

3.2

4.23

4.49

pmol/l

4.40

261

1932

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

602

1.61

4.38

2.8

3.4

4.39

4.63

pmol/l

1.82

527

Other diseases of gallbladder

125

850

1.51

4.38

3.0

3.2

4.41

4.45

pmol/l

0.24

114

746

Other disorders starting during childhood or adolescence

162

1145

1.43

4.37

2.7

3.3

4.98

4.86

pmol/l

0.34

149

1040

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

232

1754

1.35

4.37

3.2

3.3

4.46

4.44

pmol/l

0.11

207

1560

Basal cell carcinoma

1112

6756

1.15

4.37

3.0

4.37

4.39

pmol/l

0.38

946

5892

Use of levodopa decarboxylase inhibitor

281

2176

1.31

4.36

2.5

3.2

4.34

pmol/l

0.02

233

1877

Unspecified lump in breast

561

4700

1.21

4.36

2.9

3.3

4.46

pmol/l

0.01

496

4173

Other and unspecified disorders of skin and subcutaneous tissue

182

1326

1.40

4.36

3.1

3.2

4.38

4.46

pmol/l

0.47

150

1179

Total colectomy

117

786

1.53

4.36

4.2

3.5

4.40

4.61

pmol/l

1.38

107

704

Total colectomy operation

117

786

1.53

4.36

4.2

3.5

4.40

4.61

pmol/l

1.38

107

704

Malignant cancer of tonsil and base of tongue, including Hilmo

319

1.84

4.35

3.6

3.3

4.09

4.55

pmol/l

2.55

274

Volvulus

424

1.72

4.33

3.7

3.3

4.35

4.58

pmol/l

0.93

367

Pediculosis, acariasis and other infestations

515

4279

1.22

4.32

2.7

3.4

4.60

4.57

pmol/l

0.24

449

3858

Pneumocystosis

277

1.91

4.32

2.4

3.3

3.86

4.50

pmol/l

3.85

233

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

248

1.96

4.32

3.6

3.0

4.05

4.35

pmol/l

1.40

213

Malignant neoplasm of head and neck

158

1122

1.43

4.32

2.8

3.0

4.04

4.46

pmol/l

4.79

140

963

Asthma and opportunity respiratory infection

124

845

1.50

4.31

3.3

3.2

4.20

4.39

pmol/l

1.86

109

736

Synovial cyst of popliteal space [Baker]

200

1481

1.37

4.31

3.5

3.3

4.58

4.45

pmol/l

0.44

180

1318

Optic atrophy

307

1.86

4.29

2.4

3.4

4.34

4.66

pmol/l

0.91

277

Dislocation, sprain and strain of joints and ligaments of knee

2056

17273

1.10

4.29

3.2

3.4

4.55

pmol/l

0.07

1846

15525

Erythema nodosum

646

1.58

4.28

2.6

3.5

4.44

4.53

pmol/l

0.24

571

Gestational [pregnancy-induced] hypertension

1078

9489

1.15

4.27

3.4

4.53

pmol/l

0.06

990

8542

Nummular dermatitis

203

1510

1.37

4.24

3.3

4.41

4.46

pmol/l

0.33

185

1334

Malignant neoplasm of brain, including Hilmo

124

847

1.49

4.23

2.8

3.0

4.19

4.58

pmol/l

3.18

115

739

Papilloedema, unspecified

459

1.69

4.23

2.5

3.5

4.54

4.59

pmol/l

0.15

408

Hereditary hypogammaglobulinemia

3.05

4.23

2.9

3.4

4.02

4.39

pmol/l

0.87

Osteomyelitis

145

1021

1.44

4.21

2.7

3.3

4.07

4.50

pmol/l

3.64

124

896

Malignant neoplasm of oropharynx, including Hilmo

272

1.90

4.20

3.0

3.3

4.08

4.61

pmol/l

2.91

237

Mixed disorders of conduct and emotions

546

1.63

4.18

2.6

3.5

4.74

4.86

pmol/l

0.50

487

Drug-induced obesity

190

2.13

4.18

3.6

3.9

4.43

4.56

pmol/l

0.32

167

Other peripheral vertigo

253

1949

1.32

4.17

3.2

3.3

4.35

4.43

pmol/l

0.75

219

1727

Recurrent dislocation of patella

191

1415

1.38

4.17

3.6

3.4

4.55

4.59

pmol/l

0.30

170

1280

Other diseases of spinal cord

522

1.63

4.17

2.6

3.3

4.42

4.61

pmol/l

0.99

453

Mental retardation, wide definition

117

789

1.51

4.16

2.1

3.4

4.84

4.81

pmol/l

0.04

109

708

Melanocytic naevi of lower limb, including hip

139

977

1.46

4.15

3.7

3.3

4.58

4.53

pmol/l

0.21

128

865

Amputation of toe

142

998

1.45

4.15

3.4

3.2

3.82

4.41

pmol/l

10.39

127

865

Early lumbar disc prolapse, operated

318

2523

1.28

4.15

3.3

3.5

4.68

4.56

pmol/l

1.17

289

2290

SLE, strict definition

119

814

1.51

4.13

2.7

3.3

4.12

4.50

pmol/l

4.17

104

709

SLE, ICD10

119

814

1.51

4.13

2.7

3.3

4.12

4.50

pmol/l

4.17

104

709

Basal cell carcinoma, including avohilmo

1168

7116

1.14

4.13

3.0

4.38

4.40

pmol/l

0.26

996

6204

Crossbite

213

1481

1.35

4.13

3.2

4.83

4.78

pmol/l

0.23

192

1347

Malignant neoplasm of tonsil, including Hilmo

224

1.99

4.12

3.2

3.4

4.17

4.62

pmol/l

2.02

198

Erythema intertrigo

393

1.73

4.11

3.2

3.4

4.17

4.60

pmol/l

2.48

346

Amoebiasis

157

2.23

4.11

2.2

3.3

4.39

4.61

pmol/l

0.72

139

Sequelae of injuries of neck and trunk

524

1.63

4.11

3.0

3.4

4.48

4.56

pmol/l

0.36

462

Endometriosis of rectovaginal septum and vagina

266

2070

1.31

4.11

3.0

3.3

4.42

4.48

pmol/l

0.56

224

1812

Haemolytic anaemias

611

1.58

4.10

3.2

4.29

4.60

pmol/l

1.72

537

Retinal vascular occlusion

259

2003

1.31

4.10

3.2

4.21

4.38

pmol/l

1.98

228

1734

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

152

1082

1.42

4.10

2.7

3.3

4.15

4.43

pmol/l

3.25

135

935

Viral pneumonia (known virus, not influenza)

416

1.71

4.10

3.0

3.1

4.61

4.59

pmol/l

0.02

363

Umbilical hernia

693

5934

1.18

4.09

3.2

3.4

4.42

4.50

pmol/l

1.18

604

5308

Orchitis and epididymitis

150

1066

1.42

4.08

3.3

3.7

4.49

4.50

pmol/l

0.05

130

939

Ascites

182

1340

1.38

4.08

3.5

3.3

4.05

4.41

pmol/l

4.72

166

1196

Retinal vascular disorders

261

2022

1.31

4.08

3.1

3.2

4.20

4.38

pmol/l

2.12

230

1747

Open wound of wrist and hand

1293

11284

1.13

4.07

3.2

3.4

4.53

4.56

pmol/l

0.63

1144

10166

Oesophagitis

135

945

1.46

4.07

2.6

3.6

4.30

4.50

pmol/l

1.35

116

827

Presbyopia

195

1455

1.37

4.06

3.5

3.2

4.42

4.50

pmol/l

0.54

166

1293

Foreign body in respiratory tract

147

1047

1.43

4.06

3.7

3.3

4.51

4.56

pmol/l

0.23

131

924

Allergic colitis

440

1.69

4.06

3.1

3.4

4.97

4.91

pmol/l

0.14

397

Amblyopia ex anopsia

119

816

1.49

4.03

3.3

4.56

4.71

pmol/l

0.83

104

726

Conotruncal defects

241

1.95

4.03

5.4

3.6

4.80

4.85

pmol/l

0.07

220

Other diseases of biliary tract

213

1609

1.34

4.03

3.2

3.3

4.27

4.43

pmol/l

1.78

190

1414

Other and unspecified intracranial injuries

495

1.64

4.03

3.4

3.1

4.32

4.62

pmol/l

2.07

443

Other and unspecified paralytic syndromes

270

1.90

4.02

2.0

3.5

4.40

4.60

pmol/l

0.80

235

Benign intracranial hypertension

257

1.94

4.02

3.4

3.6

4.66

4.67

pmol/l

0.03

232

Benign neoplasm: Pancreas

442

1.68

4.01

3.0

3.1

4.49

4.47

pmol/l

0.03

383

Other congenital malformations of the digestive system

142

1000

1.44

4.00

2.6

3.3

4.63

4.73

pmol/l

0.47

126

893

Scabies

441

3641

1.23

4.00

2.7

3.3

4.62

4.58

pmol/l

0.29

385

3281

Optic atrophy

322

1.80

3.98

2.4

3.4

4.35

4.63

pmol/l

0.78

289

Iridocyclitis

649

5545

1.18

3.98

3.0

3.3

4.44

4.48

pmol/l

0.42

577

4927

COPD, hospital admissions 3, with asthma pneumonia sepsis

560

4025

1.20

3.98

3.1

3.2

4.18

4.34

pmol/l

2.81

475

3509

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1154

7010

1.14

3.97

3.0

4.36

4.40

pmol/l

0.63

980

6112

Convergent concomitant strabismus

182

1349

1.38

3.97

3.8

3.2

4.38

4.62

pmol/l

3.36

170

1200

Arthropod-borne viral fevers and viral haemorrhagic fevers

487

4059

1.21

3.96

3.3

4.46

4.50

pmol/l

0.38

448

3609

Seronegative rheumatoid arthritis

338

2717

1.26

3.95

2.8

3.4

4.28

4.46

pmol/l

3.31

301

2417

Macular cyst

459

1.66

3.95

3.0

3.1

4.15

4.39

pmol/l

1.64

397

Serous carcinoma of ovary, including Hilmo

107

724

1.52

3.94

6.6

2.9

4.31

4.44

pmol/l

1.07

101

619

Other obstructive and reflux uropathy

129

903

1.46

3.93

3.4

3.3

4.48

4.59

pmol/l

0.52

114

797

Viral hepatitis

206

1558

1.34

3.91

2.5

3.4

4.56

4.57

pmol/l

0.06

175

1401

Benign neoplasm: Anus and anal canal

445

1.66

3.90

2.7

3.1

4.47

4.45

pmol/l

0.04

384

Acute posthaemorrhagic anaemia

523

1.60

3.88

3.6

3.2

4.15

4.46

pmol/l

1.92

455

Secondary malignant neoplasm of other and unspecified sites

215

1.97

3.87

2.1

3.0

4.02

4.42

pmol/l

1.48

181

Spontaneous rupture of synovium and tendon

213

1620

1.33

3.87

3.2

3.4

4.36

4.46

pmol/l

0.59

191

1447

Other salmonella infections

127

890

1.46

3.86

2.6

3.3

4.40

4.53

pmol/l

0.62

108

781

Vascular dementia

154

1071

1.40

3.86

2.6

2.7

4.16

4.22

pmol/l

0.33

116

902

Benign neoplasm of brain and other parts of central nervous system

176

1304

1.38

3.85

3.1

3.3

4.39

4.49

pmol/l

0.60

161

1149

Overexertion and strenuous or repetitive movements

275

2166

1.29

3.84

3.4

4.39

4.52

pmol/l

1.77

244

1943

Other/unspecified rheumatoid arthritis

340

2745

1.25

3.84

3.0

3.2

4.30

4.42

pmol/l

0.73

308

2405

Pyothorax

588

1.56

3.83

3.3

4.26

4.48

pmol/l

0.96

522

Drug-induced neutropenia

202

1530

1.35

3.82

3.6

3.3

4.42

4.46

pmol/l

0.11

181

1353

Non-small cell lung cancer, adenocarcinoma, helper endpoint

135

957

1.43

3.82

3.2

4.19

4.34

pmol/l

1.02

126

824

Other vitreous opacities

109

744

1.50

3.81

2.4

3.2

4.44

4.46

pmol/l

0.11

102

651

Circumscribed brain atrophy

281

1.83

3.81

2.3

3.2

4.17

4.47

pmol/l

1.09

247

Other and unspecified nail disorders

418

1.68

3.81

4.9

3.4

4.31

4.53

pmol/l

0.67

366

Chronic nephritic syndrome

646

1.54

3.80

2.3

3.6

4.09

4.58

pmol/l

5.50

570

Asthma mixed form (mode), excluding more controls

134

949

1.44

3.80

3.1

3.4

4.39

4.53

pmol/l

1.17

126

835

Acute generalized exanthematous pustulosis

129

911

1.45

3.78

3.0

3.3

4.44

4.53

pmol/l

0.38

113

802

Acute bronchiolitis

164

1082

1.39

3.78

3.4

3.2

4.99

4.95

pmol/l

0.10

151

970

Acute myeloid leukaemia and myelodysplastic syndromes

238

1.90

3.77

3.2

3.1

4.20

4.41

pmol/l

0.64

206

Hepatic failure, not elsewhere classified

640

1.54

3.76

2.7

3.4

4.09

4.50

pmol/l

2.31

565

Other and unspecified injuries of lower leg

233

1804

1.31

3.76

2.6

3.2

4.52

4.58

pmol/l

0.44

213

1612

Down's syndrome

2.76

3.75

2.8

3.5

4.87

4.96

pmol/l

0.08

Myasthenia gravis

291

1.82

3.75

2.6

3.5

4.23

4.63

pmol/l

1.63

262

D07AA Corticosteroids, weak (group I)

489

4098

1.20

3.74

3.0

3.3

4.54

4.56

pmol/l

0.19

433

3681

Benign neoplasm: Peripheral nerves and autonomic nervous system

269

1.85

3.74

2.8

3.5

4.19

4.61

pmol/l

1.88

237

Benign neoplasm of bone and articular cartilage

248

1937

1.30

3.74

2.8

3.3

4.52

4.53

pmol/l

0.12

224

1744

Benign neoplasm: Small intestine

102

690

1.51

3.73

2.9

3.1

4.18

4.43

pmol/l

2.18

599

Mental and behavioural disorders due to tobacco

240

1867

1.31

3.72

3.6

3.4

4.48

4.47

pmol/l

0.08

212

1673

Generalized skin eruption due to drugs and medicaments

116

806

1.47

3.72

2.9

3.3

4.43

4.53

pmol/l

0.37

102

709

Palmar fascial fibromatosis [Dupuytren]

295

2348

1.27

3.72

2.9

3.4

4.30

4.38

pmol/l

0.60

261

2093

Autoimmune hepatitis

110

2.38

3.72

3.4

3.0

4.29

4.46

pmol/l

0.37

101

Factitial dermatitis

2.57

3.72

2.7

3.1

4.36

4.56

pmol/l

0.18

Burns and corrosions

373

3052

1.24

3.71

3.4

3.3

4.57

pmol/l

0.01

334

2719

Viral encephalitis, not elsewhere classified/unspecified

344

1.74

3.71

2.5

3.2

4.12

4.58

pmol/l

3.19

304

Preterm labour and delivery

998

8849

1.14

3.70

3.2

3.4

4.42

4.50

pmol/l

2.00

892

7970

Late syphilis

205

1.98

3.70

2.9

3.4

4.00

4.60

pmol/l

3.87

182

Spinal instabilities

579

1.56

3.70

2.9

3.5

4.38

4.51

pmol/l

0.61

513

Other secondary gonarthrosis

137

981

1.42

3.70

2.8

3.5

4.56

4.44

pmol/l

0.48

124

865

Spasmodic torticollis

105

718

1.51

3.69

3.1

3.3

4.49

4.51

pmol/l

0.05

629

Diabetic maculopathy

344

2631

1.25

3.69

3.0

3.2

4.27

4.45

pmol/l

2.23

294

2331

Malignant neoplasm of brain

562

1.57

3.69

2.5

2.9

4.17

4.63

pmol/l

2.89

490

Later onset COPD

546

3678

1.19

3.67

3.2

3.1

4.21

4.27

pmol/l

0.62

466

3165

Other injuries of upper limb, level unspecified

206

1.98

3.66

2.7

3.3

4.42

4.69

pmol/l

0.64

181

Exposure to other and unspecified animate mechanical forces

670

1.52

3.65

2.8

3.4

4.53

4.66

pmol/l

0.65

594

Anxious personality disorder

431

1.66

3.65

2.1

3.6

4.42

4.67

pmol/l

1.51

392

Chronic suppurative otitis media, including avohilmo

211

1618

1.32

3.65

3.5

3.2

4.44

4.56

pmol/l

0.97

181

1428

Barrett oesophagus

109

750

1.48

3.64

3.3

3.5

4.62

4.44

pmol/l

1.22

658

Coxarthrosis, primary, with hip surgery

1201

10064

1.12

3.64

3.1

3.3

4.34

4.37

pmol/l

0.48

1068

8822

Other superficial mycoses

320

2585

1.26

3.63

2.7

3.4

4.55

4.57

pmol/l

0.12

276

2325

Supplementary factors related to causes of morbidity and mortality classified elsewhere

916

8081

1.14

3.62

2.9

3.3

4.44

4.52

pmol/l

1.46

805

7191

Presence of other devices

566

4800

1.18

3.62

3.0

3.2

4.40

4.41

pmol/l

0.06

496

4164

Benign neoplasm: Liver/bile ducts

583

1.56

3.62

3.1

3.4

4.51

4.56

pmol/l

0.20

510

Other and unspecified mononeuropathies of upper limb

582

1.55

3.61

2.5

3.7

4.43

4.55

pmol/l

0.52

520

Chronic suppurative otitis media

177

1327

1.36

3.58

3.7

3.3

4.46

4.54

pmol/l

0.48

147

1182

Smoking dependency

240

1878

1.30

3.58

3.6

3.4

4.48

4.46

pmol/l

0.11

212

1680

Diffuse brain injury

542

1.56

3.56

2.6

3.4

4.51

4.60

pmol/l

0.44

484

Benign neoplasm: Skin of eyelid, including canthus

417

3471

1.21

3.52

3.2

4.40

4.43

pmol/l

0.28

367

3063

Other disorders involving the immune mechanism, not elsewhere classified

521

1.57

3.52

3.7

3.6

4.45

4.67

pmol/l

0.68

464

Other and unspecified follicular disorders

111

774

1.47

3.51

3.8

3.4

4.27

4.57

pmol/l

2.54

103

691

ILD medications: azathioprine

428

3573

1.21

3.50

2.7

3.4

4.35

4.57

pmol/l

4.75

384

3180

Benign neoplasm: Descending colon

164

1221

1.37

3.50

3.1

3.3

4.29

4.39

pmol/l

0.61

153

1063

Congenital deformities of feet

547

1.56

3.49

2.4

3.4

4.64

4.70

pmol/l

0.20

487

5-aminosalicylic acid

622

5357

1.17

3.49

3.3

3.4

4.48

4.58

pmol/l

1.68

550

4793

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

228

1752

1.30

3.48

3.0

3.4

4.85

4.68

pmol/l

1.22

201

1584

Personal history of allergy to drugs, medicaments and biological substances

225

1.91

3.46

3.8

3.4

4.17

4.64

pmol/l

3.81

206

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

329

1.73

3.46

3.7

3.5

4.43

4.87

pmol/l

3.00

294

Drug-induced tremor

108

2.36

3.46

1.7

3.0

4.23

4.39

pmol/l

0.32

Endometriosis ASRM stages 3,4

868

7672

1.14

3.44

3.3

4.46

4.48

pmol/l

0.29

773

6812

Certain conditions originating in the perinatal period

260

1830

1.28

3.42

3.1

3.3

4.94

4.83

pmol/l

0.47

237

1658

Mental retardation

109

756

1.46

3.42

2.0

3.4

4.88

4.83

pmol/l

0.07

101

679

Primary biliary cholangitis (PBC)

337

1.71

3.41

2.4

3.1

4.44

4.54

pmol/l

0.25

303

Chromosomal abnormalities, not elsewhere classified

446

1.62

3.40

3.1

3.6

4.79

4.81

pmol/l

0.05

398

LSIL lesion of the cervix uteri, vagina or vulva

567

4873

1.18

3.38

3.1

3.4

4.51

4.52

pmol/l

0.08

497

4399

Tongue abnormality

169

1273

1.35

3.38

2.7

3.3

4.41

4.47

pmol/l

0.39

145

1117

Other encephalitis

527

1.56

3.37

3.2

3.4

4.32

4.57

pmol/l

1.23

466

Ulcer of vagina/vulva

659

1.50

3.37

3.3

4.35

4.53

pmol/l

1.34

590

Failed induction of labour

254

2024

1.28

3.37

3.3

3.4

4.63

4.58

pmol/l

0.35

221

1836

Non-small cell lung cancer, squamous

429

1.61

3.37

5.2

2.8

4.39

4.33

pmol/l

0.18

363

Benign neoplasm: Other/unspecified site

271

1.80

3.36

4.0

3.4

4.41

4.56

pmol/l

0.53

236

Other specified/unspecified inflammatory spondylopathies

154

1145

1.37

3.36

3.0

3.4

4.56

4.53

pmol/l

0.16

137

1031

Habit and impulse disorders

324

1.73

3.36

2.5

3.7

4.63

4.73

pmol/l

0.32

294

Bronchitis, not specified as acute or chronic

213

1655

1.30

3.35

3.0

3.4

4.44

4.48

pmol/l

0.25

189

1457

Trichomoniasis

143

2.14

3.35

3.7

3.0

4.11

4.48

pmol/l

1.48

121

Allergic contact dermatitis

453

3822

1.20

3.34

3.2

3.4

4.49

4.52

pmol/l

0.34

388

3445

Hydrocele

179

1356

1.33

3.34

3.4

3.5

4.37

4.40

pmol/l

0.15

156

1194

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

570

1.54

3.33

5.2

2.9

4.42

4.46

pmol/l

0.11

485

Benign neoplasm: Choroid

159

1190

1.36

3.31

3.8

3.3

4.33

4.44

pmol/l

0.79

139

1044

Other congenital malformations of peripheral vascular system

288

1.77

3.31

2.7

3.3

4.54

4.65

pmol/l

0.38

254

Diabetic retinopathy

942

5205

1.14

3.31

3.0

3.2

4.26

4.39

pmol/l

3.68

821

4623

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

791

6958

1.14

3.31

2.9

3.4

4.51

pmol/l

0.04

704

6206

Spermatocele

117

830

1.42

3.31

3.2

3.6

4.44

4.42

pmol/l

0.08

104

726

Crystal arthropathies, rheuma endpoint

242

1.83

3.30

3.0

3.2

4.00

4.43

pmol/l

1.93

209

Leisure time condition

498

4237

1.19

3.30

2.9

3.3

4.37

4.51

pmol/l

2.90

423

3767

Other infective otitis externa

163

1226

1.35

3.29

2.5

3.3

4.43

4.52

pmol/l

0.59

139

1095

Alzheimer’s disease (Atypical or mixed)

179

1351

1.33

3.27

2.8

2.9

4.21

4.25

pmol/l

0.22

150

1121

Other specified/unspecified spondylopathies

372

1.65

3.26

3.4

3.2

4.03

4.43

pmol/l

2.64

320

Syphilis

388

1.64

3.25

3.0

3.5

4.24

4.63

pmol/l

2.61

348

Syphilis

388

1.64

3.25

3.0

3.5

4.24

4.63

pmol/l

2.61

348

Inflammatory bowel disease

949

8458

1.13

3.23

3.4

4.53

pmol/l

0.00

848

7552

Other and unspecified psoriasis

168

1272

1.34

3.23

2.8

3.5

4.39

4.47

pmol/l

0.49

150

1132

Benign neoplasm: Conjunctiva

622

1.50

3.23

2.8

3.3

4.31

4.55

pmol/l

1.59

540

Neovascular glaucoma

654

1.48

3.22

3.9

3.4

4.36

4.49

pmol/l

0.55

575

Meningitis

136

999

1.39

3.21

3.1

3.3

4.47

4.54

pmol/l

0.31

115

881

Systemic lupus erythematosus, unspecified

101

707

1.47

3.21

2.7

3.3

4.12

4.51

pmol/l

4.12

619

Lack of expected normal physiological development

346

1.63

3.20

2.4

3.3

4.89

5.05

pmol/l

0.52

318

Other epidermal thickening

115

822

1.43

3.20

3.0

3.3

4.34

4.55

pmol/l

1.40

103

730

Fasciculation

232

1.85

3.17

2.9

3.6

4.47

4.61

pmol/l

0.43

207

Other and unspecified bullous disorders

181

1.96

3.17

2.5

3.5

4.26

4.55

pmol/l

0.79

159

Carcinoma in situ of skin of trunk

406

1.61

3.17

3.0

2.9

4.29

4.27

pmol/l

0.10

346

Infective dermatitis

298

2428

1.24

3.16

3.1

3.3

4.30

4.49

pmol/l

2.85

262

2157

Benign neoplasm of middle ear and respiratory system

184

1415

1.32

3.16

2.9

3.3

4.36

4.46

pmol/l

0.57

167

1250

Azathioprine

428

3611

1.20

3.15

2.7

3.3

4.35

4.58

pmol/l

4.79

384

3212

Isolated proteinuria

503

1.55

3.15

3.3

3.6

4.28

4.61

pmol/l

1.90

439

Abdominal aortic aneurysm (AAA)

140

1023

1.37

3.15

2.9

3.2

3.97

4.28

pmol/l

2.94

125

866

Infective bursitis

415

1.60

3.14

3.4

3.6

4.65

4.48

pmol/l

0.65

378

Frontotemporal dementia

2.64

3.13

2.1

3.3

4.04

4.36

pmol/l

0.34

Traumatic subarachnoid haemorrhage

478

1.55

3.13

2.7

3.2

4.29

4.52

pmol/l

1.12

425

Alopecia universalis

2.92

3.13

3.9

3.6

4.31

4.64

pmol/l

0.67

Injuries to the shoulder and upper arm

2640

19858

1.07

3.13

3.0

3.3

4.46

4.50

pmol/l

1.04

2305

17719

Alopecia areata

603

1.50

3.12

3.4

3.1

4.52

4.60

pmol/l

0.35

531

Haemorrhagic disorder due to circulating anticoagulants

146

2.05

3.12

3.4

2.8

3.63

4.25

pmol/l

2.48

130

Glaucoma-related operations

127

927

1.39

3.11

3.7

3.2

4.35

4.39

pmol/l

0.16

112

799

Burns and corrosions confined to eye and internal organs

521

1.54

3.11

4.0

3.5

4.60

4.67

pmol/l

0.26

468

Congenital malformations of the urinary system

165

1255

1.34

3.10

3.2

3.3

4.29

4.60

pmol/l

3.08

151

1114

Somnolence

256

1.79

3.10

2.9

3.3

4.43

4.65

pmol/l

0.82

228

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

231

1835

1.28

3.10

3.3

4.37

4.42

pmol/l

0.34

204

1630

Other orthopaedic follow-up care

145

1082

1.36

3.10

3.5

3.2

4.47

4.49

pmol/l

0.11

131

965

Foreign body in alimentary tract

135

997

1.38

3.08

2.9

3.3

4.58

4.55

pmol/l

0.14

121

886

Malignant neoplasm of breast, ER-negative, including Hilmo

690

5763

1.15

3.08

3.0

2.9

4.37

4.41

pmol/l

0.60

614

4997

Other disorders of bone density and structure

539

1.53

3.08

3.8

3.4

4.49

4.62

pmol/l

0.47

479

Lesion of plantar nerve

180

1389

1.32

3.07

2.8

3.3

4.46

4.47

pmol/l

0.05

161

1235

Psoriasis vulgaris

490

4192

1.18

3.06

2.9

3.3

4.44

4.49

pmol/l

0.40

435

3739

Malignant neoplasm of corpus uteri

227

1804

1.28

3.06

3.5

2.8

4.44

4.39

pmol/l

0.14

198

1533

Polypectomy (DHB20)

149

1118

1.35

3.06

3.0

3.5

4.67

4.48

pmol/l

0.71

138

994

Intrahepatic Cholestasis of Pregnancy (ICP)

287

2347

1.25

3.05

2.9

3.4

4.58

4.54

pmol/l

0.27

265

2118

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

483

1.55

3.04

3.7

3.6

4.40

4.67

pmol/l

0.96

432

Any dementia, excluding more controls

743

4491

1.14

3.04

2.7

3.3

4.26

4.33

pmol/l

1.12

616

3917

Myocardial infarction, with ST-elevation

314

2580

1.23

3.03

3.3

3.2

4.34

4.36

pmol/l

0.11

281

2245

Adenocarcinoma and ductal carcinoma of pancreas

462

0.49

3.03

1.7

2.8

4.04

4.41

pmol/l

1.08

395

Vascular dementia (other)

2.57

3.03

2.6

2.8

3.98

4.19

pmol/l

—

Other localized connective tissue disorders

413

1.60

3.02

3.4

3.3

4.53

4.51

pmol/l

0.03

369

Follow-up care involving plastic surgery

124

909

1.40

3.02

4.0

3.2

4.33

4.50

pmol/l

1.11

809

Malignant neoplasm of bladder

685

1.44

3.02

3.6

2.9

4.24

4.34

pmol/l

0.42

580

Early complications of trauma

108

772

1.43

3.02

3.3

3.5

4.26

4.59

pmol/l

3.31

684

!Aliquae complicationes praecoces traumatis

108

772

1.43

3.02

3.3

3.5

4.26

4.59

pmol/l

3.31

684

Vertigo of central origin

250

1.78

3.01

2.7

3.1

4.24

4.45

pmol/l

0.65

211

Other osteochondrodysplasias

221

1.84

3.01

2.3

3.6

4.68

4.67

pmol/l

0.01

190

Postpartum haemorrhage

1073

8145

1.12

3.00

3.7

3.4

4.58

4.55

pmol/l

0.26

968

7365

Benign neoplasm: Liver

535

1.52

3.00

3.0

3.4

4.44

4.55

pmol/l

0.51

466

Other crystal arthropathies

250

1.77

2.99

3.0

3.2

4.00

4.40

pmol/l

1.80

222

Family history of certain disabilities and chronic diseases leading to disablement

163

1247

1.33

2.98

3.0

3.4

4.52

4.61

pmol/l

0.64

146

1115

Other viral hepatitis

173

1333

1.32

2.98

2.5

3.4

4.54

4.61

pmol/l

0.32

144

1201

Unspecified contracted kidney

2.38

2.97

3.9

3.0

4.10

4.48

pmol/l

0.95

Nonspecific lymphadenitis

184

1431

1.31

2.97

3.3

4.56

4.52

pmol/l

0.19

171

1278

Other renal tubulo-interstitial diseases

511

1.53

2.97

3.0

3.4

4.48

4.54

pmol/l

0.12

446

Eustachian salpingitis and obstruction

250

2017

1.26

2.97

3.5

4.46

4.62

pmol/l

1.90

230

1822

Recurrent dislocation and subluxation of joint

207

1634

1.29

2.95

3.2

3.5

4.46

4.57

pmol/l

0.90

177

1478

Other and specified injuries of hip and thigh

367

1.62

2.95

3.1

3.2

4.26

4.58

pmol/l

1.67

323

Unspecified visual impairment (binocular)

252

1.76

2.94

2.3

3.1

4.19

4.54

pmol/l

1.77

220

Chronic conjunctivitis

627

1.47

2.94

2.5

3.3

4.21

4.59

pmol/l

3.75

547

Idiopathic hypercalciuria

103

2.27

2.93

3.0

3.7

4.63

4.56

pmol/l

0.10

Asthma mixed form (mode)

134

997

1.36

2.92

3.1

3.4

4.39

4.51

pmol/l

0.95

126

879

Dislocation, sprain and strain of joints and ligaments of head

127

940

1.38

2.91

3.4

3.3

4.58

4.63

pmol/l

0.21

108

836

Parkinson's disease, strict definition

278

2269

1.24

2.91

2.5

3.2

4.42

4.34

pmol/l

0.81

233

1961

Other bursitis of hip

417

1.58

2.90

3.5

3.2

4.46

4.45

pmol/l

0.02

367

Superficial injury of shoulder and upper arm

302

2490

1.23

2.89

2.7

3.3

4.48

4.52

pmol/l

0.30

259

2227

Parkinson's disease, including avohilmo

313

2587

1.22

2.89

2.6

3.2

4.38

4.34

pmol/l

0.38

264

2235

Lesion of sciatic nerve

652

1.45

2.89

3.0

3.2

4.16

4.35

pmol/l

1.07

561

Lichen simplex chronicus

629

1.46

2.88

2.7

3.4

4.47

4.55

pmol/l

0.32

556

Atlantoaxial subluxation

124

2.13

2.88

4.0

3.4

4.26

4.58

pmol/l

1.00

111

Special screening examination for neoplasms

124

914

1.37

2.87

2.9

3.7

4.36

4.49

pmol/l

0.89

111

818

Superficial injuries involving multiple body regions

531

1.51

2.87

2.6

3.3

4.63

4.60

pmol/l

0.11

467

Other juvenile arthritis

126

934

1.38

2.86

3.4

4.38

4.69

pmol/l

3.46

118

841

Glaucoma secondary to other eye disorders

679

1.44

2.86

3.9

3.4

4.37

4.48

pmol/l

0.46

594

Moderate visual impairment, binocular

425

1.56

2.85

2.2

3.1

4.15

4.41

pmol/l

1.24

360

Unspecified chronic bronchitis

538

1.49

2.85

3.2

3.3

4.19

4.46

pmol/l

2.05

466

Injury of muscle and tendon at shoulder and upper arm level

854

7626

1.13

2.85

2.9

3.4

4.47

4.45

pmol/l

0.27

758

6815

Parkinson's disease

300

2473

1.22

2.85

2.6

3.2

4.39

4.34

pmol/l

0.40

252

2137

Cerebral aneurysm, nonruptured

239

1928

1.26

2.85

3.3

4.46

4.45

pmol/l

0.05

209

1712

Idiopathic thrombocytopenic purpura

532

1.50

2.83

4.5

3.4

4.34

4.61

pmol/l

1.37

472

Other and unspecified haemorrhagic conditions

278

1.71

2.83

4.0

3.4

4.60

4.55

pmol/l

0.06

250

Antepartum haemorrhage, not elsewhere classified

350

2941

1.21

2.82

3.6

3.5

4.65

4.54

pmol/l

0.67

325

2641

Primary open-angle glaucoma, strict

611

5334

1.15

2.82

3.0

3.2

4.33

pmol/l

0.03

527

4606

Other disorders of iris and ciliary body

419

1.56

2.81

3.1

3.4

4.24

4.55

pmol/l

1.70

363

Other deformities of toe(s)

102

733

1.42

2.81

2.9

3.3

4.38

4.50

pmol/l

0.68

656

Other congenital malformations of skin

119

878

1.38

2.80

3.5

3.4

4.74

4.63

pmol/l

0.22

111

785

Biological medicines for asthma

405

1.58

2.80

3.3

3.5

4.57

4.72

pmol/l

0.63

363

Anisometropia and aniseikonia

625

1.46

2.80

3.4

3.0

4.44

4.63

pmol/l

1.05

544

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

331

2772

1.21

2.78

2.8

3.4

4.56

4.52

pmol/l

0.32

304

2494

Alcohol abuse, main dg

388

3287

1.19

2.77

2.5

3.4

4.46

4.55

pmol/l

0.83

335

2952

Other and unspecified abdominal hernia

101

726

1.42

2.77

3.6

3.5

4.36

4.43

pmol/l

0.35

634

Malignant neoplasm of bronchus and lung, including Hilmo

422

3005

1.18

2.77

3.8

2.9

4.24

4.37

pmol/l

1.94

383

2586

Drug-induced hypoglycaemia without coma

249

1.74

2.77

3.0

3.5

4.04

4.64

pmol/l

2.69

221

Monoplegia

265

1.72

2.75

2.4

3.5

4.47

4.58

pmol/l

0.31

231

Panniculitis affecting regions of neck and back

103

744

1.41

2.75

3.4

4.18

4.51

pmol/l

3.76

656

Periodontal disease, other/unspecified

528

1.49

2.75

3.6

3.0

4.45

4.48

pmol/l

0.11

454

Malignant neoplasm of ovary, including Hilmo

189

1492

1.29

2.75

5.7

2.9

4.41

4.45

pmol/l

0.28

175

1303

Social disorders starting during childhood or adolecense, excluding more controls

126

2.07

2.74

5.4

3.5

4.74

5.21

pmol/l

1.43

116

Atrial septal defect, secundum type

568

1.47

2.73

3.3

3.2

4.62

4.77

pmol/l

0.49

513

Erosion and ectropion of cervix uteri

612

1.46

2.73

3.5

3.0

4.44

4.48

pmol/l

0.11

534

Atherosclerosis, excluding cerebral and coronary sclerosis

874

6193

1.12

2.72

3.0

3.2

4.08

4.37

pmol/l

13.72

762

5394

Lesion of lateral popliteal nerve

119

882

1.37

2.71

2.7

3.5

4.46

4.47

pmol/l

0.05

108

777

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

287

2380

1.23

2.70

2.9

3.5

4.58

pmol/l

0.02

265

2163

Other melanin hyperpigmentation

384

1.58

2.70

2.6

3.0

4.32

4.49

pmol/l

0.72

338

Myocardial infarction, unclassifiable

400

3032

1.18

2.70

3.2

3.0

4.07

4.32

pmol/l

5.82

354

2582

Viral meningitis

113

833

1.39

2.70

3.1

3.3

4.50

4.60

pmol/l

0.58

102

747

Bitten or struck by other mammals

361

3052

1.20

2.69

3.7

3.4

4.67

4.54

pmol/l

1.40

312

2733

Anterior Iridocyclitis

562

4913

1.15

2.68

3.0

3.3

4.45

4.48

pmol/l

0.26

500

4367

Other bullous disorders

506

1.50

2.68

3.1

3.3

4.37

4.57

pmol/l

1.09

446

Other surgical follow-up care

672

1.43

2.68

3.6

3.3

4.53

4.60

pmol/l

0.25

599

Disorders of speech understanding and production

107

766

1.39

2.68

3.3

3.2

4.66

4.80

pmol/l

0.52

677

Benign neoplasm: Skin of ear and external auricular canal

638

1.44

2.67

3.0

3.2

4.25

4.45

pmol/l

1.05

550

Other congenital malformations of skin

241

1962

1.25

2.67

3.2

3.3

4.55

4.56

pmol/l

0.02

221

1748

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

124

928

1.36

2.67

3.3

4.49

pmol/l

0.00

114

813

Contusion of ankle

112

825

1.38

2.67

3.0

3.3

4.59

4.64

pmol/l

0.16

101

743

Other and unspecified acne

299

1.66

2.66

2.8

3.5

4.62

4.68

pmol/l

0.14

270

Procedures for purposes other than remedying health state

574

1.47

2.66

2.6

3.3

4.37

4.56

pmol/l

1.37

503

Other and unspecified vascular occlusions

194

1540

1.27

2.65

3.1

3.2

4.28

4.39

pmol/l

0.83

167

1328

Other protozoal intestinal diseases

284

1.68

2.64

3.0

3.3

4.47

4.58

pmol/l

0.42

248

Mild mental retardation

475

1.51

2.64

2.0

3.6

5.22

4.78

pmol/l

0.61

426

Dermatopolymyositis (FG)

230

1.75

2.64

3.1

3.2

4.17

4.54

pmol/l

1.94

200

Divergent concomitant strabismus

227

1839

1.25

2.64

3.6

3.2

4.44

4.52

pmol/l

0.65

209

1636

Postpartum hemorraghe, all women as controls

1073

9604

1.11

2.64

3.7

3.4

4.58

4.56

pmol/l

0.15

968

8704

Maternal care for known or suspected malpresentation of fetus

785

5079

1.13

2.63

3.4

3.5

4.59

4.56

pmol/l

0.25

723

4588

Disorders of brain, other and unspecified

142

1.97

2.63

2.4

3.5

4.05

4.52

pmol/l

1.25

126

Burn and corrosion confined to eye and adnexa

443

1.53

2.63

4.2

3.5

4.58

4.70

pmol/l

0.51

398

Senility

2.19

2.62

2.5

2.8

3.81

4.25

pmol/l

0.86

Other protozoal intestinal diseases

460

1.52

2.62

3.0

3.4

4.43

4.61

pmol/l

1.05

407

Malignant neoplasm of mesothelium and soft tissue

557

1.46

2.62

4.3

3.0

4.50

4.54

pmol/l

0.11

479

Dementia in other diseases classified elsewhere

708

1.41

2.61

2.8

3.2

4.47

4.40

pmol/l

0.21

617

Frontotemporal dementia, wide, incl. Pick's disease

2.32

2.61

2.0

3.3

4.04

4.41

pmol/l

0.41

Campylobacter enteritis

501

1.49

2.61

2.6

3.4

4.30

4.62

pmol/l

2.05

435

445

1.53

2.60

3.7

3.3

4.75

4.82

pmol/l

0.22

401

Keratoconus

428

1.53

2.59

3.1

3.5

4.75

4.70

pmol/l

0.15

387

Ulcerative ileocolitis

114

847

1.37

2.59

2.9

3.4

4.44

4.58

pmol/l

0.93

100

763

Fistulae involving female genital tract

349

1.60

2.58

2.5

2.9

4.58

4.52

pmol/l

0.12

305

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

331

2794

1.20

2.58

2.8

3.4

4.56

4.55

pmol/l

0.10

304

2528

Malignant neoplasm of testis

164

1.87

2.58

2.2

2.9

5.13

4.82

pmol/l

0.40

149

Acute peritonitis

142

1089

1.32

2.57

2.8

3.4

3.96

4.46

pmol/l

6.24

125

955

Congenital malformations of the urinary system

151

1169

1.31

2.56

3.2

3.3

4.29

4.60

pmol/l

2.82

141

1037

Primary open-angle glaucoma

744

6415

1.13

2.56

2.9

3.2

4.35

4.34

pmol/l

0.11

644

5543

Vestibular neuronitis

227

1845

1.25

2.56

3.5

3.3

4.40

4.45

pmol/l

0.30

200

1643

Bullous disorders

136

1038

1.33

2.56

3.0

3.3

4.26

4.47

pmol/l

1.75

114

907

Complications following abortion and ectopic and molar pregnancy

116

869

1.37

2.54

3.9

3.3

4.33

4.42

pmol/l

0.56

104

766

L02BA Anti-estrogens

427

4941

0.86

2.54

3.0

3.3

4.47

4.44

pmol/l

0.29

379

4347

Other and unspecified mononeuropathies, also in other diseases

512

1.48

2.53

3.4

4.23

4.54

pmol/l

1.99

443

Perichondritis of external ear

279

1.66

2.53

3.2

2.7

4.24

4.49

pmol/l

0.77

238

Other mycoses, not elsewhere classified/unspecified

2.72

2.53

1.9

3.8

3.92

4.46

pmol/l

1.14

Pilonidal cyst

233

1901

1.24

2.53

3.2

3.5

4.51

4.64

pmol/l

1.33

215

1712

Other inflammation of vagina/vulva

137

1053

1.33

2.52

3.1

3.5

4.56

4.52

pmol/l

0.07

121

950

Event of undetermined intent

166

1304

1.29

2.52

2.5

3.4

4.66

4.62

pmol/l

0.21

139

1164

Ankylosing spondylitis

230

1875

1.24

2.52

2.6

3.5

4.59

4.51

pmol/l

0.24

202

1682

Inflammation of lacrimal passages (acute and unspecified)

335

1.60

2.52

4.4

3.1

4.40

4.57

pmol/l

0.68

295

Lichen sclerosus et atrophicus

311

2614

1.20

2.51

3.2

3.1

4.34

4.46

pmol/l

1.44

277

2313

Crohn disease (strict definition, all UC cases excluded)

145

1121

1.32

2.51

2.9

3.3

4.64

4.58

pmol/l

0.16

131

1007

Other facial nerve disorders

564

1.45

2.50

2.1

3.4

4.19

4.51

pmol/l

2.12

495

Malignant neoplasm of breast, HER-negative

598

5182

1.14

2.50

3.0

2.9

4.35

4.41

pmol/l

0.80

529

4498

Carcinoma in situ of skin of other and unspecified parts of face

161

1260

1.29

2.50

2.8

3.0

4.32

pmol/l

0.01

135

1067

Other osteochondrodysplasias

175

1.85

2.48

2.6

3.4

4.64

4.76

pmol/l

0.30

152

Rheumatic fever incl heart disease

440

1.50

2.47

3.3

3.1

4.29

4.55

pmol/l

1.29

383

Malignant neoplasm of bronchus and lung

352

2476

1.19

2.47

3.7

2.9

4.24

4.36

pmol/l

1.51

319

2123

Retinoschisis and retinal cysts

336

1.58

2.46

4.5

3.3

4.38

4.47

pmol/l

0.32

291

Abnormal findings on diagnostic imaging of breast

306

1.63

2.46

3.4

3.0

4.16

4.48

pmol/l

2.24

268

Corneal scars and opacities

458

1.49

2.45

4.2

3.4

4.47

4.63

pmol/l

0.32

405

Cholangitis (primary sclerosing, PSC)

142

1097

1.31

2.45

2.9

3.2

4.26

4.50

pmol/l

2.44

125

967

Other and unspecified injuries of shoulder and upper arm

583

1.44

2.44

2.9

3.1

4.29

4.63

pmol/l

2.86

517

Other (seronegative) rheumatoid arthritis, wide

528

4632

1.15

2.44

2.8

3.3

4.28

4.44

pmol/l

1.86

470

4082

Medial epicondylitis

111

831

1.36

2.43

2.6

3.5

4.65

4.50

pmol/l

0.79

758

COPD, hospital admissions 1, only main diagnosis

730

5583

1.12

2.42

3.1

3.3

4.27

4.36

pmol/l

1.53

622

4899

Second line medication for Crohn's disease

1865

17401

1.08

2.42

3.1

3.4

4.43

4.51

pmol/l

2.00

1670

15552

Nonsuppurative otitis media

723

5592

1.13

2.42

3.2

3.3

4.73

4.66

pmol/l

0.60

641

5024

Background retinopathy and retinal vascular changes

306

1.61

2.42

3.1

3.3

4.06

4.50

pmol/l

2.56

269

Dyshidrosis [pompholyx]

339

1.58

2.41

2.5

3.5

4.55

4.64

pmol/l

0.28

304

Scabies

119

901

1.34

2.40

2.7

3.3

4.45

4.63

pmol/l

1.09

813

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

109

816

1.36

2.39

2.8

3.4

4.80

4.72

pmol/l

0.27

735

Retinal detachment with retinal break

281

2349

1.21

2.39

3.3

4.44

4.43

pmol/l

0.04

254

2059

Unspecified nephritic syndrome

355

1.56

2.39

4.2

3.4

4.06

4.54

pmol/l

3.44

310

Acute and subacute iridocyclitis

521

4574

1.15

2.38

3.1

3.3

4.46

4.49

pmol/l

0.24

465

4082

Other meningitis

324

1.59

2.38

3.0

3.7

4.43

4.62

pmol/l

0.57

288

Postpartum hemorraghe, parous women as controls

1073

8350

1.10

2.37

3.7

3.4

4.58

4.57

pmol/l

0.11

968

7624

Major anomalies of jaw size

579

1.43

2.37

3.1

3.3

4.40

4.64

pmol/l

1.51

511

Chorioretinal inflammation

537

1.45

2.36

2.5

3.5

4.49

4.56

pmol/l

0.23

471

Conduct disorder

446

1.49

2.36

3.8

3.4

4.66

4.79

pmol/l

0.50

402

Poisoning by medicine, drug-induced

262

1.66

2.35

3.3

3.8

4.25

4.66

pmol/l

1.99

231

Lichen ruber moniliformis

6.87

2.35

2.6

1.4

4.37

4.27

pmol/l

—

L04AX Other immunosuppressants

1805

16844

1.08

2.35

3.1

3.4

4.42

4.50

pmol/l

2.09

1615

15039

Dermatopolymyositis

254

1.66

2.35

3.3

3.0

4.20

4.56

pmol/l

1.83

220

Optic neuritis

135

1046

1.32

2.34

3.4

4.54

4.55

pmol/l

0.07

121

939

Localized scleroderma [morphea]

310

1.60

2.34

3.4

3.3

4.63

4.55

pmol/l

0.07

275

Car occupant injured in noncollision transport accident

101

750

1.37

2.34

2.7

3.4

4.57

4.62

pmol/l

0.18

673

Congenital malformations of genital organs

331

2802

1.19

2.33

3.6

3.3

4.62

4.59

pmol/l

0.22

298

2509

LSIL lesion of the cervix uteri

445

3880

1.16

2.32

3.0

3.4

4.57

4.53

pmol/l

0.41

391

3500

Other conjunctival vascular disorders and cysts

423

1.50

2.32

3.2

4.37

4.55

pmol/l

0.93

369

Bacterial, viral and other infectious agents

215

1758

1.24

2.32

3.1

3.4

4.47

4.57

pmol/l

0.99

198

1576

Distal bite

111

832

1.35

2.32

2.6

3.2

4.83

4.84

pmol/l

0.02

103

758

Idiopathic pulmonary fibrosis

141

1097

1.30

2.31

2.8

3.1

4.18

4.35

pmol/l

0.79

125

938

Mature T/NK-cell lymphomas, hilmo

186

1.77

2.30

2.9

3.2

4.04

4.42

pmol/l

1.24

165

Injury of nerves and spinal cord at neck level

342

1.56

2.30

3.3

4.37

4.58

pmol/l

0.86

301

Psoriatic and enteropathic arthropathies

321

2727

1.19

2.30

2.7

3.5

4.47

4.52

pmol/l

0.29

285

2458

Amyloidosis

278

1.62

2.30

2.1

3.0

4.05

4.37

pmol/l

0.84

244

Personal history of certain other diseases

441

1.49

2.30

3.4

3.2

4.58

4.61

pmol/l

0.10

394

Endometriosis diagnosis and infertility diagnosis occurring together

413

3587

1.17

2.29

3.4

4.46

4.52

pmol/l

0.82

364

3223

Fracture of forearm

1808

15470

1.07

2.29

3.1

3.3

4.48

4.50

pmol/l

0.30

1591

13723

Other and unspecified primary disorders of muscles

121

1.98

2.29

4.0

3.4

4.70

4.65

pmol/l

0.09

108

Indeterminate sex and pseudohermaphroditism

4.31

2.28

2.9

2.6

4.44

4.50

pmol/l

—

Malignant neoplasm of corpus uteri, including Hilmo

259

2163

1.21

2.28

3.8

2.8

4.45

4.39

pmol/l

0.17

229

1856

Use of antiglaucoma preparations and miotics

166

1322

1.27

2.27

3.1

4.36

4.37

pmol/l

0.03

144

1127

Malignant neoplasm of vulva, including Hilmo

257

1.65

2.27

2.1

2.9

4.60

4.48

pmol/l

0.17

218

Poisoning by narcotics and psychodysleptics [hallucinogens]

312

1.58

2.26

3.0

3.4

4.71

4.75

pmol/l

0.08

285

Other noninflammatory disorders of cervix uteri

141

1104

1.30

2.26

4.0

3.2

4.40

4.46

pmol/l

0.26

121

971

Malignant neoplasm of ovary

138

1078

1.30

2.26

6.3

2.9

4.41

4.45

pmol/l

0.22

132

933

Other and unspecified acute skin changes due to ultraviolet radiation

368

1.52

2.25

2.3

3.4

4.23

4.50

pmol/l

0.87

321

Pedestrian injured in transport accident

177

1424

1.26

2.24

3.0

3.2

4.37

4.54

pmol/l

1.45

148

1257

Other chondrocalcinosis

158

1.82

2.23

2.2

3.0

4.10

4.37

pmol/l

0.65

137

Traumatic ischaemia of muscle

211

1.71

2.23

3.5

3.6

4.20

4.61

pmol/l

1.91

186

Acute alcohol intoxication

590

5244

1.13

2.22

2.7

3.4

4.45

4.51

pmol/l

0.75

506

4712

Pediculosis, acariasis and other infestations

148

1167

1.29

2.22

2.7

3.4

4.48

4.59

pmol/l

0.54

125

1048

Bicuspidal aortic valve syndrome

611

1.40

2.21

3.9

3.5

4.53

4.66

pmol/l

0.48

547

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

688

1.37

2.21

2.7

3.3

4.30

4.49

pmol/l

0.99

601

Benign neoplasm: Skin, unspecified

103

775

1.35

2.20

3.1

3.4

4.38

4.51

pmol/l

0.80

678

Inflammatory disorders of breast

242

2019

1.22

2.20

2.8

3.3

4.50

4.51

pmol/l

0.07

217

1795

Carcinoma in situ of other and unspecified sites

427

1.47

2.20

2.8

3.5

4.30

4.33

pmol/l

0.10

367

Other keratitis

315

2685

1.18

2.19

2.8

3.4

4.47

4.53

pmol/l

0.58

284

2413

Other, unspecified and serous retinal detachments

486

1.45

2.19

4.0

3.4

4.47

4.48

pmol/l

0.03

423

Outcome of delivery

668

3695

1.13

2.19

3.3

3.6

4.58

4.56

pmol/l

0.18

613

3319

Other overlap syndromes

364

1.53

2.18

2.7

3.3

4.23

4.55

pmol/l

1.09

316

Macular hole

130

1012

1.30

2.17

3.4

3.1

4.43

4.37

pmol/l

0.24

115

879

Burn and corrosion of trunk

521

1.43

2.16

3.5

4.56

4.68

pmol/l

0.52

461

Seminoma of testis

2.11

2.16

2.2

2.9

4.72

4.75

pmol/l

0.03

Dermatitis due to ingested food

100

720

1.35

2.16

2.9

3.4

4.83

4.96

pmol/l

0.65

652

Female infertility, tubal origin

166

1335

1.26

2.15

3.5

4.41

4.57

pmol/l

1.63

151

1198

Other fall from one level to another

575

5115

1.13

2.15

3.3

4.66

4.56

pmol/l

1.43

511

4575

Other maltreatment syndromes

581

1.40

2.15

2.6

3.6

4.53

4.73

pmol/l

0.81

523

Post-traumatic wound infection, not elsewhere classified

464

1.45

2.13

3.4

3.6

4.35

4.65

pmol/l

1.75

414

Femoral hernia, unilateral

464

1.45

2.13

2.6

3.3

4.33

4.46

pmol/l

0.61

403

Inguinal hernia, unilateral

464

1.45

2.13

2.6

3.3

4.33

4.46

pmol/l

0.61

403

Inguinal of femoral hernia, unilateral

464

1.45

2.13

2.6

3.3

4.33

4.46

pmol/l

0.61

403

Inflammatory disease of cervix uteri

197

1616

1.24

2.13

3.2

3.1

4.44

pmol/l

0.02

172

1434

Conductive hearing loss, unspecified

218

1804

1.22

2.13

3.5

3.3

4.48

4.49

pmol/l

0.03

196

1611

Other disorders of Eustachian tube

643

1.38

2.12

2.5

3.4

4.42

4.56

pmol/l

0.79

568

Embedded teeth, including avohilmo

291

2474

1.19

2.12

3.4

3.3

4.64

4.66

pmol/l

0.16

264

2229

Use of other anti-dementia drugs

512

3745

1.14

2.12

2.4

3.0

4.31

4.26

pmol/l

0.61

418

3170

Use of memantine

512

3745

1.14

2.12

2.4

3.0

4.31

4.26

pmol/l

0.61

418

3170

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

2.11

0.0

3.0

—

4.43

—

Carcinoma in situ, bladder

398

1.48

2.11

2.7

3.4

4.25

4.30

pmol/l

0.17

341

Chronic viral hepatitis

139

1097

1.28

2.10

2.2

3.4

4.46

4.62

pmol/l

0.93

112

997

Pneumonia due to Streptococcus pneumoniae

695

1.36

2.08

3.9

3.4

4.52

4.59

pmol/l

0.24

611

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

705

1.36

2.08

3.3

4.24

4.49

pmol/l

1.67

623

Benign neoplasm: Ill-defined sites within the digestive system

2.05

2.07

3.6

3.5

4.17

4.39

pmol/l

0.75

Alcoholic liver disease

124

1583

0.78

2.07

2.2

3.4

4.10

4.46

pmol/l

2.85

102

1402

Corneal degeneration

271

1.59

2.07

2.8

3.4

4.26

4.50

pmol/l

0.94

234

Behçet disease

2.45

2.07

2.5

4.8

4.14

4.48

pmol/l

0.61

Labour and delivery complicated by umbilical cord complications

122

1552

0.77

2.06

3.4

3.3

4.46

4.52

pmol/l

0.30

105

1394

Squamous cell neoplasms and carcinomas of the skin

132

1035

1.28

2.05

2.3

2.8

4.25

4.33

pmol/l

0.29

109

868

Anoxic brain damage

170

1.75

2.05

3.6

3.4

4.10

4.54

pmol/l

1.27

147

Burns and corrosions of multiple and unspecified body regions

410

1.47

2.04

3.0

3.6

4.34

4.73

pmol/l

2.17

365

Other other unspecified disorders of the circulatory system

655

1.37

2.04

3.4

4.28

4.50

pmol/l

1.52

568

Seminoma of testis, including Hilmo

2.01

2.04

2.7

4.74

4.71

pmol/l

0.03

Urethral stricture

671

1.35

2.03

3.1

3.4

4.66

4.45

pmol/l

0.34

588

Combinations of oral blood glucose lowering drugs

639

5743

1.12

2.03

2.7

3.4

4.32

4.44

pmol/l

2.88

569

5117

Duodenal ulcer

196

1611

1.23

2.03

3.0

3.4

4.27

4.41

pmol/l

0.70

173

1404

Acute alcohol intoxication, ICD10

485

4290

1.14

2.03

2.8

3.4

4.51

4.55

pmol/l

0.27

419

3849

Maternal care for known or suspected fetal abnormality and damage

639

4943

1.12

2.02

3.4

3.5

4.62

4.56

pmol/l

0.77

578

4461

Other specific arthropathies, wide

403

1.47

2.02

3.1

3.3

4.19

4.56

pmol/l

2.04

359

Helminthiases

117

910

1.31

2.01

3.3

3.2

4.68

4.60

pmol/l

0.42

106

808

Ectropion of eyelid

477

1.42

2.01

3.0

2.9

4.52

4.28

pmol/l

1.05

412

Generalized epilepsy

121

946

1.30

2.00

2.5

3.4

4.47

4.66

pmol/l

1.53

107

848

Unspecified abortion

175

1431

1.24

1.99

3.3

3.5

4.45

4.47

pmol/l

0.10

152

1301

Other and unspecified injuries of ankle and foot

119

929

1.30

1.99

3.1

3.3

4.65

4.60

pmol/l

0.11

829

Other acute skin changes due to ultraviolet radiation

624

1.37

1.98

3.1

3.4

4.29

4.51

pmol/l

1.12

549

Congenital malformations of great arteries

356

1.49

1.98

3.3

3.6

4.63

4.92

pmol/l

1.50

325

Acute inflammation of orbit

113

1.94

1.98

1.6

3.8

4.57

4.78

pmol/l

0.48

101

Foreign body entering into or through eye or natural orifice

182

1491

1.23

1.98

3.2

3.4

4.43

4.58

pmol/l

1.65

158

1336

Measles

251

1.61

1.98

3.1

3.9

4.51

4.58

pmol/l

0.17

220

Other and unspecified aplastic anaemias

180

1.72

1.98

5.8

3.2

4.62

4.65

pmol/l

0.04

160

Glaucoma, exfoliation

216

1799

1.21

1.97

2.9

3.0

4.44

4.30

pmol/l

0.94

190

1514

Sacroiliitis, not elsewhere classified

146

1170

1.27

1.97

2.8

3.5

4.63

4.59

pmol/l

0.10

133

1054

Peripheral retinal degeneration

591

1.38

1.97

3.0

3.3

4.47

4.54

pmol/l

0.26

519

Granulomatous disorders of skin and subcutaneous tissue

575

1.39

1.96

3.6

3.3

4.60

4.55

pmol/l

0.11

515

Myositis

447

1.44

1.96

3.1

3.5

4.30

4.57

pmol/l

1.65

398

Other specified/unspecified hearing loss

188

1547

1.23

1.96

2.7

3.2

4.48

4.44

pmol/l

0.25

170

1354

Erythema multiforme

431

1.45

1.95

2.9

3.2

4.49

4.55

pmol/l

0.15

380

Femoral hernia

100

764

1.33

1.95

2.8

3.4

4.30

4.44

pmol/l

0.77

662

Spirochaetal infections, other/unspecified

219

1832

1.21

1.94

2.7

3.3

4.45

4.46

pmol/l

0.05

191

1631

Amputation of foot

315

1.52

1.94

2.3

3.4

3.58

4.43

pmol/l

5.78

274

Crohn disease

364

3172

1.16

1.94

3.5

3.3

4.55

pmol/l

0.02

324

2841

Hypothermia

259

1.58

1.94

2.8

3.5

4.12

4.59

pmol/l

1.52

228

Other hammer toe(s) (acquired)

451

3674

1.14

1.94

2.7

3.4

4.34

4.41

pmol/l

0.63

380

3216

Oral leukoplakia, including avohilmo

465

1.42

1.94

4.2

3.2

4.48

4.55

pmol/l

0.18

406

Benign neoplasm: Skin of trunk

108

836

1.31

1.93

4.0

3.4

4.38

4.49

pmol/l

0.62

728

Other and unspecified epidermal thickening

491

1.41

1.93

3.2

3.3

4.42

4.59

pmol/l

0.74

435

severe traumatic brain injury, does not include concussion

455

4022

1.14

1.92

2.8

3.2

4.26

4.41

pmol/l

2.42

383

3543

HSIL lesion of the vulva

392

1.47

1.92

3.7

3.4

4.54

4.55

pmol/l

0.03

342

Viral conjunctivitis

110

855

1.31

1.92

3.3

4.46

4.58

pmol/l

0.71

103

758

Acquired haemolytic anaemia

399

1.46

1.92

3.2

3.3

4.11

4.58

pmol/l

2.35

349

Pneumothorax

134

1065

1.27

1.92

3.6

3.4

4.15

4.49

pmol/l

3.53

116

931

Other and unspecified injuries of abdomen, lower back and pelvis

293

1.54

1.91

3.5

3.6

4.45

4.63

pmol/l

0.51

261

All dysplastic lesions of the cervix uteri, vagina or vulva

1189

10877

1.08

1.91

3.3

3.4

4.55

4.53

pmol/l

0.18

1054

9831

Ulcerative colitis

696

6310

1.11

1.91

3.4

3.3

4.51

4.54

pmol/l

0.32

620

5655

Benign neoplasm: Long bones of lower limb

681

1.35

1.91

2.9

3.3

4.52

4.60

pmol/l

0.38

606

Disturbances of smell and taste

114

891

1.30

1.90

3.0

3.3

4.34

4.49

pmol/l

1.20

101

784

Polyhydramnios

180

1485

1.23

1.90

3.2

3.4

4.49

4.53

pmol/l

0.21

164

1322

Bacterial meningoencephalitis and meningomyelitis

3.13

1.90

2.9

2.4

4.14

4.34

pmol/l

—

Melanoma in situ

733

1.33

1.90

3.4

3.3

4.26

4.42

pmol/l

1.12

638

Sixth [abducent] nerve palsy

552

1.38

1.89

3.6

3.2

4.50

4.51

pmol/l

0.03

478

Crohn disease (strict definition, require KELA)

179

1474

1.23

1.89

3.1

3.3

4.69

4.58

pmol/l

0.38

160

1320

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

151

1221

1.25

1.88

3.2

3.4

4.57

4.48

pmol/l

0.52

133

1078

Scleritis

254

1.58

1.88

2.8

3.5

4.37

4.63

pmol/l

0.93

226

Iridocyclitis in diseases classified elsewhere

343

1.49

1.88

2.7

3.5

4.49

4.65

pmol/l

0.28

304

Alcohol-induced chronic pancreatitis

119

935

1.29

1.88

2.9

3.7

4.25

4.50

pmol/l

1.99

102

842

Valgus deformity, not elsewhere classified

130

1.83

1.88

2.2

3.2

4.67

4.52

pmol/l

0.28

115

Other congenital malformations of tongue, mouth and pharynx

341

1.49

1.87

2.8

3.2

4.81

4.99

pmol/l

0.63

308

Vascular syndromes of brain in cerebrovascular disorders

647

1.35

1.87

2.2

3.1

4.12

4.37

pmol/l

1.78

559

Injury of muscle and tendon at forearm level

327

1.50

1.87

3.4

3.5

4.35

4.55

pmol/l

0.85

287

Carcinoma in situ of skin of ear and external auricular canal

137

1.79

1.86

2.6

2.9

4.23

4.20

pmol/l

0.06

117

Benign neoplasm: Rectosigmoid junction

640

1.35

1.85

3.0

3.2

4.43

pmol/l

0.00

555

Other or unspecified common variable immunodeficiency

2.31

1.85

2.4

3.0

4.66

4.73

pmol/l

0.10

Other appendicitis

231

1952

1.20

1.85

3.1

3.4

4.49

4.50

pmol/l

0.06

202

1744

Other puerperal infections

305

2640

1.17

1.85

3.6

3.4

4.47

4.58

pmol/l

1.83

283

2370

Reimbursement for rheumatic diseases

1821

17091

1.06

1.85

2.9

3.3

4.40

4.48

pmol/l

2.37

1617

15207

Polyarthritis, unspecified

684

1.34

1.85

2.8

3.4

4.29

4.53

pmol/l

1.94

618

Galactorrhea

281

1.55

1.84

3.6

3.7

4.58

4.64

pmol/l

0.19

253

Varicose veins of other sites

138

1108

1.26

1.83

2.8

3.5

4.63

4.56

pmol/l

0.24

119

985

Cutaneous lupus erythematosus

488

1.40

1.83

2.6

3.3

4.27

4.57

pmol/l

2.04

428

Injury of muscle and tendon at lower leg level

345

3009

1.15

1.83

3.4

3.3

4.46

4.50

pmol/l

0.22

315

2707

Abnormal findings in nipple discharge synovial fluid wound secretions

305

1.52

1.82

3.9

3.3

4.51

4.63

pmol/l

0.34

269

Hereditary corneal dystrophies

626

1.35

1.81

3.2

3.3

4.48

4.47

pmol/l

0.04

546

Deep bite

317

2410

1.16

1.81

3.1

3.2

4.71

4.69

pmol/l

0.17

283

2175

Mixed conductive and sensorineural hearing loss

280

2408

1.17

1.80

3.1

3.3

4.44

4.42

pmol/l

0.09

242

2103

Pathological resorption of teeth

679

1.33

1.79

2.9

3.4

4.39

4.59

pmol/l

1.21

598

Injury of muscle and tendon at wrist and hand level

326

2837

1.16

1.79

3.1

3.4

4.56

4.52

pmol/l

0.27

285

2548

Fall involving bed

430

1.42

1.78

3.1

3.94

4.45

pmol/l

3.70

370

Other and unspecified iridocyclitis

116

918

1.28

1.77

3.1

3.4

4.58

4.53

pmol/l

0.15

108

818

Placenta praevia

180

1498

1.22

1.77

3.0

3.4

4.59

4.51

pmol/l

0.68

164

1339

Tooth eruption problems

467

4063

1.13

1.76

3.1

3.3

4.75

4.72

pmol/l

0.21

420

3688

Other bacterial agents as the cause of diseases classified to other chapters

179

1.67

1.75

3.1

3.5

4.43

4.63

pmol/l

0.54

157

Acute otitis externa, noninfective

299

1.51

1.75

2.3

3.4

4.26

4.56

pmol/l

1.28

262

Other disorders of pigmentation

114

902

1.28

1.75

3.0

3.3

4.44

4.49

pmol/l

0.19

796

Vascular dementia (subcortical)

364

1.45

1.75

2.8

2.6

4.14

4.28

pmol/l

0.42

312

Injury of muscle and tendon at hip and thigh level

243

2074

1.18

1.74

2.7

3.3

4.44

4.50

pmol/l

0.45

216

1853

380

3359

1.14

1.72

3.2

3.4

4.59

4.57

pmol/l

0.15

347

3032

Crohn disease (strict definition, require KELA, min 2 HDR)

176

1463

1.22

1.72

3.1

3.4

4.68

4.59

pmol/l

0.34

157

1309

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

259

1.53

1.72

3.4

3.0

4.18

4.44

pmol/l

1.01

219

LSIL lesion of the vagina

368

1.45

1.71

4.5

3.4

4.42

4.60

pmol/l

0.76

323

Burns and corrosions of external body surface, specified by site

267

2300

1.17

1.71

3.3

4.56

pmol/l

0.01

239

2054

Other infections specific to the perinatal period

1.97

1.70

2.5

2.7

4.86

5.13

pmol/l

0.71

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

305

2659

1.16

1.70

3.2

4.53

4.47

pmol/l

0.42

284

2379

Deep endometriosis

323

2827

1.16

1.70

3.1

3.2

4.47

4.49

pmol/l

0.10

276

2508

Hyphaema and other vascular disorders of iris and ciliary body

293

1.50

1.69

1.9

3.3

4.09

4.50

pmol/l

1.79

253

Colectomy operation

381

3368

1.14

1.68

3.4

3.2

4.31

4.42

pmol/l

1.58

337

2951

Malignant neoplasm of floor of mouth, including Hilmo

105

1.86

1.67

2.4

2.7

4.12

4.47

pmol/l

0.86

Fall on and from ladder

138

1122

1.24

1.66

3.1

3.5

4.76

4.45

pmol/l

1.50

124

987

Supervision of normal pregnancy

871

4580

1.09

1.66

3.4

3.5

4.60

4.56

pmol/l

0.61

794

4128

Other congenital malformations of circulatory system

497

1.37

1.66

3.8

3.5

4.45

4.66

pmol/l

0.89

445

Enterobiasis

524

1.37

1.66

2.8

3.2

4.83

4.64

pmol/l

0.93

466

Chronic myringitis

2.00

1.66

2.9

3.6

4.62

4.52

pmol/l

0.25

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

191

1607

1.20

1.65

3.1

3.4

4.70

4.58

pmol/l

0.49

170

1435

All dysplastic lesions of the vagina

699

1.32

1.65

3.4

3.2

4.50

4.53

pmol/l

0.13

613

Alzheimer’s disease (Early onset)

618

0.69

1.64

3.0

4.28

4.38

pmol/l

0.28

525

Cystic kidney disease

628

1.33

1.63

3.2

3.5

4.02

4.60

pmol/l

4.02

553

Fetus and newborn affected by complications of placenta, cord and membranes

2.87

1.63

5.9

2.7

5.33

5.12

pmol/l

—

Ankylosing spondylitis, ICD10

222

1895

1.18

1.62

2.4

3.4

4.58

4.53

pmol/l

0.16

195

1702

Nystagmus and other irregular eye movements

272

1.51

1.61

2.2

3.7

4.43

4.80

pmol/l

1.56

243

Other specified/unspecified disorders of bone/cartilage

474

1.37

1.60

3.8

3.2

4.39

4.57

pmol/l

0.87

410

Carcinoma in situ of skin of lower limb, including hip

297

1.48

1.59

4.0

2.7

4.22

4.33

pmol/l

0.37

251

Fracture of shoulder and upper arm

970

8997

1.08

1.58

3.3

4.37

4.48

pmol/l

2.67

831

7953

Other specified/unspecified nutritional deficiencies

130

1.75

1.58

3.8

3.0

4.25

4.57

pmol/l

1.13

116

Benign neoplasm: Other and unspecified parts of mouth

614

1.32

1.58

3.8

3.3

4.31

4.51

pmol/l

1.13

532

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

694

1.31

1.58

3.6

3.3

4.38

4.60

pmol/l

1.30

623

Endometroid carcinoma of ovary, including Hilmo

169

1.65

1.58

4.1

2.9

4.40

4.49

pmol/l

0.22

144

Early lumbar disc prolapse operation

324

2851

1.15

1.58

3.3

3.4

4.67

4.58

pmol/l

0.88

295

2579

Embolic stroke

621

1.32

1.58

3.0

3.1

4.23

4.40

pmol/l

0.99

531

Hirsprung

3.63

1.57

2.6

2.4

4.31

5.20

pmol/l

—

Toxic effect of ethanol

100

791

1.28

1.57

2.6

3.5

4.58

4.67

pmol/l

0.38

716

Pedestrian injured in collision with pedal cycle

580

1.33

1.57

3.3

4.33

4.60

pmol/l

1.57

515

Other specified disorders of external ear

510

1.35

1.56

2.7

3.5

4.43

4.50

pmol/l

0.17

452

Other/unspecified soft tissue disorders related to use, overuse and pressure

607

1.32

1.56

3.1

3.3

4.40

4.55

pmol/l

0.76

543

Simple and mucopurulent chronic bronchitis

641

1.31

1.55

3.4

3.2

4.55

4.42

pmol/l

0.59

546

Bacterial, viral and other infectious agents

224

1921

1.18

1.55

3.1

3.4

4.48

4.57

pmol/l

0.91

206

1716

Contusion of toe(s) without damage to nail

547

1.34

1.55

2.5

3.3

4.61

4.64

pmol/l

0.10

490

Common variable immunodeficiency

116

1.79

1.54

2.4

2.9

4.50

4.66

pmol/l

0.44

102

Childhood allergy (age < 16)

472

3500

1.12

1.54

2.9

3.3

4.88

4.82

pmol/l

0.56

425

3169

Juvenile arthritis (FINNGEN)

138

1135

1.23

1.54

3.3

4.41

4.67

pmol/l

2.69

127

1018

Chalazion

293

2565

1.15

1.54

3.3

3.2

4.45

4.49

pmol/l

0.29

263

2277

Malignant neoplasm of testis, including Hilmo

193

1.58

1.53

2.2

3.1

5.13

4.74

pmol/l

0.53

174

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

335

1.45

1.53

2.6

3.6

4.58

4.61

pmol/l

0.08

299

Contracture of joint

202

1.57

1.52

2.4

3.4

4.64

4.51

pmol/l

0.29

183

Contact with heat and hot substances

130

1064

1.24

1.51

3.2

3.3

4.57

4.63

pmol/l

0.21

113

943

Behavioural disorders

480

1.36

1.50

3.9

3.4

4.65

4.82

pmol/l

0.61

430

Unspecified dementia

173

1306

1.20

1.50

2.2

3.0

4.13

4.28

pmol/l

0.98

144

1095

Open wound of hip and thigh

584

1.32

1.50

1.9

3.5

4.44

4.66

pmol/l

1.07

522

Carcinoma in situ of other and unspecified digestive organs

497

1.35

1.50

2.9

3.3

4.39

4.47

pmol/l

0.24

432

Secondary sideroblastic anaemia

2.49

1.49

2.3

3.3

3.93

4.63

pmol/l

—

Certain zoonotic bacterial diseases

541

1.33

1.49

3.1

3.4

4.41

4.58

pmol/l

1.03

480

Focal brain injury

116

938

1.25

1.49

2.7

3.3

4.29

4.50

pmol/l

1.41

839

Crushed, pushed or stepped on by crowd or human stampede

190

1615

1.19

1.48

3.1

3.3

4.69

4.67

pmol/l

0.06

166

1436

Benign mammary dysplasia

443

3992

1.12

1.48

2.8

3.2

4.43

4.44

pmol/l

0.04

398

3516

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

588

1.32

1.47

2.5

3.4

4.55

pmol/l

0.01

523

Crohn's disease of small intestine

186

1581

1.19

1.46

3.4

3.3

4.65

4.56

pmol/l

0.34

166

1415

Nonpyogenic thrombosis of intracranial venous system

197

1.57

1.46

2.4

3.5

4.18

4.58

pmol/l

1.07

171

Calculus of lower urinary tract

665

1.29

1.45

2.9

3.3

4.46

4.41

pmol/l

0.18

581

Purulent endophthalmitis

1.88

1.45

3.0

2.7

4.06

4.23

pmol/l

0.42

103

822

1.26

1.45

3.0

3.2

4.53

4.46

pmol/l

0.29

699

Non-small cell lung cancer, squamous, helper endpoint

516

1.33

1.45

5.2

3.2

4.39

4.28

pmol/l

0.34

441

Other acute disseminated demyelination

230

1.52

1.45

3.1

3.5

4.51

4.63

pmol/l

0.39

205

Cystic kidney disease

571

1.32

1.43

3.2

3.5

3.98

4.62

pmol/l

4.27

504

Use of rasagiline

381

1.39

1.42

2.2

3.3

4.43

4.45

pmol/l

0.05

327

Hepatocellular carcinoma, including Hilmo

279

1.45

1.42

3.4

3.0

4.22

4.45

pmol/l

0.73

240

Other condition

371

3317

1.13

1.42

2.8

3.3

4.47

4.50

pmol/l

0.18

343

2959

Vasculitis limited to skin, not elsewhere classified

459

1.35

1.41

2.9

3.2

4.07

4.52

pmol/l

3.53

411

Seropositive rheumatoid arthritis

693

6365

1.09

1.41

2.9

3.4

4.28

4.44

pmol/l

4.82

614

5637

Open wound of abdomen, lower back and pelvis

555

1.32

1.41

3.3

4.28

4.66

pmol/l

2.50

494

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

101

811

1.26

1.40

3.2

2.9

4.13

4.44

pmol/l

2.58

687

Ectopic pregnancy

626

5754

1.10

1.40

3.3

4.45

4.49

pmol/l

0.49

560

5157

Melanocytic naevi of upper limb, including shoulder

495

1.34

1.40

2.8

3.3

4.40

4.60

pmol/l

1.02

437

Perforation of tympanic membrane

246

2145

1.16

1.40

2.8

3.3

4.33

4.50

pmol/l

2.20

216

1908

Chronic iridocyclitis

124

1021

1.23

1.39

3.7

3.2

4.37

4.53

pmol/l

1.04

111

904

Lesion of radial nerve

671

1.28

1.39

4.0

3.3

4.54

4.52

pmol/l

0.05

583

Congenital malformations of ovaries, fallopian tubes and broad ligaments

203

1751

1.17

1.38

3.6

3.3

4.44

4.53

pmol/l

0.84

184

1560

Contact with hypodermic needle

147

0.46

1.38

1.7

4.1

4.44

4.79

pmol/l

—

135

Normotensive glaucoma

186

1590

1.18

1.38

2.8

3.0

4.26

4.34

pmol/l

0.57

163

1362

Dementia due to Parkinsons disease, excluding more controls

223

1.50

1.38

2.5

3.0

4.42

4.29

pmol/l

0.38

193

Contracture of muscle

2.05

1.37

6.2

2.7

4.40

4.57

pmol/l

0.30

Xerosis cutis

249

1.48

1.37

2.9

4.04

4.50

pmol/l

1.68

222

Thrombocytopenia, unspecified

156

1315

1.20

1.36

3.7

3.3

4.17

4.49

pmol/l

3.09

141

1154

Congenital deformities of hip

393

1.38

1.36

3.7

3.1

4.88

4.74

pmol/l

0.39

345

Undefined dementia

176

1378

1.18

1.36

2.2

2.9

4.11

4.28

pmol/l

1.25

147

1140

Wilms' tumor, including Hilmo

1.97

1.36

5.1

3.1

4.19

4.65

pmol/l

0.72

Maternal care for cervical incompetence

125

1036

1.23

1.35

2.6

3.2

4.44

4.51

pmol/l

0.31

115

913

Complications of other internal prosthetic devices, implants and grafts

746

1.26

1.34

3.0

3.2

4.35

4.45

pmol/l

0.46

658

Mantle cell lymphoma

1.78

1.34

1.6

2.8

3.94

4.37

pmol/l

1.96

Antenatal screening

898

4697

1.08

1.33

3.4

3.5

4.60

4.57

pmol/l

0.45

826

4238

Bilateral sagittal split ramus osteotomy operation

107

874

1.24

1.33

3.4

3.5

4.44

4.59

pmol/l

1.06

788

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

334

1.39

1.33

2.3

3.0

4.12

4.42

pmol/l

1.71

281

Chronic lymphocytic leukaemia

334

1.39

1.33

2.3

3.0

4.12

4.42

pmol/l

1.71

281

Chronic lymphocytic leukaemia, helper endpoint

334

1.39

1.33

2.3

3.0

4.12

4.42

pmol/l

1.71

281

Psoriatic arthropathies

253

2220

1.15

1.33

2.6

3.5

4.49

4.51

pmol/l

0.07

222

1997

Carcinoma in situ of skin of scalp and neck

292

1.42

1.33

3.3

3.2

4.57

4.23

pmol/l

1.41

252

Poor fetal growth

489

4461

1.11

1.32

4.0

3.4

4.63

4.56

pmol/l

0.89

443

4023

Congenital malformations of uterus and cervix

625

1.29

1.32

3.7

3.3

4.71

4.58

pmol/l

0.57

558

Congenital malformations of breast

519

1.32

2.8

3.6

4.49

4.62

pmol/l

0.60

463

Oral lichen planus, including avohilmo , including avohilmo

181

1553

1.18

1.31

2.8

3.3

4.29

4.46

pmol/l

2.47

162

1372

Ulcerative proctitis

166

1414

1.19

1.31

3.7

3.4

4.52

4.56

pmol/l

0.26

151

1265

Left hemicolectomy

310

1.41

1.31

2.8

3.3

4.28

4.46

pmol/l

0.77

270

Contact with machinery

193

1662

1.17

1.31

3.4

4.58

4.54

pmol/l

0.13

176

1479

Carcinoma in situ of skin

173

1478

1.18

1.30

2.9

3.2

4.33

4.38

pmol/l

0.29

151

1265

Malignant neoplasm of stomach, including Hilmo

765

1.25

1.30

3.3

2.9

4.23

4.43

pmol/l

1.12

643

Exposure to other and unspecified forces of nature

115

1.71

1.29

2.5

3.6

4.37

4.74

pmol/l

1.04

101

Other osteochondropathies

173

1480

1.18

1.29

3.5

4.61

4.54

pmol/l

0.49

152

1334

Fitting and adjustment of other devices

819

6883

1.08

1.29

2.9

3.2

4.33

4.44

pmol/l

3.05

710

5993

Mucosal proctocolitis

343

3074

1.12

1.29

3.3

3.4

4.51

4.55

pmol/l

0.32

307

2754

Dissection of aorta

405

1.35

1.28

4.2

3.2

4.05

4.50

pmol/l

3.08

346

Congenital deformities of hip

441

1.34

1.28

3.5

3.1

4.80

4.71

pmol/l

0.24

389

Juvenile cataract

1.85

1.28

3.8

3.3

4.89

4.80

pmol/l

0.13

Fibrosis and cirrhosis of liver

166

1417

1.18

1.27

2.4

3.3

4.06

4.43

pmol/l

4.05

148

1244

Malignant neoplasm, without specification of site, including Hilmo

607

1.28

1.27

3.4

2.9

4.13

4.43

pmol/l

2.23

516

Pneumonia derived septicemia

582

1.29

1.27

3.1

3.3

4.60

4.57

pmol/l

0.07

509

Injury of other and unspecified intrathoracic organs

123

1023

1.21

1.26

3.3

4.50

4.51

pmol/l

0.03

108

904

Infections of genitourinary tract in pregnancy

325

2912

1.13

1.26

3.4

4.50

pmol/l

0.01

295

2595

6-mercaptopurine

744

1.25

3.4

3.2

4.63

4.67

pmol/l

0.15

671

Female infertility, uterine origin

101

1.76

1.25

2.8

3.7

4.39

4.60

pmol/l

0.60

Fibrosis of liver

116

1.69

1.25

2.7

2.8

4.12

4.52

pmol/l

0.92

105

Disorders of eyelid in diseases classified elsewhere

646

1.27

1.25

4.3

3.2

4.37

4.58

pmol/l

1.37

570

Sequelae of injuries of head

115

952

1.22

1.25

2.9

3.6

4.44

4.57

pmol/l

0.67

849

Toxic effects of substances chiefly nonmedicinal as to source

288

2565

1.13

1.22

2.9

3.3

4.55

4.54

pmol/l

0.01

263

2296

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

214

1.48

1.22

3.4

3.7

4.64

4.65

pmol/l

0.02

190

Increased muscle tone

125

1.65

1.22

4.8

3.5

4.36

4.63

pmol/l

0.93

108

Transient synovitis

157

1.57

1.21

4.8

3.3

4.90

4.71

pmol/l

0.47

143

malignant neoplasm of male genital organs

400

2202

1.11

1.20

3.1

3.2

4.53

4.44

pmol/l

0.68

353

1966

Disorder of external ear, unspecified

632

1.27

1.20

2.5

3.4

4.44

4.54

pmol/l

0.42

558

Embedded and impacted teeth

890

6883

1.07

1.19

3.2

3.4

4.73

4.68

pmol/l

0.64

814

6218

Transitory endocrine and metabolic disorders specific to fetus and newborn

202

1.48

1.19

2.0

2.7

5.28

5.13

pmol/l

0.12

183

Other proliferative retinopathy

1.87

1.18

2.0

3.3

3.99

4.47

pmol/l

1.02

Polydactyly

2.68

1.18

2.4

3.0

5.18

4.71

pmol/l

—

Seropositive rheumatoid arthritis, strict definition

337

3735

0.90

1.18

2.6

3.3

4.28

4.45

pmol/l

2.44

298

3311

Pemphigoid

377

1.34

1.18

2.7

3.0

4.15

4.41

pmol/l

1.02

324

Use of rivastigmine

265

2347

1.13

1.17

2.4

2.9

4.26

4.27

pmol/l

0.12

223

1960

Marfan's syndrome

103

1.71

1.17

5.4

3.4

4.66

4.79

pmol/l

0.28

Reactive arthropathies, FINNGEN

178

1542

1.16

3.5

4.46

4.52

pmol/l

0.36

156

1384

Dermatitis herpetiformis

318

1.38

1.16

3.3

4.44

4.60

pmol/l

0.65

281

Pyogenic arthritis

134

1134

1.19

1.16

3.3

3.4

4.39

4.48

pmol/l

0.40

117

1008

Juvenile rheumatoid arthirtis

511

1.29

1.15

2.8

3.5

4.24

4.59

pmol/l

2.51

465

Primary angle-closure glaucoma

707

1.24

1.15

2.7

3.0

4.41

4.37

pmol/l

0.20

610

Tooth agenesis EXCLUDE clefts and syndromes

107

890

1.22

1.14

3.4

4.85

4.74

pmol/l

0.43

801

Etanercept

184

1602

1.16

1.14

2.4

3.2

4.30

4.56

pmol/l

3.22

168

1439

Occupational exposure to risk-factors

538

1.28

1.14

3.5

3.7

4.57

4.52

pmol/l

0.22

478

Chronic hepatitis, not elsewhere classified

709

1.24

1.14

2.6

3.4

4.40

4.57

pmol/l

0.79

622

Oral lichen planus

548

1.28

1.14

3.3

3.1

4.32

4.46

pmol/l

0.83

470

Carcinoma in situ of skin, other sites/unspecified

184

1.49

1.13

2.1

2.6

4.28

4.23

pmol/l

0.08

156

Any dementia

794

5156

1.07

1.12

2.7

3.1

4.26

4.31

pmol/l

0.77

659

4431

Disorders of vagus nerve

2.56

1.12

2.6

4.3

4.50

4.55

pmol/l

—

Malignant neoplasm of other connective and soft tissue

346

1.35

1.11

4.2

2.9

4.59

4.53

pmol/l

0.15

295

Carcinoma in situ of skin of lip

2.03

1.11

3.1

2.8

4.17

4.36

pmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

303

1.37

1.10

3.7

3.1

4.04

4.41

pmol/l

1.48

258

Delivery, wide proxy

1182

5944

1.06

1.09

3.4

3.2

4.56

4.47

pmol/l

1.75

1044

5172

Telogen effluvium

2.10

1.09

5.3

3.9

4.41

4.64

pmol/l

—

Cysts of oral region, not elsewhere classified

134

1143

1.18

1.08

4.0

3.3

4.57

4.54

pmol/l

0.13

120

1015

Ulcerative colitis, NAS

369

3358

1.10

1.08

3.3

4.48

4.53

pmol/l

0.41

328

3000

Malignant neoplasm of oral cavity, including Hilmo

658

1.24

1.08

3.1

3.0

4.18

4.50

pmol/l

1.57

573

Crystalline deposits in vitreous body

121

1.61

1.08

1.4

3.4

4.18

4.41

pmol/l

0.43

108

Other and unspecified injuries of wrist and hand

814

1.22

1.07

2.6

3.4

4.56

4.64

pmol/l

0.34

729

Reduction defects of upper limb

2.05

1.07

2.1

3.8

4.43

5.09

pmol/l

—

Pneumococcal septicemia

552

1.26

1.07

3.1

3.3

4.66

4.63

pmol/l

0.07

489

Other bacterial agents as the cause of diseases classified to other chapters

229

1.43

1.07

3.3

3.4

4.47

4.63

pmol/l

0.46

205

Mandibular retrognathia AND surgery (BSSO)

662

1.24

1.06

3.5

3.6

4.50

4.61

pmol/l

0.57

594

Dislocation, sprain and strain of joints and ligaments of elbow

170

1481

1.16

1.06

3.3

3.2

4.42

4.60

pmol/l

1.92

150

1320

Toxic effect of organic solvents

1.90

1.06

2.5

4.8

4.67

4.71

pmol/l

0.05

Other forms of systemic lupus erythematosus

197

1.46

1.04

2.9

3.7

4.17

4.63

pmol/l

1.28

175

Complications of genitourinary prosthetic devices, implants and grafts

492

1.28

1.04

3.2

3.4

4.48

pmol/l

0.02

434

Livedoid vasculitis

1.84

1.04

2.3

3.1

3.92

4.26

pmol/l

0.80

Osteosarcoma, including Hilmo

1.96

1.04

6.0

3.5

5.03

pmol/l

—

Pigmented purpuric dermatosis

155

1.52

1.04

2.7

3.2

4.67

4.47

pmol/l

0.34

141

Carcinoma in situ of middle ear and respiratory system

1.94

1.03

4.7

3.0

4.21

4.20

pmol/l

—

Asymmetry of jaw

343

1.34

1.03

1.8

3.3

4.42

4.65

pmol/l

0.94

306

Impaction of intestines

1.66

1.02

1.3

3.0

4.37

4.43

pmol/l

—

Hordeolum and other deep inflammation of eyelid

147

1271

1.17

1.02

3.6

3.2

4.58

4.54

pmol/l

0.14

131

1139

Sequelae of other and unspecified infectious and parasitic diseases

136

1169

1.17

1.02

3.5

3.4

4.42

4.55

pmol/l

0.83

125

1047

Need for immunization against single bacterial diseases

1.92

1.02

2.3

3.3

4.64

5.28

pmol/l

—

Chondromalacia

566

1.25

1.01

2.7

3.6

4.61

4.55

pmol/l

0.21

499

Contact with sharp glass

820

1.21

1.01

3.2

3.5

4.55

4.66

pmol/l

0.50

738

Precocious puberty

108

1.63

1.00

3.4

2.7

5.34

4.88

pmol/l

1.28

Oesophageal obstruction

521

1.26

1.00

3.9

3.4

4.19

4.44

pmol/l

1.18

455

Varicella [chickenpox]

802

1.21

1.00

3.6

3.4

4.54

4.68

pmol/l

0.80

729

All dysplastic lesions of the cervix uteri

1029

9684

1.06

1.00

3.3

3.4

4.58

4.54

pmol/l

0.54

916

8771

Injury of nerves at forearm level

241

1.40

0.99

2.4

3.8

4.11

4.71

pmol/l

2.70

211

Infections of breast associated with childbirth

134

1157

1.17

0.98

3.8

3.3

4.41

4.57

pmol/l

1.15

121

1035

Carcinoma in situ of skin of upper limb, including shoulder

328

1.33

0.97

2.1

3.0

4.25

4.32

pmol/l

0.21

290

Malignant neoplasm of digestive organs

727

6109

0.94

0.97

3.0

4.24

4.41

pmol/l

4.61

636

5327

Congenital malformation syndromes predominantly affecting facial appearance

1.83

0.97

2.0

3.5

4.99

4.92

pmol/l

—

Other and unspecified mononeuropathies of lower limb

542

1.25

0.97

3.4

3.2

4.45

pmol/l

0.02

470

Pityriasis lichenoides chronica

1.84

0.97

4.3

3.7

4.60

4.53

pmol/l

0.08

Monoarthritis, not elsewhere classified

100

842

1.20

0.97

2.9

3.5

4.53

4.52

pmol/l

0.01

762

302

1.34

0.97

3.3

2.9

4.14

4.30

pmol/l

0.49

256

Other acute viral hepatitis

251

1.38

0.97

2.8

3.6

4.73

4.64

pmol/l

0.25

224

IBD patients in KELA-register

639

5982

1.07

0.97

3.3

4.56

pmol/l

0.01

572

5387

Puerperal sepsis

425

3922

1.09

0.97

3.5

3.3

4.43

4.47

pmol/l

0.36

375

3497

Paralytic ileus

578

1.24

0.96

2.1

3.2

4.36

4.51

pmol/l

0.70

496

Nightmares

1.91

0.96

4.6

3.4

4.43

4.69

pmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

124

1438

0.85

0.96

3.1

3.2

4.45

4.49

pmol/l

0.21

115

1279

Congenital myopathies

2.34

0.96

2.3

3.7

4.75

4.16

pmol/l

—

Reactive arthropathies

211

1879

1.13

0.96

3.3

3.5

4.45

4.51

pmol/l

0.42

186

1684

Benign neoplasm: Cranial nerves

498

1.26

0.96

2.7

3.3

4.52

4.50

pmol/l

0.05

428

Patent foramen ovale

400

1.29

0.96

3.3

3.4

4.69

4.72

pmol/l

0.11

357

Male infertility

578

1.24

0.95

2.5

3.9

4.62

4.77

pmol/l

0.79

530

Assault by hanging, strangulation and suffocation

1.80

0.95

2.4

4.0

4.88

4.87

pmol/l

—

Congenital malformations of breast

482

1.27

0.95

2.9

3.6

4.51

4.63

pmol/l

0.49

429

Varicella [chickenpox]

114

972

1.18

0.95

3.3

3.4

4.60

4.70

pmol/l

0.53

107

881

Mitochondrial myopathy

1.69

0.94

2.6

3.8

4.01

4.76

pmol/l

1.58

Twin gestation

330

3017

1.10

0.94

3.6

3.4

4.54

4.52

pmol/l

0.07

308

2714

Social disorders starting during childhood or adolescence

176

1.46

0.94

5.4

3.4

4.74

5.06

pmol/l

0.89

163

Contact with other hot fluids

617

1.23

0.94

3.0

3.3

4.71

4.72

pmol/l

0.01

552

Chronic mastoiditis

401

1.29

0.94

3.4

3.2

4.53

4.48

pmol/l

0.11

346

Labyrinthitis

1.82

0.93

3.3

3.7

4.54

4.48

pmol/l

0.08

Contact with other sharp object(s)

166

1460

1.15

0.93

2.5

3.5

4.58

4.64

pmol/l

0.42

149

1314

LeFortI or BSSO operation

122

1051

1.17

0.92

3.4

4.45

4.59

pmol/l

0.91

113

949

Aneurysms, operations, SAH

389

3582

1.09

0.92

3.1

3.2

4.45

4.44

pmol/l

0.12

344

3176

Acne keloid

2.18

0.92

5.2

4.2

4.40

4.69

pmol/l

—

Fetal death of unspecified cause

1.99

0.92

3.3

3.9

4.38

4.73

pmol/l

—

Juvenile osteochondrosis

692

1.21

0.91

3.0

3.4

4.76

4.71

pmol/l

0.12

624

Malignant neoplasm of prostate, including Hilmo

395

2156

1.09

0.91

3.4

3.1

4.47

4.43

pmol/l

0.28

351

1924

Injury of eye and orbit

340

3114

1.10

0.91

3.1

3.3

4.61

4.57

pmol/l

0.36

303

2785

Haematosalpinx/Haematoma of broad ligament

1.97

0.91

2.4

3.6

4.54

4.60

pmol/l

—

Environmental-pollution-related condition

2.16

0.91

4.2

3.9

4.47

4.74

pmol/l

—

Other intracranial haemorrhages

403

1.28

0.90

2.9

3.0

4.31

4.40

pmol/l

0.21

343

Other contact dermatitis

217

1946

1.12

0.90

3.1

3.3

4.40

4.51

pmol/l

1.26

188

1741

Osteomyelitis of vertebra

1.92

0.89

2.4

2.8

4.22

4.45

pmol/l

—

Carcinoma in situ of other and unspecified genital organs

423

1.27

0.89

3.2

3.3

4.44

4.53

pmol/l

0.15

364

Cardiomyopathy due to drugs and other external agents

1.91

0.89

2.5

3.9

4.05

4.63

pmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

459

1.26

0.88

2.3

3.3

4.22

4.60

pmol/l

2.67

407

Demyelinating diseases of the central nervous system

262

2378

1.11

0.88

3.3

4.45

4.53

pmol/l

0.71

230

2131

Retained placenta and membranes, without haemorrhage

362

3925

0.92

0.88

3.1

3.3

4.44

4.50

pmol/l

0.49

318

3530

Benign neoplasm: Mediastinum

1.82

0.86

5.4

3.3

3.95

4.59

pmol/l

—

Malignant neoplasm, without specification of site

370

1.28

0.86

3.1

2.9

3.95

4.39

pmol/l

2.78

311

Cardiomyopathies, Secondary/extrinsic

1.66

0.86

3.5

3.7

4.28

4.85

pmol/l

1.04

Acquired atrophy of ovary and fallopian tube

1.77

0.86

2.5

2.6

4.41

4.75

pmol/l

0.60

Fourth [trochlear] nerve palsy

389

1.28

0.86

3.3

3.2

4.47

4.58

pmol/l

0.37

339

Disorders of acoustic nerve

488

1.24

0.85

2.7

3.4

4.56

4.50

pmol/l

0.13

424

Fracture of neck

111

956

1.17

0.85

2.9

3.4

4.26

4.46

pmol/l

1.52

838

Residual foreign body in soft tissue

113

975

1.17

0.85

2.4

3.6

4.61

4.55

pmol/l

0.15

888

Other congenital malformations of kidney

1.75

0.85

2.3

3.8

4.35

4.71

pmol/l

0.55

Viral agents as the cause of diseases classified to other chapters

444

1.26

0.84

2.5

3.4

4.45

4.58

pmol/l

0.64

391

Injury of blood vessels at lower leg level

1.69

0.84

2.9

3.0

3.92

4.52

pmol/l

1.77

Labour and delivery complicated by fetal stress [distress]

1010

6302

1.05

0.84

3.4

3.5

4.60

4.58

pmol/l

0.31

905

5717

Assault by blunt object

249

1.35

0.84

2.7

3.8

4.47

4.74

pmol/l

0.67

227

Allergic purpura

617

1.21

0.83

3.7

3.3

4.49

4.62

pmol/l

0.39

545

Benign neoplasm: Larynx

462

1.25

0.83

2.9

3.4

4.33

4.52

pmol/l

0.73

402

Struck by thrown, projected or falling objec

108

930

1.17

0.83

2.8

3.4

4.68

4.62

pmol/l

0.19

841

Other Crohn's disease

179

1597

1.13

0.83

3.2

3.3

4.43

4.59

pmol/l

1.31

163

1440

Pregnancy, childbirth and the puerperium

1013

5038

1.05

0.83

3.3

3.2

4.58

4.48

pmol/l

1.92

890

4366

Hip and thigh

1.77

0.83

6.6

4.1

5.08

4.51

pmol/l

—

Toxic colitis

1.79

0.82

2.2

2.9

4.31

4.45

pmol/l

—

Occlusion and stenosis of arteries, not leading to stroke

155

1.44

0.82

3.2

3.1

4.35

4.31

pmol/l

0.05

133

Schistosomiasis [bilharziasis]

0.00

0.82

0.0

3.7

—

4.40

—

UC patients in KELA-register (code 208), prior to 1994

784

1.18

0.82

4.0

3.3

4.29

4.49

pmol/l

1.35

685

Drug-induced fever

1.90

0.81

1.8

3.3

4.57

4.56

pmol/l

—

HSIL lesion of the cervix uteri, vagina or vulva

765

7258

1.06

0.81

3.4

4.60

4.53

pmol/l

0.87

684

6570

Abscess of anal and rectal regions

186

1666

1.12

0.80

2.8

3.4

4.49

4.59

pmol/l

0.53

161

1495

Pseudopolyposis of colon

1.72

0.80

1.1

3.4

4.84

4.56

pmol/l

—

Other and unspecified hydrocephalus

295

1.30

0.80

2.7

3.0

4.53

4.56

pmol/l

0.06

257

Methotrexate

382

3543

1.08

0.80

2.8

3.4

4.39

4.51

pmol/l

0.87

343

3122

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.80

0.0

2.1

—

4.44

—

Foreign body in ear

367

1.27

0.79

2.1

3.2

4.57

4.61

pmol/l

0.11

325

Malignant neoplasm of stomach

629

1.20

0.79

3.5

3.0

4.24

4.44

pmol/l

0.87

532

Other and unspecified vasculitis limited to skin

412

1.25

0.79

2.8

3.2

4.10

4.52

pmol/l

2.57

373

Other articular cartilage disorders

394

1.26

0.78

2.0

3.6

4.40

4.48

pmol/l

0.26

359

Clubfoot

209

1.37

0.78

2.5

3.2

4.54

4.73

pmol/l

0.38

182

Pyogenic granuloma

332

1.28

0.78

4.0

3.3

4.19

4.62

pmol/l

2.39

298

Unspecified jaundice

778

1.18

0.78

3.6

3.3

4.53

4.44

pmol/l

0.27

687

Other ill-defined and unspecified causes of mortality

123

1076

1.15

0.78

3.3

3.1

4.19

4.36

pmol/l

1.07

106

921

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

440

1.24

0.78

4.2

3.3

4.35

4.56

pmol/l

0.80

381

Congenital malposition of the kidney

2.23

0.77

3.4

4.4

4.06

4.56

pmol/l

—

Lymphoid leukaemia

100

862

1.17

0.77

3.2

3.1

4.46

4.47

pmol/l

0.03

754

Vascular diseases of the intestine

558

1.21

0.77

2.7

3.1

4.16

4.40

pmol/l

0.98

478

Allergic contact dermatitis due to drugs in contact with skin

450

1.24

0.77

3.8

3.4

4.38

4.54

pmol/l

0.44

404

Other/unspecified reactive arthropathies

160

1427

1.13

0.77

3.5

3.4

4.40

4.51

pmol/l

0.84

139

1268

Sequelae of infectious and parasitic diseases

167

1493

1.12

0.76

3.4

4.41

4.48

pmol/l

0.40

153

1323

Multiple gestation

338

3131

1.09

0.76

3.6

3.5

4.53

4.52

pmol/l

0.07

316

2817

Vascular dementia (undefined)

391

1.25

0.76

2.5

2.6

4.25

4.21

pmol/l

0.10

331

Rheumatoid arthritis, including avohilmo

1101

10555

1.05

0.76

2.8

3.3

4.34

4.43

pmol/l

2.01

973

9311

Recurrent and persistent haematuria

150

1.43

0.75

3.1

3.5

4.55

4.54

pmol/l

0.03

132

Other ulcerative colitis

142

1259

1.14

0.75

3.6

3.3

4.43

4.57

pmol/l

1.20

126

1131

Impacted teeth

620

5212

1.06

0.75

3.2

3.4

4.76

4.71

pmol/l

0.54

571

4717

Rhabdomyosarcoma, including Hilmo

2.08

0.74

2.4

4.5

5.62

5.03

pmol/l

—

Cleft lip and palate

109

0.54

0.74

5.3

3.4

4.33

4.83

pmol/l

—

Alzheimer’s disease (Late onset)

399

3125

1.08

0.74

2.4

3.0

4.30

4.23

pmol/l

0.66

325

2644

Acquired keratosis [keratoderma] palmaris et plantaris

1.66

0.74

1.8

3.8

4.45

4.51

pmol/l

0.06

Melanocytic naevi of scalp and neck

498

1.22

0.74

2.8

3.4

4.69

4.61

pmol/l

0.14

442

Contact with other hot metals

255

1.31

0.73

4.0

3.5

4.43

4.64

pmol/l

0.63

226

Benign neoplasm: Endocrine gland, other/unspecified

1.63

0.73

1.7

3.8

4.37

4.62

pmol/l

—

Gender identity disorders

300

1.29

0.73

3.4

5.02

4.76

pmol/l

0.77

268

Generalized epilepsy, mode (most common among epilepsy diagnosis)

683

1.18

0.72

2.2

3.4

4.47

4.70

pmol/l

1.20

615

Use of bromocriptine

2.01

0.72

7.2

1.9

4.24

4.40

pmol/l

—

Systemic sclerosis (FG)

518

1.21

0.72

1.8

3.3

4.18

4.48

pmol/l

1.99

460

Glaucoma secondary to drugs

1.70

0.71

3.3

2.9

4.73

4.55

pmol/l

—

Crushing injury of wrist and hand

228

0.69

0.71

5.1

3.9

4.44

4.73

pmol/l

0.85

212

Injury of cranial nerves

127

1.45

0.70

3.0

2.8

4.81

4.57

pmol/l

0.30

113

Hydrocephalus

144

1285

1.13

0.70

2.8

3.1

4.48

4.46

pmol/l

0.07

124

1113

Psoriasis (vulgaris), strict definition

593

1.19

0.69

2.1

3.3

4.37

4.60

pmol/l

1.32

533

MS-disease / Multiple Sclerosis

218

1991

1.10

0.69

3.5

3.4

4.47

4.55

pmol/l

0.59

190

1791

Adenocarcinomas of cervix

1.54

0.69

4.0

3.2

4.28

4.52

pmol/l

0.41

Follicular lymphoma, hilmo

695

1.17

0.69

2.4

3.3

4.38

4.45

pmol/l

0.31

609

Crohn's disease NAS

158

1419

1.12

0.69

3.6

3.3

4.44

4.59

pmol/l

1.33

139

1281

Burn and corrosion of shoulder and upper limb, except wrist and hand

356

1.25

0.69

3.8

3.5

4.33

4.76

pmol/l

2.02

315

Slow fetal growth and fetal malnutrition

1.53

0.69

2.1

2.7

5.19

5.27

pmol/l

0.11

Fetus and newborn affected by maternal complications of pregnancy

1.52

0.68

1.3

2.6

5.25

5.14

pmol/l

0.19

Complications of labour and delivery

2470

13371

1.03

0.68

3.4

3.3

4.50

pmol/l

0.09

2195

11953

Any death

1492

11049

0.96

0.67

3.1

3.3

4.01

4.46

pmol/l

41.66

1293

9805

Assault by unspecified means

412

1.23

0.67

3.1

3.7

4.42

4.77

pmol/l

1.29

375

Use of ropinirole

577

1.19

0.67

2.8

3.4

4.37

4.39

pmol/l

0.08

504

Lesion of medial popliteal nerve

1.66

0.67

2.7

2.9

4.62

4.45

pmol/l

—

Congenital malformations of lung

1.64

0.67

1.3

2.9

4.83

5.11

pmol/l

—

Other and unspecified injuries of thorax

331

1.25

0.66

2.0

3.4

4.29

4.63

pmol/l

1.38

297

Other corneal oedema

120

1.44

0.66

2.8

2.9

4.89

4.42

pmol/l

0.64

106

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

213

1.32

0.65

3.7

3.0

5.25

5.16

pmol/l

0.14

194

Amputation of thigh

322

1.25

0.65

1.8

3.2

3.76

4.32

pmol/l

2.28

275

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

578

1.18

0.65

3.6

2.9

4.05

4.45

pmol/l

2.70

491

Cyst of Bartholin Gland

123

1097

1.13

0.64

3.1

3.4

4.53

4.47

pmol/l

0.27

110

988

Malignant neoplasm of cervix uteri, including Hilmo

600

1.18

0.63

3.9

3.1

4.49

4.52

pmol/l

0.08

522

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

234

2540

0.92

0.63

2.5

3.4

3.96

4.45

pmol/l

9.66

201

2243

Hand

1.49

0.63

3.2

3.8

4.56

4.57

pmol/l

0.01

Cleft palate

233

0.72

0.63

1.8

3.8

4.75

4.83

pmol/l

0.11

207

HSIL lesion of the cervix uteri

699

6676

1.05

0.63

3.4

4.60

4.55

pmol/l

0.62

627

6053

Other injuries of lower limb, level unspecified

156

1.37

0.62

2.4

3.4

4.59

4.68

pmol/l

0.22

137

Erythrasma

1.71

0.62

3.2

4.4

4.06

4.92

pmol/l

—

Hereditary nephropathy, not elsewhere classified

1.62

0.62

10.0

2.9

4.61

4.39

pmol/l

—

Desensitization to allergens

157

1422

1.11

0.62

2.8

3.4

4.73

4.67

pmol/l

0.15

138

1279

Right hemicolectomy

106

938

1.14

0.61

3.2

3.3

4.20

4.40

pmol/l

1.30

806

Abnormalities of forces of labour

333

3556

0.93

0.61

3.2

3.3

4.53

4.51

pmol/l

0.08

305

3236

Mumps

463

1.20

0.61

2.4

3.4

4.33

4.57

pmol/l

1.48

408

Torticollis

317

1.24

0.61

3.6

3.5

4.17

4.75

pmol/l

2.83

284

conjunctival degenerations and deposits

390

1.22

0.61

3.5

3.2

4.40

4.54

pmol/l

0.42

339

Cardiovascular disorders originating in the perinatal period

1.57

0.60

1.5

2.2

5.15

5.29

pmol/l

—

Benign neoplasm: Vagina

282

1.26

0.60

3.4

3.0

4.59

4.57

pmol/l

0.05

246

Abscess of external ear

273

1.26

0.59

2.9

3.9

4.57

4.65

pmol/l

0.11

241

Neonatal jaundice from other and unspecified causes

212

1.29

0.59

2.2

2.9

5.63

5.21

pmol/l

0.49

194

Other obstructed labour

257

2387

1.08

0.59

3.2

3.3

4.59

4.49

pmol/l

0.62

237

2141

Acute alcohol intoxication ICD-9

492

1.19

0.59

2.4

3.5

4.00

4.50

pmol/l

3.17

440

Systemic sclerosis, icd10

530

1.18

0.59

1.8

3.1

4.18

4.50

pmol/l

2.15

465

Impetigo

109

970

1.13

0.59

4.7

3.4

4.68

4.71

pmol/l

0.11

102

874

Single delivery by forceps and vacuum extractor

522

3313

0.95

0.59

3.2

3.5

4.73

4.56

pmol/l

2.10

476

2955

Other spirochaetal diseases

849

8156

1.04

0.59

2.9

3.3

4.52

4.46

pmol/l

0.79

731

7268

Degenerative diseases of the nervous system

680

4769

1.05

0.58

2.7

3.1

4.25

4.29

pmol/l

0.62

566

4078

Carcinoma in situ of uteri, other/unspecified

150

1.37

0.58

5.3

3.3

4.55

4.59

pmol/l

0.08

133

Cicatricial alopecia [scarring hair loss]

141

1.37

0.58

3.7

3.4

4.27

4.54

pmol/l

0.63

119

Inflammatory bowel disease, strict (require KELA)

639

6103

1.05

0.58

3.3

3.4

4.56

4.55

pmol/l

0.08

572

5492

Postpartum haemorrhage due to anatomy

404

3816

1.06

0.57

3.7

3.5

4.54

4.62

pmol/l

1.14

356

3490

Membranous nephropathy

1.58

0.57

2.3

3.3

4.31

4.47

pmol/l

—

Transient global amnesia

195

1793

1.09

0.57

3.2

3.1

4.32

4.39

pmol/l

0.57

171

1558

Benign neoplasm: Connective and other soft tissue of abdomen

1.58

0.57

4.7

4.4

4.43

4.74

pmol/l

—

Reduction defects of upper limb

1.57

0.56

2.1

3.7

4.43

5.10

pmol/l

—

Other complications of labour and delivery, not elsewhere classified

460

4003

1.06

0.56

3.1

3.5

4.59

pmol/l

0.05

420

3617

Eclampsia

1.55

0.56

3.6

3.3

4.46

4.71

pmol/l

0.43

Hypertensive encephalopathy

1.56

0.56

2.4

3.0

4.03

4.25

pmol/l

—

Systemic sclerosis

533

1.18

0.56

1.8

3.1

4.18

4.48

pmol/l

1.97

471

Small plaque parapsoriasis

1.62

0.55

4.8

3.4

4.57

4.35

pmol/l

—

Other spirochaetal diseases

836

8044

1.04

0.55

2.9

3.3

4.52

4.46

pmol/l

0.79

720

7167

Malignant neoplasm of prostate

369

2076

1.06

0.55

3.1

3.2

4.48

4.42

pmol/l

0.40

328

1853

Dementia

898

5948

1.04

0.54

2.7

3.2

4.30

4.32

pmol/l

0.30

744

5138

Caries in Clefts patients

226

0.74

0.53

3.6

4.39

4.78

pmol/l

1.20

202

Cirrhosis of liver, NAS

845

1.13

0.53

2.5

3.3

3.76

4.42

pmol/l

8.61

739

Alcohol-induced acute pancreatitis

498

1.17

0.53

2.4

3.5

4.35

4.61

pmol/l

0.63

450

Other congenital malformations of nervous system

242

1.26

0.53

3.6

4.59

4.82

pmol/l

0.56

215

Sulfonylureas

631

5246

0.96

0.52

3.0

3.2

4.14

4.34

pmol/l

5.63

528

4556

Alzheimer disease

587

4103

1.05

0.52

2.6

3.1

4.26

4.28

pmol/l

0.23

488

3477

Burn and corrosion of wrist and hand

734

1.14

0.52

2.9

3.3

4.77

4.70

pmol/l

0.16

656

Spirochaetal infections, other/unspecified

832

8018

1.04

0.52

2.9

3.3

4.52

4.46

pmol/l

0.91

716

7144

Other infestations

297

1.23

0.51

1.8

3.3

4.39

4.48

pmol/l

0.26

258

Pedal cyclist injured in transport accident

587

5618

1.05

0.51

3.1

3.4

4.53

4.54

pmol/l

0.10

514

5023

Benign neoplasm of ovary

529

5053

1.05

0.51

3.2

4.46

4.43

pmol/l

0.27

470

4450

Congenital hydrocephalus

1.53

0.51

4.0

3.4

5.01

4.73

pmol/l

—

Cleft lip, lip and palate or palate

345

0.80

0.50

2.7

3.6

4.54

4.74

pmol/l

0.57

309

Other/unspecified postprocedural disorders of ear and mastoid process

1.56

0.49

1.6

2.2

4.31

4.32

pmol/l

—

Other infiltrative disorders of skin and subcutaneous tissue

1.48

0.49

3.4

2.8

4.31

4.53

pmol/l

0.44

Monocytic leukaemia

1.55

0.49

13.9

3.8

4.59

4.40

pmol/l

—

therapeutic use

521

1.16

0.49

3.2

3.1

4.10

4.43

pmol/l

1.95

453

Other congenital malformations of urinary system

1.47

0.49

2.6

4.0

5.03

4.81

pmol/l

0.26

Malignant neoplasm of colon

267

2503

1.07

0.49

2.9

4.23

4.38

pmol/l

1.99

229

2143

Sleep terrors [night terrors]

1.53

0.49

1.6

3.1

4.30

4.95

pmol/l

—

Malignant neoplasm of gum, including Hilmo

119

1.36

0.49

3.4

2.6

4.30

4.36

pmol/l

0.10

102

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

710

1.14

0.48

4.1

3.3

4.66

4.62

pmol/l

0.15

627

Other secondary coxarthrosis

625

1.14

0.48

2.5

3.2

4.35

4.51

pmol/l

0.75

551

Lyme disease

824

7954

1.04

0.48

3.0

3.3

4.52

4.46

pmol/l

0.84

709

7086

Abnormality of red blood cells

1.44

0.48

3.0

3.4

4.21

4.50

pmol/l

0.41

Use of interferon beta-1a

589

1.15

0.48

3.3

3.6

4.47

4.52

pmol/l

0.20

532

Obstructed labour due to malposition and malpresentation of fetus

823

7944

0.96

0.47

3.5

3.4

4.55

pmol/l

0.02

755

7196

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

111

1.37

0.47

3.8

2.8

4.27

4.32

pmol/l

0.09

Prolonged pregnancy

542

4947

0.96

0.47

3.2

3.5

4.57

pmol/l

0.02

493

4466

Other congenital malformations of digestive system

1.46

0.47

1.6

2.8

4.46

4.58

pmol/l

—

Benign neoplasm: Ciliary body

1.46

0.47

2.4

4.0

4.31

4.55

pmol/l

—

Disorder of carbohydrate metabolism, other/unspecified

1.45

0.47

2.1

3.2

4.26

4.54

pmol/l

—

Alcohol withdrawal state with delirium

110

997

1.11

0.46

2.3

3.5

4.40

4.47

pmol/l

0.28

893

IgA nephropathy (IgA glomerulonephritis)

412

1.17

0.46

3.4

3.5

3.91

4.65

pmol/l

4.27

367

Tetraplegia

103

1.38

0.46

2.9

4.71

4.46

pmol/l

0.28

Sickle-cell disorders

1.43

0.46

3.1

3.2

4.23

4.76

pmol/l

—

Malignant neoplasm of breast, including Hilmo

1493

9419

1.03

0.46

3.0

4.45

pmol/l

0.05

1332

8283

Carcinoma in situ of breast, intraductal

240

2252

1.07

0.46

2.8

3.2

4.33

4.45

pmol/l

1.24

208

1995

Malignant neoplasm of breast

1452

9229

1.03

0.45

3.0

4.45

pmol/l

0.05

1291

8108

Colorectal adenocarcinoma

315

3320

0.94

0.45

2.9

4.27

4.38

pmol/l

1.27

281

2865

Suppurative otitis media, unspecified

516

1.15

0.45

2.8

3.5

4.54

4.64

pmol/l

0.31

460

Medicines for HER+ breast cancer

1134

11051

0.97

0.45

3.1

3.2

4.50

4.41

pmol/l

1.50

1013

9718

Corrosions classified according to extent of body surface involved

1.69

0.44

2.2

2.4

4.88

4.69

pmol/l

—

Alzheimer’s disease (Early onset), excluding more controls

463

0.85

0.44

3.0

3.1

4.28

4.43

pmol/l

0.43

408

Intracerebral haemorrhage

216

2020

1.07

0.44

3.3

3.1

4.16

4.39

pmol/l

3.21

186

1745

Foreign body on external eye

285

2691

1.06

0.44

3.4

4.62

4.57

pmol/l

0.33

257

2415

Other endophthalmitis

1.43

0.44

2.7

4.51

4.57

pmol/l

0.04

Dementia due to Parkinson's disease

275

1.21

0.44

2.5

2.7

4.42

4.24

pmol/l

0.58

238

L04AC Interleukin inhibitors

141

1299

1.09

0.44

2.4

3.3

4.46

4.57

pmol/l

0.80

125

1167

Arthropathic psoriasis

267

2518

1.06

0.44

2.7

3.4

4.49

4.50

pmol/l

0.03

231

2254

Hereditary lymphedema

1.62

0.43

4.6

3.3

4.08

4.52

pmol/l

—

Other early complications of trauma

0.00

0.43

0.0

2.7

—

4.27

—

Congenital nasolacrimal duct obstruction or stenosis

0.65

0.43

2.5

2.8

4.32

5.07

pmol/l

—

Other disorders of skin and subcutaneous tissue related to radiation

1.61

0.43

8.0

3.4

4.78

4.45

pmol/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.64

0.43

3.7

3.5

4.62

4.60

pmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1491

9419

1.03

0.43

3.0

4.45

pmol/l

0.05

1330

8283

Severe visual impairment, binocular

1.45

0.42

1.4

3.0

4.47

4.36

pmol/l

—

Labyrinthine dysfunction

0.00

0.42

0.0

4.0

—

4.32

—

Pedal cyclist injured in noncollision transport accidents

277

2619

1.06

0.42

3.0

3.3

4.52

4.56

pmol/l

0.24

244

2342

Cerebral oedema

1.55

0.42

1.0

3.6

5.04

4.63

pmol/l

—

Endometroid carcinoma of ovary

114

1.34

0.42

4.0

2.7

4.39

4.46

pmol/l

0.15

Foreign body or object entering through skin

130

1198

1.09

0.41

2.5

3.5

4.48

4.60

pmol/l

0.96

118

1069

Donors of organs and tissues

278

1.20

0.41

2.4

3.5

4.43

4.63

pmol/l

0.61

253

Bacterial meningitis

644

1.12

0.41

3.1

3.4

4.33

4.58

pmol/l

0.91

562

Sequelae of poliomyelitis

101

0.69

0.40

1.3

2.4

4.36

4.30

pmol/l

—

Malignant neoplasm of thymus, including Hilmo

1.33

0.40

2.5

3.5

4.13

4.64

pmol/l

—

Medical treatment for female infertility

832

8023

1.03

0.40

3.6

3.4

4.51

4.57

pmol/l

0.84

756

7294

Ulcerative enterocolitis

664

1.12

0.40

3.8

3.5

4.46

4.57

pmol/l

0.51

594

1.45

0.40

4.2

2.5

4.86

5.25

pmol/l

—

Dementia in Alzheimer disease

285

2280

1.06

0.40

2.7

3.0

4.26

4.24

pmol/l

0.08

230

1930

Exposure to uncontrolled fire in building or structure

115

1.32

0.39

2.3

3.7

4.40

4.58

pmol/l

0.38

102

Toxic effect of other noxious substances eaten as food

1.39

0.39

3.7

3.0

4.34

4.58

pmol/l

—

Injury of nerves at hip and thigh level

1.37

0.39

3.0

3.5

4.59

4.42

pmol/l

—

Postpartum haemorrhage due to retained placenta

464

4459

1.04

0.39

3.7

3.4

4.63

4.56

pmol/l

0.46

422

4073

Cleft lip and cleft lip and palate

136

0.73

0.38

4.4

3.3

4.09

4.87

pmol/l

—

122

Syndactyly

1.35

0.38

2.7

3.4

4.43

4.83

pmol/l

—

Benign neoplasm: Uterine tubes and ligaments

112

0.70

0.38

20.8

3.0

5.83

4.51

pmol/l

—

Apocrine sweat disorders, other sweat gland disorders

1.42

0.38

2.5

3.0

4.67

4.52

pmol/l

—

Adalimumab

256

2427

1.06

0.37

2.7

3.4

4.52

4.57

pmol/l

0.26

236

2180

Systemic atrophies primarily affecting the central nervous system

648

1.12

0.37

2.4

3.3

4.32

4.47

pmol/l

0.55

565

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

134

1442

0.93

0.36

3.1

2.9

4.35

4.40

pmol/l

0.26

126

1238

Malignant neoplasm of other and unspecified parts of mouth

1.28

0.36

2.4

3.0

4.19

4.37

pmol/l

—

Alzheimer disease, including avohilmo

694

4733

1.03

0.36

2.6

3.1

4.25

4.29

pmol/l

0.65

577

4029

Generalized epilepsy, strict definition

470

1.14

0.36

2.2

3.5

4.55

4.76

pmol/l

0.74

419

Exposure to uncontrolled fire, not in building or structure

1.43

0.36

5.7

3.9

4.44

4.55

pmol/l

—

Rickettsioses

1.43

0.36

6.0

4.5

4.73

4.67

pmol/l

—

Small kidney of unknown cause

1.43

0.36

2.5

3.5

4.27

4.41

pmol/l

—

Biological medication for rheuma

482

4647

1.04

0.35

2.8

3.4

4.55

4.56

pmol/l

0.02

444

4192

Unicornuate uterus

0.68

0.34

2.7

4.3

4.80

4.87

pmol/l

—

Syndactyly

1.36

0.34

1.7

3.3

4.67

4.89

pmol/l

—

Unspecified event, undetermined intent

501

1.12

0.34

2.4

3.4

4.71

4.65

pmol/l

0.17

443

Molar incisor enamel hypoplasia

740

1.10

0.33

3.0

3.4

4.91

pmol/l

0.02

678

Tumor necrosis factor alpha inhibitors

433

4172

1.04

0.33

2.8

3.4

4.56

pmol/l

0.01

403

3759

Pneumoconiosis due to dust containing silica

1.32

0.33

2.3

3.8

4.30

4.36

pmol/l

—

Acute appendicitis, with complications

435

4513

0.96

0.33

3.8

3.4

4.45

4.48

pmol/l

0.27

393

4019

Small cell lung cancer

238

1.18

0.32

4.9

3.0

4.05

4.37

pmol/l

0.69

198

Small cell lung cancer, including Hilmo

238

1.18

0.32

4.9

3.0

4.05

4.37

pmol/l

0.69

198

Contact with sharp object, undetermined intent

436

1.13

0.32

2.8

3.5

4.65

4.69

pmol/l

0.08

390

Hypoplasia of dental enamel , including avohilmo

701

1.10

0.32

3.1

3.4

4.90

4.91

pmol/l

0.02

644

Labyrinthine fistula

1.37

0.32

2.9

2.7

3.64

4.42

pmol/l

—

Hypertension, portal

1.37

0.32

7.1

3.2

3.46

4.44

pmol/l

—

Other demyelinating diseases of the central nervous system

102

945

1.09

0.32

3.1

3.4

4.41

4.57

pmol/l

1.28

850

Congenital ovarian cysts

144

1352

1.07

0.32

3.2

3.3

4.49

4.53

pmol/l

0.25

130

1212

Other congenital malformations of integument

1.34

0.31

3.1

3.4

4.33

4.46

pmol/l

—

CR(E)ST syndrome

343

1.15

0.31

2.1

3.0

4.12

4.47

pmol/l

1.48

300

Other sideroblastic anaemias

1.34

0.31

3.9

3.5

3.34

4.40

pmol/l

—

Impacted maxillary molar

174

1644

1.06

0.31

3.2

3.4

4.80

4.71

pmol/l

0.55

164

1479

Use of entacapone

0.71

0.31

2.0

3.0

4.49

4.25

pmol/l

—

Malignant neoplasm of oral cavity

456

1.12

0.31

2.5

2.9

4.13

4.51

pmol/l

1.31

395

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

138

1.24

0.31

2.1

3.4

4.51

4.49

pmol/l

0.02

122

Adenocarcinoma and papilloma adenocarcinoma of rectum

129

1378

0.93

0.31

3.0

2.9

4.33

4.40

pmol/l

0.32

121

1183

Dementia, including avohilmo

953

6395

1.03

0.31

2.7

3.2

4.29

4.32

pmol/l

0.45

787

5542

Endovascular or surgical operations to intracerebral aneurysms

118

1262

0.93

0.30

2.9

3.4

4.54

4.46

pmol/l

0.45

103

1109

Carcinoma in situ of cervix uteri

333

3204

1.04

0.30

3.6

3.3

4.66

4.54

pmol/l

0.96

293

2875

Cleft hard palate NOS

107

0.74

0.30

2.6

3.3

4.82

4.86

pmol/l

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

326

1.15

0.29

3.2

3.5

4.55

4.67

pmol/l

0.45

288

Effects of other external causes

573

1.10

0.29

2.6

3.5

4.88

4.73

pmol/l

0.34

521

Malignant neoplasm of vagina, including Hilmo

1.24

0.29

3.0

3.4

4.90

4.43

pmol/l

—

Viral agents as the cause of diseases classified to other chapters

526

1.11

0.29

2.6

3.4

4.49

4.59

pmol/l

0.51

464

Patellar tendinitis

302

0.86

0.29

2.9

3.7

4.32

4.76

pmol/l

1.36

274

Other obstetric trauma

167

1762

0.94

0.29

3.4

3.3

4.62

4.56

pmol/l

0.26

151

1596

Contact with lifting and transmission devices, not elsewhere classified

280

0.85

0.28

3.8

3.6

4.52

4.71

pmol/l

0.51

251

Rubella [German measles]

422

1.12

0.28

3.7

3.8

4.52

4.63

pmol/l

0.38

390

Foreign body granuloma of skin and subcutaneous tissue

1.25

0.27

1.6

3.4

4.67

4.66

pmol/l

—

Benign neoplasm of other and unspecified female genital organs

1060

0.93

0.27

5.8

3.2

4.59

4.45

pmol/l

0.52

929

Other primary thrombocytopenia

1.22

0.27

1.4

4.0

4.67

4.55

pmol/l

—

Motorcycle rider injured in noncollision transport accidents

538

1.10

0.27

2.9

3.6

4.84

4.80

pmol/l

0.09

492

Sleepwalking [somnambulism]

0.68

0.27

1.4

4.0

4.58

4.86

pmol/l

—

Typhoid and paratyphoid fevers

1.28

0.27

2.6

3.0

4.47

4.43

pmol/l

0.07

Arnold-Chiari syndrome

225

1.17

0.27

3.9

3.8

4.64

4.84

pmol/l

0.43

202

Tuberculosis

884

0.93

0.26

2.5

3.3

4.46

4.35

pmol/l

0.28

759

Accidental poisoning by and exposure to alcohol

367

1.12

0.26

2.0

3.6

4.70

pmol/l

0.00

330

Use of donepezil

322

3195

0.96

0.26

2.6

3.0

4.43

4.26

pmol/l

2.45

249

2702

Crohn's disease of large intestine

120

1130

1.07

0.26

3.7

3.3

4.54

4.58

pmol/l

0.15

104

1016

Ill-defined and unknown causes of mortality

129

1217

1.06

0.26

3.2

3.1

4.21

4.36

pmol/l

0.94

111

1050

Other sexually transmitted chlamydial diseases

294

2833

1.04

0.26

3.0

3.4

4.88

4.71

pmol/l

0.83

251

2573

Prepatellar bursitis

695

1.08

0.25

3.1

3.7

4.59

4.50

pmol/l

0.41

629

Malignant neoplasm of ureter, including Hilmo

1.27

0.24

2.9

2.7

3.46

4.36

pmol/l

2.34

Burn and corrosion of hip and lower limb, except ankle and foot

465

1.10

0.24

3.2

3.5

4.72

4.67

pmol/l

0.07

411

Use of selegiline

667

1.08

0.24

2.5

3.3

4.40

4.34

pmol/l

0.24

580

Melanoma in situ of scalp and neck

1.37

0.24

3.6

3.2

4.50

4.38

pmol/l

—

Otosclerosis

168

1603

1.05

0.24

2.9

3.4

4.44

pmol/l

0.01

144

1422

Choroidal haemorrhage and rupture

1.33

0.23

2.2

3.3

4.54

4.56

pmol/l

—

Assault by sharp object

294

1.13

0.23

1.8

3.6

4.37

4.76

pmol/l

1.82

270

Aortic arch syndrome [Takayasu]

1.30

0.23

5.8

2.8

4.78

4.40

pmol/l

—

Other cestode infections

1.29

0.23

6.4

3.0

4.46

4.33

pmol/l

—

Premature separation of placenta [abruptio placentae]

699

1.08

0.23

3.0

3.4

4.38

4.52

pmol/l

0.75

629

Pleural plaque

117

1106

1.06

0.23

4.0

3.2

4.21

4.29

pmol/l

0.39

947

Diving or jumping into water causing injury other than drowning or submersion

0.76

0.23

1.0

4.0

4.57

4.67

pmol/l

—

Cyst of spleen

1.27

0.23

5.8

3.7

4.75

4.54

pmol/l

—

Malignant neoplasm of palate, including Hilmo

0.74

0.23

2.0

2.8

4.23

4.42

pmol/l

—

Malignant neoplasm of rectum, including Hilmo

201

1929

1.04

0.22

3.0

2.9

4.34

4.40

pmol/l

0.40

180

1672

Other parasitologically confirmed or unspecified malaria

1.23

0.22

5.0

4.36

4.43

pmol/l

—

Malignant neoplasm of colon, including Hilmo

342

3313

1.03

0.22

2.8

2.9

4.28

4.39

pmol/l

1.45

300

2867

Other fluke infections

0.00

0.22

0.0

6.1

—

4.52

—

Injury of nerves at wrist and hand level

690

1.08

0.22

2.6

3.6

4.56

4.65

pmol/l

0.27

625

Freckles

0.00

0.22

0.0

3.8

—

4.47

—

Brucellosis

0.00

0.22

0.0

4.8

—

4.48

—

Pleural plaque without asbestos

410

1.10

0.22

4.0

2.9

3.94

4.25

pmol/l

1.51

352

Fibrosarcoma

107

1.23

0.22

3.6

3.1

4.59

4.73

pmol/l

0.25

Kissing spine

1.20

0.22

1.2

3.7

4.02

4.64

pmol/l

—

Acquired ichthyosis

0.00

0.22

0.0

5.6

—

4.23

—

N06DA Anticholinesterases

615

4958

0.98

0.22

2.5

3.1

4.37

4.28

pmol/l

1.65

501

4233

Use of anticholinesterases

615

4958

0.98

0.22

2.5

3.1

4.37

4.28

pmol/l

1.65

501

4233

Toxic effect of contact with venomous animals

856

1.07

0.22

3.6

3.3

4.47

4.56

pmol/l

0.50

757

Echinococcosis

0.00

0.22

0.0

3.1

—

4.53

—

Pedal cyclist injured in collision with motor vehicle

653

1.08

0.21

3.2

3.3

4.60

4.63

pmol/l

0.10

581

Other disorders of breast and lactation associated with childbirth

528

1.09

0.21

3.3

4.63

4.61

pmol/l

0.05

471

Moderate visual impairment, monocular

1.27

0.21

3.6

4.33

4.55

pmol/l

—

Unspecific neurodegenerative disorder

823

5519

1.02

0.21

2.6

3.2

4.30

pmol/l

0.01

690

4728

Otorrhoea

1.27

0.20

3.3

3.6

4.10

4.72

pmol/l

—

Contact with nonpowered hand tool

683

1.07

0.20

4.3

3.6

4.51

4.61

pmol/l

0.47

616

1.24

0.20

3.8

3.6

5.09

4.56

pmol/l

—

Cholesteatoma of middle ear

878

1.06

0.20

3.4

4.33

4.46

pmol/l

0.75

761

Respiratory distress of newborn

196

1.14

0.20

3.2

2.8

5.71

5.24

pmol/l

1.12

178

Sequelae of poliomyelitis

114

0.78

0.20

1.7

2.7

4.34

pmol/l

—

101

Multiple delivery

259

2674

0.97

0.20

3.2

3.4

4.48

4.47

pmol/l

0.09

235

2373

Benign neoplasm: Eye, unspecified

1.25

0.19

1.7

3.9

4.55

4.46

pmol/l

—

Need for immunization against other single viral diseases

332

0.90

0.19

3.5

3.4

4.22

4.64

pmol/l

1.70

294

Lumbosacral plexus disorders

1.20

0.18

1.6

3.3

4.19

4.37

pmol/l

—

Subarachnoid haemorrhage

186

1928

0.96

0.18

3.0

3.2

4.44

4.43

pmol/l

0.07

168

1681

Malignant neoplasm of pancreas

929

0.95

0.18

2.3

2.9

4.09

4.40

pmol/l

1.72

791

Perineal laceration during delivery

648

5319

1.02

0.18

3.5

3.4

4.61

4.59

pmol/l

0.17

592

4797

Colon adenocarcinoma

191

1843

1.04

0.18

3.0

2.8

4.23

4.37

pmol/l

1.41

165

1559

Bullous pemphigoid

281

1.11

0.18

2.7

3.0

3.94

4.38

pmol/l

1.49

242

Malignant neoplasm of breast, ER-positive, including Hilmo

1036

7876

1.02

0.17

3.1

3.0

4.48

4.44

pmol/l

0.53

922

6889

Congenital malformations of ear causing impairment of hearing

0.76

0.17

2.4

3.3

4.28

4.93

pmol/l

—

Tuberculosis, wide

116

1109

1.05

0.17

2.4

3.3

4.34

4.38

pmol/l

0.10

107

952

0.71

0.17

1.4

3.0

4.30

4.71

pmol/l

—

Neuroendocrine tumor and carcinoma of stomach

0.76

0.17

2.4

2.9

4.38

4.35

pmol/l

—

Peptic ulcer

129

1.17

0.17

2.2

3.3

4.56

4.38

pmol/l

0.31

115

Mucinous and mucinous cystic tumor

101

1.20

0.17

8.4

3.6

4.62

4.50

pmol/l

0.21

Malignant neoplasm of breast, HER2-negative

1410

9115

1.01

0.17

3.0

4.44

4.45

pmol/l

0.05

1251

8005

Other disorders of carbohydrate metabolism

1.18

0.17

2.1

3.4

4.26

4.57

pmol/l

—

Degenerative conditions of globe

1.17

0.16

2.9

2.6

4.55

4.47

pmol/l

—

Hair colour and hair shaft abnormalities

1.15

0.16

8.9

3.2

4.19

4.41

pmol/l

—

Oesophageal varices

628

0.94

0.16

2.9

3.5

3.80

4.48

pmol/l

3.51

543

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.12

0.16

6.5

3.6

4.64

4.50

pmol/l

—

Universal erythroderma, KELA reimbursement

214

0.88

0.16

2.1

3.7

3.73

4.60

pmol/l

2.37

192

Congenital nasolacrimal duct obstruction or stenosis

0.76

0.16

2.5

4.32

5.21

pmol/l

—

Deaf mutism, not elsewhere classified

1.22

0.16

3.5

3.3

4.35

4.50

pmol/l

—

Injury of intra-abdominal organs

448

1.08

0.15

3.5

3.4

4.40

4.69

pmol/l

0.81

399

Acute hepatitis B

1.13

0.15

4.4

4.0

4.70

4.66

pmol/l

—

Delivery

1389

7247

1.01

0.15

3.3

3.2

4.52

4.47

pmol/l

0.97

1238

6329

L02BX Other hormone antagonists and related agents

575

1.06

0.15

3.4

3.5

4.43

4.30

pmol/l

0.36

504

Adhesive middle ear disease

313

1.09

0.15

2.4

3.5

5.09

4.67

pmol/l

0.24

278

Benign neoplasm: Vulva

492

0.93

0.15

5.7

3.0

4.36

4.47

pmol/l

0.43

430

Other and unspecified disease of Bartholin gland

684

1.06

0.14

3.2

3.4

4.45

4.49

pmol/l

0.15

602

Fibrosarcoma, including Hilmo

131

1.15

0.14

3.8

3.1

4.56

4.73

pmol/l

0.36

115

Orthopaedic devices associated with adverse incidents

285

1.09

0.14

2.9

3.1

4.17

4.38

pmol/l

0.59

244

Thiamine deficiency

1.20

0.14

3.7

3.9

4.41

4.64

pmol/l

—

Bus occupant injured in other and unspecified transport accidents

122

1.16

0.14

4.9

3.3

4.83

4.49

pmol/l

0.28

108

Inguinal hernia

1372

9077

1.01

0.14

2.9

3.4

4.47

4.52

pmol/l

0.78

1219

8080

Malignant neoplasm of pancreas, including Hilmo

120

1244

0.96

0.13

2.7

2.8

4.19

4.40

pmol/l

0.92

104

1062

Caught, crushed, jammed or pinched in or between objects

102

981

1.04

0.13

2.3

3.4

4.91

4.63

pmol/l

1.20

884

Leiomyosarcoma, including Hilmo

142

1.13

0.13

3.6

3.3

4.24

4.53

pmol/l

0.84

122

Ankylosing spondylitis, strict definition

925

1.04

0.12

2.2

3.4

4.68

4.61

pmol/l

0.11

835

Arthropod-borne viral fevers and viral haemorrhagic fevers

184

1887

0.97

0.11

3.7

3.4

4.52

4.47

pmol/l

0.27

170

1678

Psoriatic arthropathies, ICD10

243

2378

1.02

0.11

2.6

3.4

4.48

pmol/l

0.00

214

2136

Small cell lung cancer, helper endpoint

259

1.08

0.11

4.9

3.5

4.05

4.40

pmol/l

0.78

224

Tuberculosis, IBD comorbidity

111

1074

1.03

0.11

2.3

3.3

4.33

4.37

pmol/l

0.11

102

924

Inhalation and ingestion of food causing obstruction of respiratory tract

134

1.12

0.11

4.3

2.8

4.54

4.56

pmol/l

0.03

115

Alzheimer’s disease, strict definition

429

3480

1.02

0.11

2.4

3.1

4.29

4.27

pmol/l

0.14

351

2959

Laparoscopic right hemicolectomy

957

1.04

0.11

3.0

3.2

4.31

4.36

pmol/l

0.23

831

Gonococcal infection

751

1.04

0.10

3.7

3.3

4.36

4.59

pmol/l

1.51

669

Hereditary sideroblastic anaemia

1.14

0.10

1.6

2.7

4.16

4.59

pmol/l

—

Use of galantamine

107

1103

0.97

0.10

2.8

4.47

4.27

pmol/l

1.53

922

General- and plastic-surgery devices associated with adverse incidents

1.12

0.10

1.0

3.8

3.92

4.81

pmol/l

—

Cerebral arteritis

1.12

0.10

3.6

3.4

4.10

4.62

pmol/l

—

Leiomyosarcoma

106

1.14

0.10

3.2

3.5

4.30

4.52

pmol/l

0.48

Immunodeficiency associated with other major defects

1.09

0.10

6.0

3.0

4.66

4.84

pmol/l

—

Obstructed labour due to maternal pelvic abnormality

469

4750

0.99

0.09

3.1

3.3

4.43

4.46

pmol/l

0.33

417

4252

Congenital malformations of nose

1.07

0.09

3.0

2.6

4.44

4.57

pmol/l

—

Congenital ichthyosis

1.04

0.09

4.4

3.4

4.80

4.64

pmol/l

—

Oher contracture of tendon (sheath)

1.04

0.09

2.0

3.1

3.30

4.25

pmol/l

—

Other/unspecified seropositive rheumatoid arthritis

681

6878

0.99

0.09

2.9

3.3

4.28

4.43

pmol/l

4.03

604

6044

Abscess of Bartholin gland

754

1.04

0.09

3.0

3.5

4.39

4.53

pmol/l

0.55

677

Chorioretinal scars

1.12

0.09

1.3

3.4

4.43

4.45

pmol/l

—

Pediculosis and phthiriasis

1.10

0.09

1.3

4.3

4.85

4.74

pmol/l

—

Rare circulating lymphoid malignancy

1.04

0.08

2.0

2.4

3.95

4.29

pmol/l

—

Mucinous and mucinous cystic tumor of rectum

0.81

0.08

5.4

3.1

4.63

4.36

pmol/l

—

Ulcerative rectosigmoiditis

187

1835

1.02

0.08

3.3

4.50

4.53

pmol/l

0.18

168

1649

Pneumonia due to Haemophilus influenzae

1.10

0.08

3.0

3.2

4.23

4.52

pmol/l

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

1.10

0.08

9.1

3.4

4.26

4.58

pmol/l

—

Actinomycosis

1.08

0.08

3.6

4.52

4.66

pmol/l

—

Other psoriatic arthropathies

237

2332

1.02

0.08

2.6

3.4

4.48

pmol/l

0.01

208

2092

Generalized pustular psoriasis

0.85

0.08

1.3

3.3

4.61

4.58

pmol/l

—

Defect, injury or illness of lumbar spine

0.80

0.08

1.5

3.3

4.10

4.72

pmol/l

—

Ulcerative colitis (strict definition, require KELA)

411

4157

0.99

0.07

3.4

4.54

pmol/l

0.00

370

3733

Viral haemorrhagic fevers, not elsewhere classified/unspecified

157

1541

1.02

0.07

4.0

3.4

4.56

4.50

pmol/l

0.33

145

1371

Vaginal lichen planus

1.06

0.07

2.3

3.3

4.24

4.43

pmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

672

6774

0.99

0.07

2.9

3.3

4.27

4.43

pmol/l

4.25

595

5958

Feeding problems of newborn

1.04

0.07

3.0

3.1

5.13

5.19

pmol/l

—

Polyarteritis nodosa

101

0.89

0.06

1.3

2.9

4.43

4.30

pmol/l

—

Maternal care for known or suspected disproportion

146

1435

1.02

0.06

3.5

3.4

4.52

4.51

pmol/l

0.06

130

1283

Malignant neoplasm of breast, HER-positive

1003

7775

1.01

0.05

3.1

3.0

4.49

4.44

pmol/l

0.59

891

6800

Malignant neoplasm of rectum

142

1397

1.02

0.05

3.3

2.9

4.34

4.40

pmol/l

0.26

131

1198

Open wound of shoulder and upper arm

356

1.04

0.05

3.9

3.5

4.91

4.65

pmol/l

0.49

319

L02BB Anti-androgens

959

0.98

0.05

3.3

3.4

4.34

4.25

pmol/l

0.36

818

Pterygium

416

1.04

0.05

2.6

3.2

4.53

4.44

pmol/l

0.26

364

Seropositive rheumatoid arthritis, wide

693

6967

0.99

0.04

2.9

3.3

4.28

4.43

pmol/l

4.13

614

6123

Single spontaneous delivery

1360

7227

1.00

0.04

3.3

3.2

4.51

4.47

pmol/l

0.83

1206

6310

Mandibular prognathia AND surgery (LeFortI or BSSO)

109

0.91

0.04

1.7

3.9

4.58

4.78

pmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

445

4475

0.99

0.03

3.5

3.4

4.52

4.53

pmol/l

0.15

400

4016

Sulfasalazine

764

7671

1.00

0.03

2.7

3.4

4.36

4.51

pmol/l

4.35

687

6813

Colorectal cancer

417

4056

1.01

0.03

3.0

2.9

4.27

4.39

pmol/l

1.86

366

3521

ILD medications: pirfenidone

128

0.94

0.02

1.2

2.7

4.08

4.32

pmol/l

—

108

Effects of air pressure and water pressure

1.08

0.02

4.0

4.2

4.33

4.83

pmol/l

—

Abnormal spermatozoa

147

1459

1.01

0.02

3.3

3.6

4.36

pmol/l

0.02

131

1293

Nontraumatic intracranial haemmorrhage

378

3790

1.00

0.01

3.1

3.2

4.30

4.39

pmol/l

1.10

332

3288

Ulcerative colitis (strict definition, all Crohn cases excluded)

351

3499

1.00

0.01

3.3

3.4

4.60

4.53

pmol/l

0.63

316

3125

Pleural plaque with presence of asbestos

783

1.01

0.01

4.6

3.5

4.33

4.28

pmol/l

0.16

669

Benign neoplasm: Lip

354

1.02

0.00

4.8

3.4

4.51

4.55

pmol/l

0.12

306

L02BG Aromatase inhibitors

903

9023

1.00

0.00

3.1

3.2

4.51

4.39

pmol/l

1.72

805

7905

Normal-pressure hydrocephalus

696

0.99

0.00

3.1

3.0

4.32

4.31

pmol/l

0.01

591

Crowding of teeth, including avohilmo

243

2014

1.00

0.00

3.1

3.3

4.78

4.80

pmol/l

0.16

221

1825

Long labour

922

7895

1.00

0.00

3.3

3.4

4.54

4.55

pmol/l

0.04

833

7134

Motorcycle rider injured in other and unspecified transport accidents

106

1061

1.00

0.00

3.7

3.4

4.82

4.71

pmol/l

0.56

958

Carcinoma in situ of breast, other/unspecified

275

0.98

0.00

2.1

2.9

4.52

4.46

pmol/l

0.08

238

Other sexually transmitted chlamydial diseases

182

1821

1.00

0.00

2.7

3.4

4.85

4.67

pmol/l

0.54

148

1652

Exclusion endpoint for supernumerary teeth

257

1.01

0.00

3.2

3.4

4.64

4.85

pmol/l

0.50

231

Unspecified parasitic disease

138

1.02

0.00

4.0

3.2

4.26

4.57

pmol/l

0.45

126

Carcinoma in situ of cervix uteri, exocervix

192

0.99

0.00

4.5

3.7

4.61

4.64

pmol/l

0.05

172

Degeneration of nervous system due to alcohol

272

0.99

0.00

2.6

3.7

4.10

4.51

pmol/l

1.00

243

101

0.99

0.00

3.5

4.12

4.73

pmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

129

1.01

0.00

5.0

3.1

4.43

4.52

pmol/l

0.13

112

Pedal cyclist injured in other and unspecified transport accidents

251

2513

1.00

0.00

3.0

3.3

4.49

4.54

pmol/l

0.32

215

2243

Degeneration of the brain due to alcohol

269

1.00

0.00

2.6

3.7

4.10

4.50

pmol/l

0.98

241

Golimumab

801

1.00

0.00

2.8

3.3

4.77

4.61

pmol/l

0.22

715

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

402

4019

1.00

0.00

3.4

4.55

4.54

pmol/l

0.05

362

3606

Blood alcohol or alcohol intoxication level

463

0.99

0.00

3.3

3.5

4.93

4.71

pmol/l

0.75

419

Noise effects on inner ear

535

1.01

0.00

3.2

3.7

4.56

4.51

pmol/l

0.16

487

Systemic sclerosis,strict definition

204

0.98

0.00

1.6

3.1

4.43

4.52

pmol/l

0.22

183

Complications specific to multiple gestation

125

0.96

0.00

5.5

3.8

4.29

4.64

pmol/l

0.77

111

Discontinuity and dislocation of ear ossicles

102

0.98

0.00

2.7

3.6

4.52

4.81

pmol/l

—

Alcoholic cardiomyopathy

0.91

0.00

5.0

4.0

4.66

4.74

pmol/l

—

Immobility syndrome (paraplegic)

0.00

0.0

3.0

—

4.74

—

Other accidental hanging and strangulation

0.00

0.0

3.2

—

4.87

—

Glanders and melioidosis

0.00

0.0

4.3

—

4.66

—

Other hyperphenylalaninaemias

0.00

0.0

1.6

—

4.78

—

Bullous disorders in diseases classified elsewhere

0.00

0.0

9.4

—

4.80

—

Traumatic anuria

0.00

0.0

4.5

—

4.50

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

0.0

6.2

—

4.22

—

Keratoderma in diseases classified elsewhere

0.00

0.0

6.8

—

5.00

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

1.2

—

4.38

—

Other helminthiases

0.94

0.00

5.8

3.5

4.84

4.49

pmol/l

—

Anthrax

0.00

-0.00

0.0

5.8

—

4.53

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

4.0

—

4.56

—

Malignant neoplasm of gum

0.96

-0.00

4.0

2.6

4.08

4.46

pmol/l

—

Other and unspecified acantholytic disorders

0.00

-0.00

0.0

4.3

—

4.57

—

Alopecia mucinosa

0.00

-0.00

0.0

4.0

—

4.63

—

Listeriosis

0.97

-0.00

5.4

3.0

3.77

4.29

pmol/l

—

Sequelae of transport accidents

0.89

-0.00

5.1

4.0

4.51

4.54

pmol/l

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

8.8

—

4.32

—

Melanocytic naevi of ear and external auricular canal

120

1.00

-0.00

4.8

3.4

4.47

4.68

pmol/l

0.26

108

Heredofamilial amyloidosis, unspecified

0.00

-0.00

0.0

1.6

—

4.13

—

Niacin deficiency [pellagra]

0.00

-0.00

0.0

1.6

—

4.58

—

Pinta [carate]

0.00

-0.00

0.0

1.4

—

4.01

—

Disorders of glycosaminoglycan metabolism

0.00

-0.00

0.0

2.6

—

4.49

—

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

3.7

—

4.47

—

Carcinoma in situ of oral cavity, oesophagus and stomach

1.01

-0.00

1.5

2.7

3.98

4.28

pmol/l

—

Carcinoma in situ of prostate

0.87

-0.00

4.7

3.5

4.08

4.38

pmol/l

—

Carcinoma in situ of other/unspecified female genital organs

0.00

-0.00

0.0

3.9

—

4.53

—

Actinomycosis

1.02

-0.00

4.0

3.6

4.18

4.72

pmol/l

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.96

-0.00

3.7

2.5

5.48

5.21

pmol/l

—

Sclerodactyly

0.00

-0.00

0.0

5.2

—

4.67

—

Fetus and newborn affected by maternal use of alcohol

0.00

-0.00

0.0

5.5

—

6.50

—

Carcinoma in situ of other/unspecified digestive organs

0.00

-0.00

0.0

5.9

—

3.86

—

Schistosomiasis [bilharziasis]

0.93

-0.00

4.0

3.1

4.69

4.64

pmol/l

—

Malignant neoplasms of independent (primary) multiple sites

0.00

-0.00

0.0

4.0

—

3.99

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

7.4

—

4.28

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS